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§ 1.1 Introduction. 
Iron is a trace element essential to every life form (4,139), with the possible exception of 
a few microorganisms (e.g. Lactobacillus plantarum) (II). Iron is the sixth most abundant 
element in the universe, the fourth most abundant element in the earth's crust and as a 
metal only second to aluminium (176,211). 
Despite its overwhelming presence in the environment, the biological availability of iron is 
seriously impeded by the fact that, at neutral pH, iron is nearly insoluble (solubility 
product Fe(OH)3 ::::: 4 x 10-38). In order to meet their needs, micro-organisms and plants 
secrete for iron transport a variety of high-affInity iron binding compounds (siderophores), 
capable of ehelating iron (139). Iron-loaded siderophores either (re-)enter the cell by means 
of a receptor mediated process, or release their iron to a "membrane-associated iron 
shuttle" (139). 
Humans, on the other hand, do not possess such a highly specialized iron sequestering 
system and their metabolic needs can only be met by dietary intake. However, iron uptake 
in the digestive tract is rather inefficient, due to: (i) the low solubility of inorganic iron, 
(ii) the preferential mucosal uptake of iron in its ferrous state, and (iii) insuffIcient iron ab-
sorption from vegetable proteins. Furthermore, (iv) a major part of the world population 
has limited access to animal proteins (19,31,35,177). Clearly, these factors contribute to the 
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global problem of nutritional iron deficiency. It is estimated that between 500 and 600 
million people (mainly in developing countries) suffer from iron deficiency anaemia and 
this is probably a very conservative estimate (19,175). 
Although iron is essential to life, the opposite might also be true (128). There is an ever 
increasing number of publications on the subject of iron and its catalytic role in the 
formation of oxygcn free radicals (46,88,91,128). These radicals are capable of damaging 
DNA, proteins and lipids alike (98) and there is a growing list of diseases in which the 
involvement of oxygen free radicals is proven, suspected or hypothetized (see § 1.6). 
§ 1.2 The role of iron in biological processes. 
Iron, as an element essential to life, is ubiquitous in the mammalian physiology. In each 
cell a variety of iron containing proteins and enzymes can be found, especially at the inner 
membrane of mitochondria, where they have key-functions in the process known as 
oxidative phosphorylation. The iron containing proteins and enzymes can be divided in 
three groups (130,211): 
-1- Iron-tetrapyrrole complexes (haem proteins): 
these proteins characteristically consist of a protein linked to a porphyrin group. Major 
mammalian constituents of this group are: haemoglobin, myoglobin, cytochromes, catalase 
and peroxidase. 
-2- Iron-sulphur proteins: 
in these proteins iron is complexed to sulphur, more specifically to the sulfhydryl groups of 
cysteine residues. Examples of these iron-sulphur proteins are: aconitase, xanthine oxidase 
and ferredoxins (e.g. adrenodoxin). 
-3- Iron proteins (nonhaem, nonsulphur): 
a hcterogcneous group of proteins, in which iron is linked neither to sulpur nor porphyrin. 
Examples are: transferrin, ferritin, lactoferrin, superoxide dismutase, proline hydroxylase 
and ribonucleotide reductase. 
Albeit far from complete, this list gives an impression of the multitude of biological 
processes that are in one way or another dependent 011 iron. 
§ 1.3 Iron intake, absorption and distribution in the human body. 
II 
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As mentioned before (§ 1.1), inorganic iron is nearly insoluble under aerobic conditions at 
neutral pH, and can therefore not be absorbed from food products. Looking at the process 
of iron uptake into thc mucosal cells, one has to make a distinction between haem and non-
haem iron compounds. Haem iron in food, which is hardly degraded in the digestive tract, 
is rapidly taken up in the mucosal cell by means of a specific haem receptor (32,177,199). 
Non-haem iron compounds are not so readily absorbed from our daily food, as several 
factors affect their uptake: (i) pH of the gastric juice (necessary to solubilize non-haem 
iron), (ii) the iron valency (ferrous iron is lllore readily absorbed), (iii) the presence of 
enhancers (e.g. ascorbic acid, animal proteins) and (iv) inhibitors of iron absorption (e.g. 
phytate, polyphenols, calcium). The mechanisms by which non-haem iron enters the 
mucosal cell have not been clearly established. The proposed systems range from simple 
diffusion to uptake by high affinity iron receptors, and it is likely that more than one 
system is involved. Neither transcellular transport of iron, nor the mechanism by which 
iron enters the blood compartment at the basolateral side of the mucosal cell have been 
clarified yet (9). 
Regulation of iron uptake occurs at the mucosal cell lining and depends on: (i) the iron 
content of the mucosal cell (159), (ii) the degree of iron accumulation in the iron storage 
sites (9,32,138,177) and (iii) the rate of erythropoiesis (32,177). 
mg iron175 kg mg iron/kg 
(male) 
functional Haemoglobin 2300 31 
components Myoglobin 320 4 
haem cnzymes 80 I 
non-haem enzymes 100 I 
Transferrin 4 0.05 
storage Ferritin 700 9 
components Hemosiderin 300 4 
total 3800 50 
Table 1: 
Average overall distribution of iron in the human (male) body. 
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Once iron enters the circulation it will bind to transferrin, a ± 80 kDa glycoprotein 
(60,199), which regulates the iron flux between the locations of absorption, utilization and 
storage (33,95,199). 
On average, the adult male human body contains 4 g iron. Nearly two third of it is 
incorporated in haemoglobin and myoglobin (Table I) (30,198,199). 
§ 1.3.1 Cellular iron uptake: mechanism and regulation 
Three proteins playa major role in the transport, cellular uptake and processing of iron: 
transferrin, transferrin receptor and ferritin. 
§ 1.3.1. I 1/YlIIsjel'l'ill. 
Transferrin is a monomeric glycoprotein of circa 80 kDa capable of binding two Fe(III) 
ions. Transferrins from different mammalian species vary in amino acid and carbohydrate 
composition (reviewed in 4,21O,and 212), which is reflected in (minor) variations in iron 
release at acidic pH and interspecies transferrin binding by transferrin receptors (75,210). 
Transferrin (Fig. 1) consists of a single polypeptide chain with either one or two (depen-
ding 011 the species) N-lillked complex type glycan chains (210) (see also § 3.5). 
Fig. I: 
Schematic representation of the human transferrin molecule. Note the difference between 
c- and N-terminal regions. Three examples of variations in the C-terminal carbohydrate 
moieties are depicted. 
The molecule can be divided in a N-terminal and C-tenninal domain, each containing one 
iron binding site. In fact, one could better refer to these sites as llmetal binding sites", for 
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transferrin specifically binds a large number of metals ranging from aluminium to platinum 
and even elements like plutonium and curium (213). The physiological significance of this 
interaction may be questioned for most metals, but possibly transferrin participates in the 
accumulation and therefore toxicity of certain metals, e.g. aluminium , manganese and 
plutonium (54,76,140,148,178,213). 
The two iron binding sites of transferrin act virtually independent of each other and the 
affinity constants of the N- and C-terminnl lobe (at pH " 7.4) are I x 10" and 6 x 10" 
respectively (60). To bind iron specifically to one of either binding sites, the concomitant 
binding of a synergistic anion (e.g. bicarbonate (HC03") or carbonate cot) is essential 
(212). This anion is needed to stabilize the metal complex at the binding site. Without it, 
the affinity of the binding site is lowered to such extent that either hydrolysis of iron or 
nonspecific binding to other parts of the protein lllay prevail. 
The release of iron from transferrin can be induced by acidification. In tlils respect both 
binding sites behave differently, for the release of iron from the N-lobe binding site occurs 
more readily upon acidification, whereas the C-Iobe binding site releases its iron more 
gradually and at a lower pH (68,69,136). Both the presence of an additional iron chelator 
and the reduction of Fe(lII) to Fe(II) facilitate the release of iron from transferrin (71,151, 
164). 
Transferrin synthesis is mainly -although not exclusively- located witliln the hepatocytes 
of the liver. A number of other tissues have been shown to produce (limited) amounts of 
transferrin, including brain tissue, Sertoli cells, mammary gland and so on (7,29,48,60,132-
,214). Tllis extrahepatic production will hardly affect the overall concentration of transfer-
rin in plasma, but could at a local lcvel be of sigllificant importance, especially when a 
specific compartment cannot be reached by plasma transferrin due to physiological barriers 
(e.g. blood-brain barrier) (214). Transferrin displays a rather complex electrophoretic 
behaviour, due to variations in three structural deternilnants: (i) genetic polymorphism, (ii) 
iron content and (iii) degree of branching ancUor sialylation of the N-linked glycoproteins, 
also known as nlicroheterogeneity of transferrin (60,61). Variations in either (i) or (ii) can 
affect the interaction between transferrin and its receptor. The effect of transferrin 
microheterogencity in the transferrin transferrin receptor interaction is less clear. Prelimina-
ry data indicate that variations in the N-linked glycan chains could modulate transferrin-
14 
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receptor interaction (61). 
§ 1.3.1.2 Ferritin. 
The dualism of iron, being both essential to life and toxic in its free form, could well 
explain the highly efficient way in which its cellular uptake, transport and storage are orga-
nized. To cope with this dualism, an iron storage system should be able to: (i) store 
efficiently varying quantities of iron, in a way that (ii) iron camlOt exert its toxic effects, 
but (iii) without reducing the bie-availability of iron. The iron storage protein ferritin 
fulfills these requirements (95). 
All prokaryotic and eUkaryotic cells contain ferritin as their major iron storage protein 
(130). Ferritin protein is composed 0[24 subunits of two types: the H-type of circa 21 kDa 
and the L-type of circa 19 kDa amounting to a total mass of circa 450 kDa (2,55,66, !O3, 1-
05,167). Inter- and intraspecies heterogeneity is explained by the various proportions in 
which the subunits assemble. Arranged with 4:3:2 symmetry (Fig. 2) the subunits form a 
hollow shell, in which up to 5000 iron atoms can be stored (55,105,167). 
Fig. 2: 
A schematic representation of a ferritin molecule. Ferritin consists of 24 subunits, forming 
a hollow shell in which iron can be stored. Iron may enter or leave the molecule via chan-
nels in between these subunits. Courtesy Dr. J.S. Starreveld 
Due to the arrangement of the subunits, the hollow shell displays 14 channels through 
which iron can enter the ferritin core. The process of iron uptake in ferritin is not 
completely clear (56,131). Iron is almost exclusively taken up in its ferrous (Fe") state. At 
the outer surface of the ferritin shell ferrous iron is oxidized to its ferric (Fe3+) state by a 
ferroxidase centre located on the ferritin H-chains (18,95,129). Fe3+ then enters the shell 
and is stored in a complex with oxygen and phosphorus: (FeOOH),(FeO-OPO,H,). 
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Although ferritin can store up to 5000 iron atoms, in vivo it rarely contains more than 
2500 iron atoms (see also chapter 4). 
Iron release from ferritin is similar to iron uptake with respect to the obscurity of the 
process in vivo (56). In vitro experiments showed that reducing agents, free radicals and 
chelators can bring about the release of iron from ferritin (34,95,103, I 05,207) and this 
process can be enhanced by an increase in temperature (207) or a decrease in pH (207). 
Lysosomes or acidic endosomes are the most likely places for iron release from ferritin in 
vivo (95). 
Since ferroxidase seems to be exclusively located on the HMchain, a difference in subunit 
composition could lead to functional differences between ferritins (12,56,104,131). In res-
ponse to iron uptake, there appears to be a preferential synthesis of LMsubunits, and it 
would seem that ferritin rich in L-subunits is used for long term iron storage (65,95,104,-
158). H-subunit rich ferritin can take up free iron more readily than LMsubunit rich ferritin. 
The production of HMsubunit enriched ferritin is stimulated during inflammation, and tlus 
will rapidly reduce the intracellular (free) iron concentration, thus protecting the cell 
against oxygen free radical formation (see § 1.6) (102,171). 
§ 1.3.1.3 Tral/.1ferr/1I receptor. 
Under normal (physiological) conditions most, though not all, plasma iron is bound to 
transferrin. A combination of a high transferrin plasma concentration (50 - 110 ~nnolll) and 
two high affinity binding sites for iron per transferrin molecule (see § 1.3.1.1) will 
effectively prevent serious competition by other molecules. However, there are a number of 
plasma proteins capable of either binding iron (e.g. lactoferrin, ferritin) or carrying an iron 
containing compound (e.g. haemopexin, haptoglobin) (3). FUl'thermore, plasma iron can be 
bound by low molecular weight compounds (e.g. citrate, ascorbate), especially in those 
circumstances where transferrin is fully saturated with iron (iron overload). The nOllM 
transferrin plasma iron pool is discussed to some extend by Baker and Morgan (15) and a 
number of transferrinMindependent iron transport pathways are currently under investigation 
(53,112,117). 
The transfer of transferrin bound iron to the interior of a cell is mediated by the transfer-
rin receptor. The transferrin receptor is a circa 180 kDa class II transmembrane glycoproM 
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tein (192). It is a dimer, composed of two homologous subunits linked by two disulphide 
bridges and each subunit is capable of binding one transferrin molecule (110,150,192,215). 
The large C-tcrlllinal domain (Fig. 3) of the transferrin receptor subunit protrudes in the 
extracellular space, a 26 amino acid hydrophobic part spans the plasma membrane and the 
small N-terminal domain ends in the cytoplasm (192,215). 
Fig. 3: 
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The transferrin receptor is a dimer consisting of two identical 95 kDa polypeptide 
structures. Each monomer can be divided in (i) large extracellular region (empty box) with 
a number of sugar residues (I) attached to the C-tenninal end, (ii) a small and hydrophobic 
intermediate segment (gray box) that spans the plasma membrane, and (iii) a short 
cytoplasmic "tail" harbouring a phosphorylation site (P). 
The distribution of transferrin receptors in the cell can be studied by: (i) ligand (i.e. 
transferrin) binding at low temperature, or (ii) using monoclonal antibodies (e.g. OKT9). 
\Vith either technique transferrin receptors can be detected on a large number of tissues, 
ranging from bonc marrow to endothelial cells of the blood-brain barrier (3,113,192,215). 
In fact, the transferrin receptor is considered to be the most important mechanism for iron 
uptake in the majority of mammalian celJs (3,60). 
Considering the transferrin receptor distribution at a cellular level, at least two and most 
17 
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likely three different transferrin receptor pools may be discerned (see also chapter 5): (i) 
transferrin receptors located 011 the cell surface, and (ii) transferrin receptors within the 
cell, either (iia) actively taking part in the endocytic cycle, or (iib) apparantIy non-functio-
nal transferrin receptors possibly in storage pools (110,184,185,208,209). 
The affinity of the transferrin receptor for transferrin depends on two interdependent 
parameters: pH and transferrin iron saturation. At a pH of circa 7.4, comparable to that of 
the extracellular space, the transferrin receptor displays a high affinity for diferric (i.e. both 
iron binding sites occupied) transferrin, with association constant estimates ranging from 2-
7 X 10+9 (109,110). Under these circumstances the affinity of the transferrin receptor for 
apo-transferrin (i.e. devoid of iron) is nearly two orders of magnitude less (220). However, 
when the pH decreases to about 5.5, comparable to that of the endosomes (see § 1.3.1.4), 
the transferrin receptor affinity for apo-transferrin increases, whereas the affinity for 
diferric transferrin decreases (15,84,192,215). In this way, transferrin and transferrin 
receptor remain coupled during the endocytic cycle (sec § 1.3.1.4). 
§ 1.3.1.4 Cellular iroll uptake. 
As has been discussed in the previous paragraph, transferrin is the primary source of iron 
for mammalian cells. However, there is evidence that other iron containing proteins (e.g. 
ferritin) can deliver iron to the cell by means of receptor mediated or receptor independent 
mechanisms (17,165, reviewed in 3 and 15). \Vllether these mechanisms significantly 
contribute to the iron influx in vivo is still a matter of debate (IS, 215). 
The initial step in cellular iron uptake from transferrin, is the coupling of transferrin to its 
receptor. Next, either one of two mechanisms can result in the intracellular release of 
transferrin bound iron. 
(i) In the "redox model" (194), which has been described for hepatocytes, a NADH:ferri-
cyanide oxidoreductase will bring reducing equivalents near the transferrin receptor bound 
transferrin. Concomitantly, protons are released in that same area through Na+/I-r+ pumping. 
This combination will trigger the release of Fc2+ from transferrin. Fe2+ will then be bound 
by, and transferred to the cytosol by means of a Fe2+ specific membrane binder/carrier 
(15,194,215). 
(ii) The second, and probably most important, mechanism is that of "receptor mediated 
18 
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endocytosis ", The internalizntion sequence starts with the coupling of transferrin to the 
transferrin receptor. The short cytoplasmic tail of transferrin receptors (see § 1.3.1.3) 
contains an internalization sequence (84,101,195), that promotes the concentration of trans-
ferrin receptors in coated pits to nearly eigth times the concentration of these receptors in 
nOll-coated plasma membranes. Coated pits are small indentations in the cell surface coated 
with clathrin, a protein that is both involved in (i) selection of sequestered receptor type, 
and (ii) formation and internalization of coated vesicles into the cytoplasm (84,186,193). 
\Vhether the internalization sequence is actually triggered by the coupling of transferrin to 
its receptor is still a matter of debate (5,21,122). 
Once the coated vesicle has entered the cytosol, it will shed its clathrin coating and an 
ATP-dependent proton pump (217) will lower the pH to about 5-6.5 (3,15,60,186,192,202,-
215,218). As discussed by de long et al (60), lowering of the pH has three important 
effects: (i) a conformation-transition of the transferrin receptor facilitating segregation from 
other receptors (CURL), (ii) a promotion of the release of iron from transferrin, and (iii) an 
increase in the affinity of the transferrin receptor for apo-transferrin (see § 1.3.1.1). Apo-
transferrin will therefore remain complexed to the transferrin receptor and thus evade 
lysosomal degradation. The complex will remain intact until it has rehlrned to, and fused 
with the cell membrane. There, the transferrin-transferrin receptor complex will be exposed 
to extracellular pH levels and thereupon release apo-transferrin into the circulation. 
A complete cycle may take between 3 min (15) for reticulocytes and 90 min (162) for 
bovine blood-brain barrier endothelial cells (60,185). These cycle times point to a major 
flaw in the proposed mechanism. Even if the pH in the endosome would drop to about 5.5 
(202,218) it would take hours before transferrin releases both iron atoms (see § 1.3.1.1) 
(56,60). A number of additional mechanisms have been proposed to promote the iron 
release from transferrin: (i) a change in the conformation of the transferrin receptor at a pH 
of 5.6 which will accelerate the iron release from transferrin (3,16), (ii) a reduction of 
transferrin bound iron to its ferrous state, possibly by a transmembrane ferrireductasc (see 
above) or ascorbate (71,151) and (iii) the chelation of iron by low molecular weight chela-
tors derived from the cytosol. If true, the latter could also add to a better understanding of 
what will happen to iron after release from transferrin. Unfortunately, to date there is no 
evidence for the existence of these chelators (15,164,194,206). 
19 
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§ 1.3.1.5 Reglliation of celllliar iron homeostasis. 
§ 1.3.1.5.1 The IRE cOllcept. 
The duality of iron, both being essential to life and toxic in certain conditions (see § 1.6), 
requires a regulatory system within each cell that will respond quickly and adequately to 
changes in intra~ and extracelllliar iron concentrations. 
Recently, a new and fascinating concept of iron regulation at a molecular level was 
discovered: the "iron responsive element" (IRE) (160, reviewed in 102,141,171). IRE's are 
short sequences in mRNA of the transferrin receptor, ferritin and erythroid 5-aminolevuli-
nate synthase (eALAS). The IRE sequence consists of a short double stranded stem of 
variable length and capped by an unpaired loop of six nueleotides (Fig. 4), located either at 
the 5' untranslated region (UTR) of ferritin H- and L-subun.it mRNA and eALAS, or the 3' 
UTR of transferrin receptor mRNA. 
Intracellular iron concentration: 
~ IRE 
Low 
n IRE-SP 
+ 
I RE~BP activity high 
FeO«tin Tf receptor 
~ Fer~~A 
High 
+ IRE-BP activity low 
Ferritin Tf reXeptor 
Fig. 4: 
Schematic representation of the interaction between the iron responsive element (IRE) and 
the iron~binding protein (IRE-BP) and the effects of this interaction. 
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This IRE-sequence is the target of an IRE-binding protein (IRE-BP), also known as iron 
regulatory factor (JRF) (141). The IRF is an iron sulphur protein with a deep cleft, in 
structure similar to aconitase (citric acid cycle). The 4FcR 4S cluster, essential for its 
enzymatic (aconitase) function, is located within this cleft. 
\Vhen the cellular iron concentration is sufficient (or more), the iron-sulphur cluster will 
contain four iron atoms (4Fe-4S). The enzyme will then function as a cytoplasmic 
aconitase and not be able to bind an lIm. On the other hand, if the cellular iron concentra-
tion is low, the iron-sulphur cluster will loose its fourth iron. Although this is sufficient to 
inactivate the aconitase function of the protein, it will still be unable to bind an lIlli 
(141,154). It is proposed (154) that nitric oxide (NO) participates in the interaction 
between IRF and IRE, either through assistance in the complete removal of the ironR 
sulphur cluster, or by inducing a conformational change in IRF, resulting in an coupling of 
IRE and JRF. 
When IRF is aclived (reduced cellular iron), it will bind to the IRE at the 5' UTR of H-
and L-subunit mRNA and inhibit translation of this mRNA (157,173). At the same time, 
IRF will bind to the 3' UTRRlRE's of transferrin receptor mRNA and stimulate receptor 
synthesis, by blocking rapid degradation of this transferrin receptor mRNA (125,149). 
Ergo: the iron storage capacity is reduced, while the capacity for iron uptake is increased. 
The process is reversed when the cellular iron concentration is increased. 
§ 1.3.1.5.2 l\Iodulatioll of transferrin targeting and tramferrill-transferrin receptor inter-
actioll through carbohydrate chain l'arialiolls. 
Both transferrin and transferrin receptor are glycoproteins. However, despite recent 
advances in the field of giycoproteins (8), the role of carbohydrate moieties in transferrin 
and transferrin receptor are still obscure. As discussed by de Jong et al (60), certain 
conditions (e.g. pregnancy) can modulate transferrin microheterogeneity and therefore 
possibly affect interaction with the transferrin receptor (see § 1.3.1.1). Likewise, variations 
in the carbohydrate moiety of the transferrin receptor could influence the interaction with 
its ligand (61). 
Experimental data on this subject are scarce, however, it is conceivable that a systemic 
modulation of carbohydrates moieties on glycoproteins like transferrin and its receptor 
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could affect iron fluxes within the body (20 I). 
§ 1.4 Blood-brain barrier: strllcture and fUIlction. 
The survival of complex organisms depends on their ability to maintain a constant "milieu 
illterieurett • This process, known as homeostasis, should at least have the following 
properties: (i) a barrier that shields the interior of the organism from its (hostile) surroun-
dings, (ii) system(s) (active/passive) to take up nutrients to maintain a proper function of 
the organism, (iii) excretory system(s) to loose toxic or excess amounts of metabolites, and 
(iv) a metabolic system that is capable of converting nutrients and metabolites (e.g. for 
energy supply). 
AP 
A 
Fig. 5: 
Cross-section through a brain capillary. Note the basal membrane that surrounds both 
endothelial cells (Ee) and pericytcs (1'). Astroc)1ic endfeet (AP) of adjacant astrocytes (A) 
are in close contact with the basal membrane and cover most of the exterior surface of the 
capillary. Lu = lumen. 
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In man, brain tissue critically depends on a proper fUllction of homeostasis. A number of 
(known) plasma constituents like hormones (e.g. noradrenaline), amino acids (e.g. glycine) 
and ions (e.g. K+) can affect brain function. For instance glycine, an neurotransmitter with 
inhibitory effects throughout the brain and spinal chord, must be kept at a much lower 
concentration within the brain than in plasma (36,87,168). A variation in these plasma 
constituents due to meals, exercise or disease could (without homeostasis) disturb normal 
cerebral functioning. On the other hand, the effects of locally produced neurotransmitters in 
the brain would be severely reduced, should these compounds be able to leak away freely 
into the main blood stream. It is therefore essential that brain tissue is separated, but not 
completely isolated, from the circulation. 
Homeostasis within brain tissue is maintained by the endothelial cells lining the capillaries 
that penetrate the brain (Fig. 5). It is still a matter of debate whether only endothelial cells 
are rcsponsible for the blood-brain barrier. Astrocytic endfeet are in close contact with the 
endothelial celis, and in vivo as well as in vitro experiments have shown that interactions 
between both cell types do occur (41,45,116,168). However, there is also evidence that 
endothelial cells not in contact with astrocytes are still capable of maintaining a barrier 
function (41,45). To maintain a stable Hmilieu interieure l1 within the central nervous system 
(eNS), brain capillaries with a surface area of circa 240 cm'/g brain tissue (161), display 
all four properties as mentioned above: 
(ad i) The barrier function of the blood-brain barrier endothelial cells is amongst others a 
result of tight junctions (zonula occludens) counecting adjacent endothelial cells (40,41,10-
6,163). These organelles are missing in endothelial cells lining capillaries of most 11011-
neural tissues. These cells are .h-U less tightly interconnected and display fenestrations (holes 
or chalUlels) that allow free passage of plasma solutes. The tight junctions between blood-
brain barrier endothelial cells impose a twofold barrier: (a) passive, due to their non-selec-
tive obstruction of intercellular passage of polar compounds, (b) active, as they prohibit the 
lateral diffusion of plasma membrane components (e.g. transporters). TIlls morphological 
phenomenon leads to a functional polarity of the endothelial cell with respect to membrane 
constituents (e.g. receptor proteins) (26,41,86). 
(ad ii) Systems responsible for the transport of compounds into the brain via the endot-
helial cells of the blood-brain barrier are only partially understood. In general, at least four 
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(a-d) different mechanisms can be discriminated (161). 
(a) Passive diffusion through (or between) the endothelial cells of the blood-brain barrier: 
this process is limited to either lipid-soluble molecules (e.g. ethanol), which readily pass 
the lipid bilayer of the plasma membrane, or small solutes (water, urea) capable of 
trafficking the plasma membrane andlor intercellular spaces barred by tight junctions (82,R 
197). Inorganic ions cannot readily pass a lipid bilayer, and their passage depends mainly 
on the presence of active transport processes (see below under (c». 
(b) Facilitated diffusion: this process consists of the passage of substrates through pores, 
channels or Itpassive uniporterslt . Characteristics of tllis system are: Ifdownllill" transport of 
substrate (wllich does not require energy), lligh permeability, stereospecificity in selection 
(e.g. D-glucose versus L-glucose), and saturable kinetics (83,161). A major example of this 
type of transport across the bloodRbrain barrier is glucose transport. Glucose is the main 
energy source for brain cells and the presence of a stereospecific glucose transporter in the 
plasma membranes of the bloodRhrain barrier endothelial cells has long since been 
established (25,87). This transporter, identical to the glucose transporter type I (GLUT!) of 
human erythrocytes (127), is a circa 55 kDa glycoprotein, in vivo probably present as a 
dimer (83). 
(c) Active transport: this type of transport features the transport of solutes against a 
concentration gradient (uphill) at the cost of energy. Active transporters can be subdivided 
in primary and secondary active transporters. The primary active transporters are mainly 
"ion pumpslt, creating an ion and/or voltage gradient across a membrane. Their activity is 
coupled to and dependent on an energy liberating reaction (e.g. hydrolysis of ATP). 
Secondary active transporters use these ion gradients as an energy source for "uphillit solute 
transport (83). 
An example of a primary active transporter is the NalKRATPase transp0l1er located in the 
abluminal (braillside) membrane of the BBB endothelial cell (26,87,127). Tight control of 
the intracerebral potassium concentration is essential for proper neurotransmission, as 
potassium affects the excitatory threshold of neurons. 
Amino acid transport across the BBB is regulated by three different transporters: the LR. 
AR, and ASCRsystem. each displaying a lligh affinity for a select group of amino acids. 
Both the A- and ASCRSystClll are sodium dependent secondary active transporters, located 
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exclusively in the ahluminal membrane, capable of pumping small amino acids (e.g. 
glycine) uphill into the endothelial cell. The L-system on the other hand, is present on both 
the luminal and abluminal membrane. It is a sodium independent system and mediates an 
active diffusive process of the larger amino acids (24,26,87,127). The distribution of the 
various amino acid transporters illustrates the fact that -for synthesis of lleurotransmitters-
the brain has to import the larger amino acids, whereas the smaller amino acids can be 
synthesized by the brain cells themselves. 
(d) Endocytosis: a process that leads to the intracellular uptake of smaller solutes and 
macromolecules. Basically, the cell internalizes a piece of its own plasma membrane and 
associated molecules, replacing it by another piece. Endocytosis can be subdivided into 
three different processes: fluid phase endocytosis, adsorptive endocytosis and receptor 
mediated endocytosis. 
Fluid phase endocytosis is mainly a membrane recycling process, replacing old and rigid 
plasma membrane sections by freshly synthesized plasma membranes. Concomitantly, 
nearby molecules, although not associated with the membrane, will be involuntary taken up 
(43). Membrane fragments and other compounds within these vesicles will eventually be 
degraded. Horse-radish peroxidase (HRP) does not bind to the plasma membrane but is 
readily taken up in fluid phase endocytosis. Reese and Karnovsky (40,163) used HRP to 
prove that the endothelial cells lining the capillaries in fact constitute the blood-brain 
barrier. 
Adsorptive endocytosis involves the binding of positively charged molecules to oppositely 
charged membrane constituents, or the binding of lectins to carbohydrates associated with 
the cell surface. 
Receptor mediated endocytosis has been discussed in some detail in § 1.3.1.4. \Vith 
respect to the blood-brain barrier, specific receptors for transferrin, insulin and low density 
lipoprotein (LDL) have been found on the luminal side of the BBB endothelial cells 
(23,43,80,113). Following endocytosis, a number of alternative routes have been described 
for the endocytic vesicle: degradation, uncoupling of ligand (with or without receptor 
recycling), ligand modification, and transcytosis (43,80,187), The concept of transcytosis 
has aroused a lot of controversy, in part due to pitfalls in the interpretation of experimental 
results (42,43), However, should transcytosis exist, it would offer a possibility to transfer 
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drugs across the blood-brain barrier while circumventing the metabolic system of the 
endothelial cell (see below at (iv)) (43,120). 
(ad iii) Thc excretory capacity of the blood-brain barrier is probably limited. There are a 
number of transp0l1ers (active and passive) located in the abluminal membrane of the BBB 
endothelial cell (see above) that are capable of removal of specific compounds. However, 
endocytic activity is reported to be virtually absent in the abluminal membrane of the BBB 
endothelial cell (43). 
The two major pathways involved in the secretion of cerebrospinal fluid, (macro )molecu-
les, and waste products into the circulation are in fact the arachnoid villi (and granulati-
ons), and the choroid plexus (161,183,216). 
(ad iv) Metabolic barrier: The BBB endothelial cells contain several jIll.podant enzymes 
capable of modification, inactivation, or even degradation of molecules after uptake 
(13,14,26,59,87,116,142). A well known example of tltis metabolic barrier is the presence 
of both monoamine oxidase and L-Dopa decarboxylase in BBB endothelial cells. These 
enzymes impede the cerebral uptake of L-Dopa, and high systemic concentrations of L-
Dopa in combination with a L-Dopa decarboxylase inhibitor are necessary to overcome tllls 
blockade (26,87). The function of a number of enzymes in the endothelial cell are 
reviewed by J60 (116). Next to these enzymes, endothelial Iysosomes probably contribute 
to the metabolic barrier (14). The active metabolic proeesses in the BBB endothelial cells 
impose an effective barrier to a number of substances (e.g. dmgs), thereby -unfortunately-
restricting the therapeutic accessibility of brain tissue. 
Despite all the sophisticated transport mechanisms and barriers that warrant a highly 
selective passage of compounds across the blood-brain barrier, there are a number of ways 
to circumvent the blood-brain barrier: (a) fenestrated bloodvessels of the circumventricular 
organs (e.g. pineal body, neurohypophysis), (b) choroid plexus epithelium involved in two-
way transcytosis, (c) leaky superficial cortical blood vessels and (d) retrograde axoplasmic 
transport through neurons (43,58,183). It is difficult to assess the contribution of these 
pathways to the passage of compounds into the brain, however, they should not be 
underestimated (43). 
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§ 1.5 Iron homeostasis in the brain. 
Iron is an essential element in the metabolic system of the cell (see § 1.1 and 1.2), and the 
cells that constitute the brain tissue are no exception to that rule. Apart from its clucial role 
in oxidative phosphorylation, it is also a cofactor in several enzymes required in the syn-
thesis and degradation of neurotransmitters (overview in 20). Moreover, there is some 
evidence that iron deficiency affects cognitive functions (19,20,219). 
The presence of iron in brain tissue was already recognized by Spatz (I82) in the early 
part of this century. Recently, more detailed studies on the distribution of (non-haem) iron 
in the brain appeared in literature (20,22,28,107, reviewed in 52). Basal ganglia, substantia 
nigra, red nucleus and subfornical organ are the regions with the highest levels of iron in 
the brain, but in general white matter of frontal, temporal and motor cortex have quantitati 
vely more iron than their gray matter counterparts (50). Hallgren and Sourander (94) esti-
mated that the level of iron (per gram tissue weight) in basal ganglia was comparable to 
that in liver tissue. To date, there is no explanation for the high concentrations of iron in 
those areas. In fact, Morris et al (I44) were unable to match tllis distribution pattern of 
iron with that of known neurotransmitter systems (e.g. GABA). The high level of iron in 
the subfornical organ however, could be explained by the fact that the capillary endothelial 
cells in that area are of a fenestrated type (see § 1.4) and do not display the normal characw 
teristics of a BBB endothelial cell. 
At the cellular level, the distribution pattern of iron becomes more complex (52). In all 
brain regions iron is predominantly found in oligodendrocytes, which are responsible for 
the production of myelin (49,52,72,133,137). Interestingly, there seems to be a "patchwork" 
distribution of ironwpositive cells in the white matter, as if some cells accumulate iron, 
whereas others do not (49). Results on the detection of iron in neurons and endothelial 
cells are inconclusive, but seem to depend on the tissue fixation procedure and sensitivity 
of the iron staining technique (49,52,143,144). 
The distribution pattern of ferritin, the iron storage protein, coincides with that of iron and 
is also mainly found in oligodendrocytes. Furthermore, ferritin could be detected in microw 
glial cells, which have a phagocytic function in brain tissue (49,119). It is also reported 
that, with age, astrocytes (especially around the basal ganglia) are capable of accumulating 
iron (52). A possible explanation for tins finding could be the presumed alteration in 
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blood-brain barrier function with age or disease (6,49,70,118). 
Transferrin in brain tissue is predominantly located in oligodendrocytes as well (47,48,49,-
145) and in the endothelial cells of cerebral microvessels (80,113,156). Besides, some 
transferrin could be detected within astrocytes, and this amount increased with age 
(49,145). Transferrin cannot routinely be detected in neurons. Connor (49) and Morris 
(145) were able to detect transferrin in some neurons (e.g. in the amygdala), however, 
there seemed to be no consistency in this staining pattern and it was concluded that 
transferrin staining in neurons was either the result of problems with tissue fixation, or 
transferrin uptake due to neuronal cell damage or stress. Generally, the overall cellular 
distribution of transferrin appears to differ from that of iron and ferritin, as transferrin 
positive cells in the white matter do not occur in patches (49). 
The question why oligodendrocytes contain so much iron has not been solved yet. 
Speculations point either to the active metabolic requirements of'the oligodendrocyte in the 
fatly acid synthesis (52), or to an active iron distributing role (85), for oligodendroeytes in 
vitro are capable of transferrin synthesis (73). 
The distribution of iron in brain tissue is a dynamic process and changes in cellular and 
regional iron distribution occur in: (i) neonatal development (67,132), (ii) aging (1,49,52,-
172), (iii) peripheral iron accumulation (e.g. hemochromatosis) (115), (iv) iron deficiency 
(20,219), (v) neurological diseases e.g. Parkinson's disease and Alzheimer's disease (AD) 
(50,51,63,64,114,115,l35,180,181). The cause for changes in the distribution of cerebral 
iron is not very clear in most of these circumstances. 
During neonatal development there is a strong increase in cerebral iron (20,189,190), 
which could partially be the result of an increased metabolic need, but also to a still under-
developed blood-brain barrier (168). 
\Vith age, there is a predominantly cellular shift in iron localization. Astrocytes and 
microglia, especially in basal ganglia, amygdala and cerebral cortex, show an increase in 
iron and ferritin content (49). To date, there is no explanation for tlus redistribution of iron 
(191). 
In hemochromatosis, there is an increase in cerebral hemorrhages; iron depositions in 
those areas that have capillaries with fenestrated endothelial cells; and sometimes an 
increase in iron in certain brain areas (e.g. globus pallidus) (115). The high iron concentra-
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tion in the peripheral circulation could well explain these (abundant) iron depositions, 
especially in those areas that are devoid of a normal blood-brain barrier. 
In Alzheimer's disease, there is a marked increase in iron levels of the hippocampus, 
nucleus basalis of Meynert and in and around senile plaques (typical cerebral laesions in 
Alzheimer's disease) (52,114). There is sparse (and far from convincing) evidence of 
changes in blood-brain barrier permeability in Alzheimer's disease (6,70,118), which still 
leaves the question whether permeability changes cause or are a result of iron accumulati-
on. 
In general, results of morphological, histochemical and biochemical assessments of iron 
distribution in the brain all show that there is a steady increase in iron with age, and tlus 
process appears to be exacerbated in certain pathological circumstances. Some fundamental 
questions, however, remain to be solved. One of the issues that has not been clarified yet, 
is the question of how iron crosses the blood-brain barrier, i.c. the blood-brain barrier 
endothelial cell. 
In 1984, Jeffries (113) was the first to describe transferrin receptors on the luminal side of 
the blood-brain barrier endothelial cells. Naturally, tins finding supported the concept of 
receptor mediated endocytosis of transferrin at the blood-brain barrier endothelial cell (see 
§ 1.3.1.4 and § 1.4). Other results confirmed tins model of receptor mediated endocytosis, 
followed by receptor-ligand uncoupling and recycling of transferrin to the luminal 
membrane (57,80,169,170,187). This is a well established concept of iron uptake, despite 
the still elugmatic nature of the transport of iron after its release from transferrin. 
On the other hand, there is also some direct evidence (with 1251_ Tf_59Fe) to support a 
model of receptor mediated transcytosis (42,43,77,156,162). However, pitfalls in the inter-
pretation of transcytotic transport do exist and are reported on by Broadwell (42). Recently, 
a number of reports appeared in which compounds conjugated to a transferrin receptor 
antibody (OX-26) were able to pass the blood-brain barrier (27,81,120,124). However, the 
latter should not be interpreted as a direct proof of receptor mediated transcytosis. To my 
knowledge, transferrin receptors have never been detected on the abluminal side of the 
BBB endothelial cells (113), and the OX-26 conjugate transport over tins membrane could 
well be due to the involvement of other transport mechanisms. Fllrthennore, the concept of 
transcytosis will not explain the differences in the degree of sialylation of serum transferrin 
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as compared to cerebrospinal fluid transferrin (61). 
A third possibility, as proposed by Veda et al (196), would be a receptor indepcndent iron 
transport across the BBB. The authors concluded that, although a major portion of the iron 
transport is receptor mediated, non-transferrin bound iron can also cross the BBB. In my 
opinion, this could also support the relative importance of those routes that circumvent the 
blood-brain barrier (see § 1.4). 
The regulation of iron transport across the blood-brain barrier is another issue that remains 
to be solved (52). There are a fcw reports on the cffect of peripheral iron stahlS on iron 
transport across the BBB (23,115,147,190). In iron overloaded rats, high iron levels in 
brain tissue appear to downregulate receptor mediated endocytosis of iron across the BBB, 
without however, diminishing the increase in brain iron (147). Another hypothesis proposes 
a (temporary) increase in BBB permeability due to either iron deficiency (23), or iron 
overload (147). 
Considering the existence of a mobile intracerebral iron pool, one would expect the trans-
ferrin receptor distribution to coincide with those regions that accumulate iron. However, 
results with monoclonal antibodies against the transferrin receptor (e.g. OX-26) only parti-
ally confirmed this pattern in- one study (52), while another Shiely could not show any rela-
tion with stored iron at all (108). 
§ 1.6 Iron toxicity. 
Although iron is vital to and present in all mammalian cells, there are multiple regulatory 
mechanisms in each cell to restrict the amount of "free" or, better still, low molecular 
weight (LMW) iron (88,205). LM\V iron is iron weakly bound to intracellular compounds 
of low molecular weight e.g.: AlP, ADP, GIP and citrate (78,100,174,204,205). Conside-
ring the abundance of high affinity iron binding sites, it is difficult to imagine the concept 
of L:M\V iron. However, our knowledge of intracellular iron metabolism is far from 
complete, especially where it concerns the transition of iron from one carrier to another 
(e.g. transferrin to feITitin). One of the hypotheses (see § 1.3.1.4) proposes that LMW iron 
is involved in these transfers (15, 164,200). 
Iron is a transition metal, capable of participating in single electron transfer reactions, and 
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therefore a potential (Fig. 4) catalyst in the generation of highly reactive oxygen free 
radicals. Due to the nature of the iron binding sites, iron in ferritin and transferrin can not 
directly function as a catalyst (39,100,126). On the other hand, iron in LMW iron com-
pounds may readily catalyze the formation of OR (39,44,78,89,126,174,204). 
Reactive oxygen species, e.g. hydroxyl radical and ferryl species arc capable of donating a 
single electron to target compounds like DNA, RNA, proteins, lipids, thereby altering the 
structure and function of these compounds (44,46,79,91,98,99,100,153,205). Numerous 
ways exist to generate (or induce the generation of) oxygen free radical species; a few of 
those pathways arc depicted in Fig. 6. 
Fig. 6: 
,-__ -, Iron-catalyzed Haber-Weiss pathway. 
Asc. A. 
Mit. el. 
Xa. ox. 
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Microglia 
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This diagram depicts a few of the enzymes and cell types that could be involved in the 
synthesis of reactive oxygen species (e.g. OH). Asc.A.= ascorbic acid; Mit.el.= electron 
rtleakagert from mitochondrial electron carriers; Xa.ox.= xanthine oxidase; GPx = glutathio-
ne peroxidase; MAO = monoamine oxidase; SOD = superoxide dislllutase. 
Considering the presence of iron in brain tissue, there are at least two reasons to take the 
catalytic role of iron into further consideration. (i) As mentioned in § 1.5, certain regions 
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in the brain contain high amounts of iron and, even more important, the distribution of iron 
in the brain changes under certain conditions (e.g. aging). Iron uptake and redistribution 
imply transition of iron and therefore (possibly) an increase in LMW iron (200). (ii) Brain 
tissue is highly susceptible to oxydative damage, because of a high rate of oxidative 
metabolic activity, and low levels of antioxidant enzymes (e.g. catalase). Moreover, brain 
tissue contains high concentrations of readily oxidizable unsaturated fatty acids (PUFA's) 
e.g. in plasma membranes (74,92,93,96,97). These plasma membranes are essential for 
proper neuronal functioning and interneuronal communication. Moreover, neuronal cells are 
not capable of replication. 
There is a growing list of publications that link the process of oxidative damage to central 
nervous system damage in aging (10,79,179,203), Alzheimer's disease (74,134,155,166,-
188), Parkinson's disease (62,152), trauma and stroke (37,38), and on a cellular level in 
oligodendrocytes (90,121). 
Research in tlus field is, however, hampered by the inaccesibility of the brain compartM 
ment and the evidence presented is therefore mainly indirect. Nevertheless, a better 
understanding of brain iron metabolism in conjunction with extended research on oxidative 
damage in neurological disorders could increase our understanding of the pathogenesis of 
certain diseases, in casu Alzheimer's disease and Parkinson's disease (74). 
§ 1.7 Aims of the thesis. 
The intriguing duality of iron, being both essential for cellular metabolism and noxious in 
certain conditions, can be cleady discerned in the central nervous system. A decrease in 
cerebral iron concentration will affect cognitive functions, whereas certain neurological 
diseases are accompagnied by an increase in intracerebral iron concentration. These 
extreme conditions imply that the distribution of iron in brain tissue is subject to changes, 
and suggest that iron may continuously enter or leave the brain. Mechanism and regulation 
of iron transport into the brain are, however, largely unknown. 
To further investigate the transport of iron into the brain, the following isues were 
adressed: 
(i) Development of techniques to isolate blood-brain barrier microvascular endothelial 
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cells, and to grow these cells on various supports. 
(ii) Isolation and purification of the iron transport and storage proteins transferrin and 
ferritin. 
(iii) Quantification of transferrin receptor distribution in the BBB-Ee's. 
(iv) Quantification of transferrin receptor kinetics, iron uptake and release in the BBB-
EC's 
(v) Ultrastrueturalmorphology of the BBB-EC's. 
(vi) Visualization of transferrin uptake and its cellular pathway. 
(vii) Investigation on the possible adverse effccts of iron on the BBB-EC's exposed to 
oxidative stress. 
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§ 2.0 Contents. 
§ 2.1: Introduction. 
§ 2.2: Procedures for the isolation, culturing and treatment of porcine bloodRbrain barrier 
microvascular endothelial cells. 
§ 2.3: Morphological teclmiques. 
§ 2.4: Semiquantitative inununochemical procedures. 
§ 2.5: Analytical and quantitative techniques. 
§ 2.6: Protein isolation and purification procedures. 
§ 2.7: Statistical analyses and curve fittings. 
§ 2.8: Transferrin receptor quantitation and kinetics. 
§ 2.9: Rat brain dissection. 
§ 2.10 Fixation, embedding and transmission electron microscopy. 
§ 2.1 Introduction. 
This chapter gives an overview of all experimental procedures that, in one way or another, 
contributed to the results described in tIus thesis. 
A list of specific chemicals and techniques is included in each chapter. 
§ 2.2 Procedures fol' the isolation and culturing of porcine blood-brain balTier 
microvasculal' endothelial cells. 
§ 2.2.1 Blood-brain barrier micl'ovessel endothelial cell isolation and culturing. 
Microvascular cndothelial cells were isolated from fresh porcine brain using a method 
adapted from Mischeck (16) and Meresse (IS). Within 20 min after bleeding the animal, 
brain tissue was rinsed with HBSS (4°C) and homogenized after careful removal of cereR 
bellum, meninges and choroid plexus. The homogenate was resuspended in 50 ml per brain 
culture medium (M 199, containing 20 mM HEPES, 4mM L-Glutamine, 2.5 mglL Fungi-
zone and 50 mg/L Gentamyein). Dispase (4 giL) was added and the homogenate was 
gently shaken for 3 hrs at 37°C. Following filtration through a nylon mesh (150 fun), the 
filtrate was centrifuged (1800 g, 12 min), Supernatant and top layer of the pellet (con-
sisting of white matter) were removed. The bottom layer of the pellet (reddish in color) 
was resuspended in culture medium with 20 % (v/v) Fetal Calf Serum. This procedure was 
repeated 3 times and cells were plated on gelatine coated (0.2% gelatine (w/v) in PBS) 
petri dishes. After 30 min culture medium was replaced, removing most nOllRattached cells. 
The next day, cells were washed briefly with PBS and incubated with culture medium with 
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10 % (v/v) Fetal Calf Senun). Culhlre medium was changed every other day. 
§ 2.2.2 Blood-brain barrier microvessel endothelial cell culturing ill iron-enriched and 
iroll-depleted media. 
Following isolation, all cells were cultured according to the standard procedure for 3 days 
(see § 2.2.1). Subsequently, cells designated to be "iron loaded rt , were incubated with 
culture medium containing 300 11M diferric transferrin (= Fe+ medium). Fe+ medium was 
changed every other day and experiments were performed when cultures were nearly 
confluent. 
Cells designated to be "iron deficient ll were treated according to the standard procedure 
until two days before the actual experiment. At that time, Deferrioxamine (50 ~{glml) was 
added to the culture medium (= Fe- medium) and tIus was repeated on the day before the 
experiment. 
§ 2.2.3 Culturing of blood-brain barrier endothelial cells all semiporotls membranes. 
A detailed description of the BBB-Ee isolation procedure can be found in § 2.2.1. Briefly, 
brain tissue was homogenized after carefull removal of cerebellum, meninges and choroid 
plexus. The homogenate was resuspended in culture medium containing Dispase and gently 
shaken for 3 hours. Following filtration and centrifhgation (4x), cells were resuspended in 
culture medium containing Penicilline (100 U/1ll1) and Streptomycine (100 flg/ml) (instead 
of Gentamycine) and 20% fetal calf serum. 
Cells designated to be nprimary culturesn (Po) were plated on membranes, and left to stand 
for 1 h before culture medium was replaced. After 24 h culture medium was renewed and 
this was repeated every 48 h. From day 3 all, culture medium contained only 10% fetal 
calf serum. 
nFirst passage cellsn (PI) were seeded in gelatin coated plastic culture flasks, grown to 
confluency (sec § 2.2.1) and then harvested with a mixture of 0.25% (w/v) trypsine and 
0.01% (w/v) EDTA in PBS. Following resllspension in culture medium and centrifugation, 
cells were plated on membranes according to the procedure described above. 
Before plating, membranes were preconditioned for 2 h at 37 °C with culture medium 
containing 20% fetal calf serum. 
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§ 2.2.4 Incubations under hypoxic conditions. 
Primary cultures of blood-brain barrier endothelial cells, grown either in iron-enriched or 
iron-depleted medium, were exposed to hypoxic conditions as described by Pietersma et al 
(20). Briefly, when cultures reached confluency, they were placed in a incubator equipped 
with a conducting surface to maintain a temperature of 37°C. The incubator was complete-
ly sealed and could only be accessed by gloves sealed to the cabinet wal1. A continuous 
flow of 95% N2 and 5% CO2, humidified and heatcd- to 37°C was maintained tln-oughout 
the incubation period. Together, these measurements warranted a contillous low oxygen 
pressure of ± 7.5 mm Hg, as monitored by an oxygen analyzer at the cabinet outlet. Prior 
to use, buffers were gassed with 95% N2 and 5% CO2 and kept in the cabinet to equilibrate 
to hypoxic conditions. 
§ 2.2.5 Oxidizing system. 
To test the relative susceptibility of BBB-EC's to oxidative damage and the effect thereon 
of iron-emiched and iron-depleted culturing, cells were exposed to an oxidizing system 
composed of vitamin C and H20 2• 
Prior to exposing cells to the oxidizing system, culture dishes (or cover slides) were rinsed 
twice with PBS at room temperature. Next cells were incubated with M199 culture medium 
containing 2 mM vitamin C at stored at 37°C under nonnoxic circumstances (5% CO2 and 
20% 0,). After 15 min H,O, (2 mM) was added to the medium and mixed. 
Cover slides for DNPH immunofluorescense experiments (see § 2.3.4) were kept at 37°C 
for I h, rinsed 3 times with PBS, followed by immediate fixation in methanol (-20°C). 
Petri dishes for the carbonyl assay (see § 2.5.2.10) were kept at 37°C for either 1,2 or 3 
h. At the end of the incubation period cells were placed on ice, rinsed twice with icecold 
PBS and processed. 
§ 2.3 Morphological techniqucs. 
§ 2. 3.1 Anti-Von Willebrand Factor immwlOcytochemistJY. 
Glass coverslides, stored in acid bichromate, were coated with 0.2% gelatine (w/v) in PBS 
(as described in § 2.3.5) and cells were grown for 4 to 6 days. After fixation for 5 min in 
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methanol (-20°C), cells were incubated with 5% Blotto (Sigma, USA) for 30 min, rinsed 3 
times with PBS and incubated with mOllse anti-human Von \ViIlebrand Factor. Finally, 
cells were incubated with fluorescein labeled goat anti-mouse IgG for 30 min, rinsed with 
PBS and examined in a Leitz Aristoplan fluorescence microscope. 
§ 2.3.2 Coupling 0/6.6 11111 gold 10 IransjCrrin. 
According to manufacturers instructions, coupling of protein to the gold particles critically 
depends on the pH of the mixture. Coupling conditions are considered optimal when the 
mixture has a pH equal to or slightly above (::; 0.5 pH units) the iso electric point of the 
protein that is to be labeled. Therefore, diferric porcine transferrin (lEP ± 5.9, sec chapter 
3) was dialyzed for 24 h against 0.5 mM NaHCO, buffer of pH 6.4. Next, the minimal 
conccntration of protein needed to prevent the gold particles from aggregating in a 1% 
sodium chloride solution, was assessed spectrophotometrically at 580 nm. Based on the 
results of this titration, an aliquot of the 6.6 11111 gold sol waS brought to pH 6.5 and mixed 
with Tf (18.75 fIg Tf/ml gold sol solution) under continuous stirring. This solution was left 
to stand for 15 min. To further stabilize the Au-Tf mixture and block the remaining free 
snrhlce area on the gold particles, BSA (10%, pH 9.0) was added to a final concentration 
of 1% (w/v). 
To remove both unbound transferrin and gold-aggregates, the transferrin-gold (Au-TI) 
suspension was centrifuged (45000 x g, 45 min, 4°C). Supernatant and solid pellet were 
discarded, whereas the "slurry pellet" was collected and loaded on a linear (10-30%) 
sucrose gradient and centrifuged (80000 x g, 90 min, 4°C). Supernatant was carefully 
removed and the upper one third of the gradicnt was collected. Following dialyzation 
against PBS containing 1% (w/v) BSA and 20 mM NaN3 , the protein-gold mixture was 
stored at 4 'C. 
§ 2.3.3 Incubation procedure of membrane-grown endothelial cells with gold-labeled 
transferril1. 
Po and PI cells were grown on membranes until confluent (as described in § 2.2.3. Prior to 
incubation, membranes were gently washed with icecold PBS (2x) and placed on ice. The 
luminal sides of the cells (upper chamber) were then incubated with 1 Illi M199, containing 
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HEPES, L-glutamine, and ± 1 pg/ml Au-Tf for 2 h at 4°C. The lower compartment was 
filled with 1.5 ml M199 containing HEPES and L-glutamine. Next, membranes were 
washed twice with icecold PBS to remove unbound Au-Tf. Endocytosis of Au-Tf was 
started by placing the membranes in 1.5 ml MI99 of 37 "C, simultaneously replacing the 
icecold medium in the upper chamber for MI99 (37 "C) containing 100 nglml unlabeled 
diferric Tf. Endocytosis was stopped at 1, 5 or 10 min by placing the membranes on ice 
and rinsing the cells twice with icecold PBS. Membranes were then submerged in fixation 
fluid (sec § 2.10.1) and left to stand overnight at 4 "C. 
§ 2.3.4 2,4 Dinitrophenol Itydrazille imI1l1lflocytochemisIlJ
'
. 
Primary isolates of BBB-EC's were grown on glass cover slides, coated with 3-alllinopro-
pyltriethoxysilane according to the procedure described in § 2.3.5. From day 3 on, 50% of 
the cultures were exposed to iron-enriched medium as described in § 2.2.2, whereas the 
remaining 50% were treated according to normal culture conditions (see § 2.2.1). After 10 
days, cells were rinsed with PBS, and either fixed directly or fixed following exposure to 
the oxidizing system (see § 2.2.5). Cells were fixed in methanol (-20 "C) for 5 min, and 
thereupon immediately immersed in a solution of 10 Illlvi 2,4 DNPH dissolved in a mixture 
(9:5, v/v) of methanol and sodium phosphate buffer, pH ~ 3. After 10 min, cells were 
washed by repeated dipping in a 1:1 (v/v) mixhlfe of ethanol and ethyl acetate. Following 
removal of unbound DNPH, cells were incubated for 1 h at room temperature in 5% (w/v) 
Blotto to block nonspecific binding. Cells were then rinsed 3 times 5 min with PBS and 
incubated for 1 h at room temperature with rabbit anti-dinitrophenol (diluted 1: 100). Next, 
cells were rinsed again (3 times) with PBS and incubated for 1 h in the dark with Swine 
anti-rabbit Fluoresein (diluted 1:200). Coverslides were then washed with PBS and 
destilled water, mounted on glass slides and viewed with a Zeiss Axioskop fluorescence 
microscope. This microscope was equipped with a triple pass filter set for simultaneous 
viewing of FITC, Texas Red, and DAPl. Images were taken with Fugicolor Super 0400 
ASA film. 
§ 2.3.5 Coverslide coating procedures/or immlmocytocliemisfl)'. 
Glass coverslides were stored in acid bichl'Omate for pl'Olonged periods of time (weeks) 
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prior to use. Immediately before coating cover slides were extensively rinsed, first with 
96% ethanol and then followed by destilled water. 
Gelatine coating: cover slides were placed in small petri dishes and 0.2% gelatine (w/v) in 
PBS (± 90°C) was added. The cover slides were then stored overnight under sterile 
conditions in a breeding cabinet at 37 °C. Prior to use, cover slides were rinsed once with 
PBS. 
3-Aminopropyltriethoxysilane coating: cover slides were air dried prior to use, then 
immersed for 15 sec in a mixture of acetone and 3-aminopropyltricthoxysilane (50:1, v/v). 
Next, slides were repeatedly dipped in acetone, followed by dipping in regular tap watcr 
and air dricd overnight under sterile conditions in a brceding cabinet at 37 °C. 
§ 2.4 Semiquantitative hnmullochelllical pl'Ocedures. 
§ 2.4. J Crossed immul1oelectrophoresis. 
Samples from transferrin and hemopexin containing fractions were subjected to crossed 
immunoelectrophoresis (7) to assess thcir purity. Briefly, 1 g Agarose was dissolved in 100 
ml of a 0.1 molll tris-barbiturate buffer (pH 8.6) heated to 90°C under continuous stirring. 
After pouring and cooling of the gel, a well was punched and filled with 2 l-'I sample. The 
gel was mounted on a LKB 2117 Multiphor System (LKB, Sweden) and electrophoresis in 
the first dimension was performed at 10 V/cm for 30 min (1.5 h for hemopexin) at 15°C. 
The sample containing lane was cut out and transferred to another glass plate with agarose 
gel containing rabbit anti-porcine serum protein antibodies (courtesy W.L. van Noort). 
Electrophoresis in the second dimension was performed for 20 Ius at 2.5 V/cm (2 V/cm for 
hemopexin). The gel was washcd for 48 h in 0.15 molll NaCI repeatedly changing the 
washing solution. The gel was then air dried and stained with Coomassie Brilliant Blue R-
250 (0.1%, w/v) in ethanol/acetic acid/water (4.5:1:4.5, v/v/v). Similar experiments were 
performed with goat anti-swine total serum protein antibodies. 
§ 2.4.2 Alpha-2-lIIacrogloblllill alld 440 olld 660 kDa assays. 
Ouchterlony double immunodiffusion was accomplished in sodium barbiturate buffered 
1% Agarose (ICN, The Netherlands) and stained with amido black. 
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Rabbit anti-porcine-serum protein antibodies (obtained from Nordic, The Netherlands) 
were used, because neither porcine alpha-2-macroglobulin nor its antibody, are commer-
cially available. As alpha-2-macroglobulin is a serum protein, one would expect a cross 
reaction between alpha-2-macroglobulin and anti-serum protein antibodies. 
The 440 and 660 kDa ferritin Ouchteriony assays were performed with polyclonal 
antibodies raised against both purified fractions (see chapter 4). 
§ 2.4.3 Transferrin and ferritin immUllosorbellt assays. 
Standards (either rat transferrin diluted between I-IS ng/SO fli TBS, or type I horse 
ferritin diluted between 0.2S-1S ng/SO It! TBS; Sigma Chemical Co., St. Louis, MO) and 
homogenates (diluted to approximately I I11g protein/SO fli TBS) were applied in triplicate 
onto nitrocellulose membranes (MSI, \Vcstboro, MA) presoaked in TBS, using a Manifold 
II vacuum slot blot device (Schleicher and Schuell Inc., Kene, NH), as described by 
Roskams and COIlllor (22). Briefly, the membranes were blocked for 1 h at room tempera-
ture with Blotto (5% wlv, Carnation instant nonfat dried milk in TBS), rinsed for 5 min 
(3x) with TBS, and incubated overnight at 4 °C with primary antibody: either rabbit anti-
rat transferrin (1:1000) (courtesy Dr. R. Fine, Boston University, MA); or rabbit anti-horse 
ferritin (1:3000) (Jackson ImmunoResearch Lab. Inc.). Membranes were then rinsed and 
incubated in secondary antibody 125I_goat anti-rabbit IgG (NEN Research Products, 
\Villllington, DE), 4 ~lCi pel' blot for I h at room temperature. Membranes were then 
rinsed, dried, and packed with film for approximately 15 h. 
Developed films were analyzed using a Molecular Dynamics Model 100A Densitometer 
(1VIolecular Dynamics, SUIlnyvale, CA) and pdiQuantity one software (pdi, Hunington 
Station, NY). Regression analysis of the optical densities measured for the rat standards 
was used to determine sample ferritin and transferrin concentrations. Each slot blot 
contained it's own standard curve and data were only analyzed from slot blots with 
standard curve correlation coefficients ~ 0.95. All samples were run on three separate blots 
and averaged to report the final value. 
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§ 2.5 Analytical and quantitative pl'ocedul'cs. 
§ 2.5.1 Analyl;callechn;ques. 
§ 2.5.1.1 Native and SDS polyacl)'lamide gel electrophoresis. 
Native polyacrylamide gel electrophoresis (pAGE) and sodium dodeeyl sulfate (SDS) 
PAGE were performed on a PhastSystem (Pharmacia LKB, Sweden) using either 8-25%, 
10-15%, or 4-15% gradient gels depending on the mass of the protein under study. Typical 
settings of the PhastSystem are summarized in Table 1. 
Native PAGE Temp. Pre-rull Sample Separatioll 
Gel type: application 
Gradient 15°C 400 V 400 V 400 V 
4 - 15% to mA 1 mA 10 mA 
2.5 W 2.5 W 2.5 W 
20 Vh 5 Vh 300 Vh 
Gradient 15°C OV 250 V 250 V 
to - 15% OmA to mA to mA 
OW 3.0W 3.0 W 
o Vh 10 Vh 65 Vh 
Gradient 15°C OV 250 V 250 V 
8 - 25% o mA to mA to mA 
OW 3.0W 3.0 W 
o Vh to Vh 65 Vh 
Table 1. 
Parameter values of the PhastSystem used in native and SDS PAGE of porcine transferrin, 
hemopexin and ferritin. 
Native (non-denaturating) polyacrylamide gel electrophoresis (PAGE) and sodium dodeeyl 
sulfate (SDS)-PAGE were also performed on a mini protean system 2 (Bio Rad, the 
Netherlands) according to manufacturer's instmctions. 
Gels were stained for protein according to manufacturer's instructions. Iron staining was 
performed neeoJ'ding to Chung (5). Gels were analyzed and quantitated using an Ultroscan 
XL enhanced laser densitometer (LKB, the Netherlands). 
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§ 2.5.1.2 Tricille-SDS PolyaClylamide gel electrophoresis. 
Analyse~ of Land H subunit ratios in the porcine spleen ferritin fractions were performed 
on Tricine-PAGE (16.5% T and 3% C) gels according to Schiigger & Jagow (23). The 
16.5% Tricine SDS-PAGE (as compared to standard SDS-PAGE) resulted in a more dis-
tinct separation betwecn both the 19 and 21 kDa subunits and allowed a better deJlsito~ 
metric analysis of the subunit ratio. 
§ 2.5.1.3 Isoeleetric focl/ssillg. 
Isoelectric focussing of porcine spleen ferritin was performed on 1% agarose gels (pH 4-6) 
using a Pharmacia PhastSystem (for details see Table 2). 
Isoelectric focussing of porcine transferrin and hemopexin was performed on a PhastSy-
stem using PhastGel IEF (pH 4-6.5) gels (30). Typical settings are summarized in Table 2. 
Isoelectl'ic Temp. Pre- Sample Separation 
focussing focussing application 
Gel type: 
1% Agarose 15°C 1000 V 200 V 1000 V 
pH: 4 - 6 2.5 mA 2.5 mA 2.5 mA 
3.5 W 3.5 W 3.5 \V 
60 Vh 15 Vh 205 Vh 
PhastGel 15°C 2000 V 200 V 2000 V 
IEF 2.0 mA 2.0mA 5.0 mA 
pH: 4- 6.5 3.5 \V 3.5 \V 3.5 W 
15 Vh 15 Vh 1000 Vh 
lable 2. 
Parameter values of the PhastSystclll used in isoclectric focussing of porcine transferrin, 
hemopexin and ferritin. 
§ 2.5.1.4 Sephaf'Ose~col1canavalill A chromatography. 
Prior to amino acid and carbohydrate analyses, porcine transferrin was applicd to a 
column packed with Sepharose-linked concanavalin A according to a procedure described 
by Hatton et al (II). 
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§ 2.5.1.5 Determination of the iron to phosphorus ratio with Electron Probe iViicroGnalysis 
(EPMA). 
EPMA was carried out (8) with a Transmission Electron Microscope (TEM) JEOL 2000 
FX at 80 kV, with the use of an allticontamination device. The rEM was equipped with an 
X-ray detector with a high purity germaniulll crystal and ultrathin window. The detector 
was coupled to a Traeor Northern 5500 System. The specimen (ferritin) was observed in a 
single tilt holder with a graphite specimen retainer at a take-off angle of 35°. Nylon grids 
(60 mesh) were covered with a pyoloform film with multiple holes and coated with carbon. 
Ferritin suspensions were placed directly on these grids and air dried. Ivrultiple analyses 
were performed during 100 sec (irradiated area: 0.75 pm2) on that part of the ferritin 
suspension that covered the holes in the pyoloform film. Another set of analyses was 
performed under the same instrumental conditions on that part of the ferritin suspension 
that was covering the pyoloforl11 film. Horse spleen ferritin served as a calibration standard. 
Of each fraction electron micrographs were made at M = 500,000. 
§ 2.5.1.6 Protein carbonyl staining in Westem Blots. 
For \Vestern blots, sonicates of 4 rats per group were pooled in order to obtain sufficient 
protein to load 50 fIg protein per lane and treated as outlined in (§ 2.5.2.10). Control lanes 
consisted of pooled samples that were treated in the same manner, but did not undergo 
initial hydrazone derivitization. Resulting precipitates were solubilized in SDS running 
buffer and loaded onto a 10% polyacrylamide gel. Each gel contained a lane of Rainbow 
protein molecular weight markers (Amersham, Arlington Heights, IL). Gels were rlln at 
155 V (constant voltage) for approximately 4 to 5 h. Proteins were transferred to nitrocelM 
lulose electrophoretically, using a semiMdry transfer apparatus. Blots were incubated for 2 It 
at room temperature with rabbit antiMdinitrophenyl antisera (Dakopatts, Denmark), diluted 
1:1000 (v/v). Blots were rinsed and incubated for 1.5 h in mOllse anti-rabbit IgG conjuga-
tcd to alkaline phosphatase (Jackson Laboratories, \Vest Grove, PA) and developed with the 
NBTIBCIP (USB) color substrate system. 
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§ 2.5.2 Quantitative procedures. 
§ 2.5.2.1 Protein concentration measurements. 
Protein concentrations were determined according to Bradford 
(3) usiug different concentrations of BSA as a standard. 
§ 2. 5. 2. 2 Cel/u/ar protein measurements. 
Cells were washed with PBS (4°C), 250 !tl destilled water was added and cells were 
harvested. Next, dishes were rinsed 3 times with 250 pI destilled water containing 0.1 % 
Triton X-IOO. These rinses were added to the cell suspension. Following sonication of the 
suspension (10 sec, O°C), 100 pI samples were taken (in duplicate) and protein concentrati-
ons were measured according to Bradford (3), using BSA as a standard. 
§ 2.5.2.3 Cellular DNA measurements. 
Cells were harvested as described in the previous section (§ 2.5.2.2). Samples were taken 
for protein measurements and the DNA content of each sample was assessed using a 
Nuclesan DNA kit (Sanbio, the Netherlands) according to manufacturer's instructions. 
Results from three separate experiments, each performed in 6-fold, are expressed in number 
of cells per mg protein. 
§ 2.5.2.4 Carbohydrate analyses. 
Carbohydrate analyses of transferrin fractions (obtained from the Sepharose-concanavalin 
A column) and hemopexin were performed on a LKB Alpha Plus 4151 (LKB, U.K.), 
equipped with a 60 em column ( 2.4 mm) packed with UItropac II resin (31). 
§ 2.5.2.5 Amino acid and N-acetylglllcosamine analyses. 
Analyses of N-acetylglucosamine and amino acids were performed using a method 
described by van Eijk (29) on a Pharmacia Biochrom 20 (Phannacia, U.K.) equipped with 
a 20 cm COlUIllll ( 4.6 nun) packed with Ultropac 8 resin. 
In both techniques, results of duplicate nms varied less than 3% within one sample. 
Human 4 sialo transferrin (with two bi-antelUlary glycan chains) was used as an internal 
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standard in both carbohydrate- and amino acid analyses. 
§ 2.5.2.6 Sialic acid quantification. 
Following carbohydrate analysis, the runount of sialic acid in porcine trrulsferrin and 
heIllopexin was assessed according to a technique described by Horgan (13). Both 4 sialo 
transferrin (with two bi-antelmary glycan chains) and N-acetylneuraminic acid were used as 
standards. 
§ 2.5.2.7 Ferritin iron determination. 
Ferritin iron was determined according to a method adapted from Harris (10) using 
Ferrozine (Sigma, USA). To 100 ftl sample an equal amount of 37% (w/v) Hel was added, 
mixed and left to stand for 15 min. Next, 100 fll L-ascorbic acid (0.14 M), 0.5 ml sodium 
acetate (saturated) and Ferrozine (10 mM) were added to tins mixture. After 10 min the 
absorbance at 562 11m was measured and compared to a range of standard Fe(III) solutions. 
§ 2.5.2.8 Tota! iron determination (flame atomic absorption spectropJlOtometIY). 
Iron determinations in rat brain homogenates were made using atomic absorption 
spectrophotometry. Aliquots (30 fll) of rat brain homogenates were digested in polypropy-
lene tubes by adding 30 ~tl of nitric acid and incubating at 37 °C for one week in a hot 
water bath. Three tubes containing 30 fll sample buffer (0.25 M sucrose + 10 mM PMSF) 
underwent the same procedure and served as controls. Standard curves ranging from 0 to 
1.00 fIg iron/ml were prepared by diluting iron standard (I mg iron/ml, Alpha Products, 
Danvers, MA) in 5% nitric acid. Standards and digested samples were read in triplicate by 
injecting 20 pI aliquots into a teflon cup, attached to a Instnllnent Laboratories Video 11 
atoilnc absorption spectrophotometer (Allied Analytical Systems, Waltham, MA). Absor-
bance readings were recorded and used for analysis. 
§ 2.5.2.9 Phosphorus determination. 
Biochemical assessment of the amount of phosphonls in ferritin was performed according 
to Ames (1). Briefly: a ferritin containing sample is mixed with 30 ~tl of a solution of lO% 
(w/v) Mg(NO,),.6H,O dissolved in 95% ethanol and subsequently dried and ashed. After 
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cooling, 0.3 ml HCI (0.5 molll) is added, and tlus is incubated for 15 min at 100 'C. The 
tube is cooled again and 0.7 ml of a (1:6) mixture of 0.57 1110111 ascorbic acid and 3.4 
mmol ammonium molybdateAH20 dissolved in 1 molll H2S04 is added. This mixture is 
stirred and incubated for 20 min at 45 'C. Samples are read speetrophotometrically at 820 
n111 and compared to standards of inorganic phosphate treated identically. 
§ 2.5.2.10 Protein carbonyl determination 
Protein carbonyl concentration was determined by forming protein hydrazone derivatives 
using 2,4 dinitrophenylhydrazine (2,4 DNPH). 
For brain tissue, we used a technique adapted from Smith et al (24). Brain samples were 
sonicated on ice in 0.01 M sodium phosphate containing 0.1% Triton X-IOO (pH ~ 7.4). 
Sonicates were then centrifuged (10 min, 40000 x g, 4°C) and supernatants were incubated 
with equal volumes of 10 mM 2,4 DNPH in 2 M HCI (15 min). The protein hydrazone 
derivatives were extracted in 10% trichloroacetic acid and centrifuged (10 min, 20000 x g, 
4°C). Pellets were washed 3 times with 1: 1 vlv ethanol/ethyl acetate and solubilized in 6 
M guanidine hydrochloride. Samples and blanks of guanidine HCI were read spectrop-
hotometrically at 367 nm. Protein carbonyl concentrations were calculated with an 
reference absorptivity E of 21.0 m1fl em'! and expressed in nmol of 2,4,DNPH incorpora-
ted per mg of protein. 
For cell cultures: blood-brain barrier endothelial cells were grown to near confluency in 
either iron-enriched or iron-depleted culture medium. Following exposure to an oxidizing 
system (see § 2.2.5), cell wcre placed on ice and washed twice with icecold PBS. Cells 
were then incubated for 10 min with I ml of a 10 mM sodium phosphatc buffer (pH ~ 7.4) 
containing 0.1% Triton X-IOO. Cells were harvested, then sonication on melting icc and 
centrifuged (20000 x g, 10 nun, 4 'c). An 1 ml aliquot of supernatant was incubated with 
an equal volume of 2,4 DNPH and left to stand for 15 min. An additional aliquot of each 
sample was incubated with 2 M HCI instead of DNPH (blank). The remaining part of the 
procedure was as described above. Carbonyl concentration were measured directly, as 
samples were read spectrophotometrically at 367 lIDl and corrected for blanks (with 2 M 
HCI instead of DNPH) and guanidine HC!. Protein carbonyl concentrations are expressed 
in nmol/mg protein. 
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§ 2.5.2.11 j\1yelopeJ'oxidase activity assay. 
Myeloperoxidase activity was measured to assess the number of adherent granulocytes in 
the granuloc)1e adherence assay (sec § 2.5.2.12) (20). Briefly, following incubation and 
adherence of granulocytes to bloodwbrain barrier endothelial cells, myeloperoxidase was 
extracted for 15 min ill 5% hexadecyltrimethylaulllloniul11 bromide (HTAB) (Merck, 
Germany). To 50 ftl of this HT AB extraction solution 100 fll of a mixture of o-dianisidine 
hydrochloride (0.2 mg/ml) and 0.4 mM H,O, was added and the reaction was monitored at 
450 nm. The measured maximum reaction rate was compared to a standard curve obtained 
from different concentration of granulocytes incubated in HTAB, to estimate the number of 
adherent granulocytes. 
In general, porcine granulocytes showed low myelopcroxidase activity. 
§ 2.5.2.12 Granulocyte adherence assay. 
Primary cultures of bloodwbrain barrier endothelial cells were grown either in irollw 
enriched or iron-depleted medium until reaching contluency. CelJs were then placed in a 
airtight incubator (see § 2.2.4) and exposed for 2 h to hypoxic conditions as described by 
Pietersma et al (20) prior to incubation with granulocytes. Briefly, il11111ediateiy upon expow 
sure to hypoxic conditions, medium was removed and replaced by Krebs-Ringer bicarbo-
nate bnffer (~ 118 mM NaCI, 4.7 mM KCI, 1.0 111M CaCI" 1.2 111M KH,PO" 1.2 mM 
MgSO,.7H,o, 25 mM NaHC03, 5.5 mM glucose and 2.3 mg/ml HEPES) of pH ~ 7.4. 
After 2 h, hypoxic buffer was removed and replaced by Hanks' balanced salt solution 
(l1onnoxic). TIlis buffer was replaced ailer 5 min by granulocytes resuspended in Hanks' 
balanced salt solution. Cells were incubated with 1, 2, 3 or 4 x 106 granulocytes/cm2, then 
left to stand for 5 min to allow adherence. Next, cells were washed once with 1 ml Hanks' 
balanced salt solution and incubated for 15 min with HTAB to extract myeloperoxidase 
and assess the number of adherent granulocytes (see § 2.5.2.11). 
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§ 2.6 Protein isolation and purification procedures. 
§ 2.6.1 Iso/ation oj porcine t/'Gnsjerrin 
§ 2.6.1.1 SerulIl pretreatment. 
The technique used is a modification of the procedure described by Baumstark (2). Fresh 
porcine blood was obtained from the local abattoir, where citrate was added to prevent 
clotting during transport to our laboratory. Upon arrival, blood was immediately centrifuR 
ged (1000 g, 10 min). The resulting plasma was saturated with excess iron (400 I"mol 
FeCtil plasma) under continuous gentle stirring during 30 min at 37°C. Aliquots of 
plasma were then dialyzed against a 20-fold excess of a 0.14 molll NaCIIO.Ol molll CaCI, 
solution (overnight, 4°C) to precipitate fibrin. The resulting semiRelastic coagulate was left 
to stand for two hours at room temperature and the fluid oozing from tllis coagulate was 
collected for further processing. Tllis solution was brought to 50% saturation with (NH4)2-
SO" left to stand for 1 h at 4 °C and centrifuged (4000 g, 20 min, 4°C). The clear 
supernatant was then brought to 70% saturation with (NH,f)2S04' centrifuged (4000 g, 20 
min, 4 0c) and the pellet dissolved in distilled water containing 1.54 mmolll NaN,. 
Subsequently, tIus solution was rapidly dialyzed and concentrated on a Mini Ultrasette (Fil-
tron, The Netherlands). Aliquots of tltis solution were stored at -20°C until further use. 
§ 2.6.1.2 CO/WillI preparation. 
The column preparation, as described by Baumstark (2) was followed with some minor 
alterations. Briefly, Bio-Gel A 1.5m was coupled to Cibacron Blue 3GA (12): 3 g Cibacron 
Blue 3GA, dissolved in 150 ml 0.47 molll Na,CO" was mixed with 450 mI· Bio-Gel A 
1.5m and incubatcd for 42 h at 45°C. Following removal of the unbound dye on a glass 
bed filter, the gel was loaded on a column (2.1 x 95 cm) and packed under 60 cm H,O 
pressure. The gel was then washed with 3 column volumes 1.54 mmol/l NaN), followcd by 
1 column volume 0.5 molll phosphate buffer (KH,PO/K,HPO" molar ratio 1:2, pH 7.1) 
and finally with 500 ml 0.5 molll KCNS before scaling the colunm fitting. It is recom-
mended to use an adjustable end fitting, because the gel volume will change during column 
operation. 
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The column was equilibrated with 1.54 mmolll NaN, until a stable absorbance baseline 
was reached and pH and conductivity of the effluent matched those of the NaN, solution. 
§ 2.6.1.3 Separatioll procedure. 
Upon thawing, a sample of the pretreated serum (± 400 mg protein) was loaded onto the 
column, followed by circa 3 column volumes 1.54 mmolll NaN3 until the absorbance (at 
280 nm) had returned to its baseline level. Hereafter, a linear phosphate buffer gradient 
was started to elute transferrin. The gradient consisted of 500 ml 0.1 molll KH2PO/Na2H-
PO, (molar ratio 1:2, pH 7.1) in 1.54 mmol/l NaN, against 500 ml 1.54 mmolll NaN,. 
§ 2.6.1.4 Regelleratioll of the COIUIIIII. 
After each nlO, the Bio-Gel NCibacron Blue gel was regenerated using 1.54 mmol!l NaN, 
until absorbance reached the original baseline level. After each 6th nm the gel was rege-
nerated more rigorously, using 400 ml 0.5 molll KeNS. Afterwards the column was 
equilibrated as described in an earlier section. 
§ 2.6.2 Imlatiol1 of porcine hemopexin. 
Porcine serum hemopexin was isolated according to a method adapted from Noiva (17) 
and Spencer (27). Fresh pooled porcine blood was obtained from the local abattoir. Citrate 
was added to prevent clotting during transport to our laboratory. Upon arrival, blood was 
immediately centrifuged (1000 g, 10 min). Fibrin was removed as outlined above (§ 
2.6.1.1). Tills solution was brought to 50% saturation with (NH,),SO" left to stand for I h 
at 4 °C and centrifuged (4000 g, 20 min, 4°C). The supernatant was dialyzed overnight 
against running tap water, followed by dialysis for 48 h at 4 °C against 0.01 molll sodium 
citrate buffer (pH 5.7), containing 0.02% (w/v) NaN,. Aliquots (150 ml) of tillS dialyzed 
solution were applied to a CM-Sepharose CL-68 column (100 x 2.2 cm) and the colunll 
was rinsed with 0.01 molll sodium citrate buffer (pH 5.7) until a stable baseline was 
reachcd. Next, a 800 ml linear gradient of sodium citrate (0.01 to 0.06 M) was developed 
to elute hemopexin and transferrin. Hemopexin containing fructions were concentrated and 
loaded on a column (150 x 2.4 cm) packed with Sephadex G 100 to remove hemoglobin 
and hemopexin di- and polymers. Degraded hemopexin fragments and other low molecular 
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weight proteins were removed applying hemopexin containing fractions to a Sephadex G 
75 column (100 x 1.4 cm). 
§ 2.6.3 Isolation and slIbj'actiollation of porcine spleen ferritin 
§ 2.6.3.1 Ferritin isolation method 1. 
Porcine spleen ferritin was isolated according to a method adapted from Penders (18). 
Briefly, after removal of fat and connective tissue, the spleen was rinsed in 0.15 M NaCI 
(4 'C) and homogenized (Ultra-turrax, Janke & Kunkel). The homogenate was heated (80 
'C, 5 min), rapidly cooled and centrifuged (3000 g, 45 min). The supernatant was centri-
fugcd (78,000 g, I h) and the resulting pellet resuspendcd in 0.15 M NaCI and centrifuged 
(7000 g, I h). The ferritin containing supernatant was then centrifugcd at 78,000 g for 1 
hour. The last two centrifugation steps were repeated and finally the pellet was resuspended 
in 0.15 M NaCI containing 0.0 I % NaN, and centrifuged again (78,000 g, 1 h). All 
centrifugation steps were performed at 4 °C. 
§ 2.6.3.2 Ferrifin isoialionlllethod 2. 
Human placental ferritin and porcine spleen ferritin were isolated according to Konijn et al 
(14). Briefly, tissue was homogenized and then centrifuged (10,000 g, 20 min). Supernatant 
fractions were heated to 80 'C (5 min), cooled on ice and centrifuged (10,000 g, 20 min). 
The supernatant was adjusted to pH 4.2 with acetic acid, left to stand for 24 hours at 40 C 
and then centrifuged (10,000 g, 20 min). Following adjustment of the pH to 5.5 with 
sodium acetate, the supernatant was brought to 50% saturation with ammonium sulfate, left 
to stand for 1 hour at 4' C and centrifugcd (10,000 g, 25 min). The pellet was resuspended 
in water, brought to 75% saturation with ammonium sulfate and centrifuged (10,000 g, 25 
min). The clear supernatant was dialyzed against 0.15 moIIJ NaCI for 24 hours and 
centrifugcd (120,000 g, 4 h). 
§ 2.6.3.3 Separation ofisoferritins. 
Porcine spleen ferritin was separated by ion-exchange chromatography on a DEAE-Sepha-
dex A-25 column into acid, intermediate and basic fractions according to Konijn et al (14). 
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§ 2.6.3.4 Preparation and operatioll of Ihe combined Sephal'Ose 4B {Jnd Sepharose 6B 
columns. 
Two columns were packed with Sepharose 4B (207 • 2 cm) and Sepharose 6B (200 • 1.8 
em) respectively. Column dimensions required the level of the column outlet tubing to be 
adjusted during packing of the gel in order to prevent packing pressure exceeding 80 em 
H,o. Samples were loaded on the Sepharose 6B column, eluted with a 0.05 M Tris-HCL 
buffer (pH 8.0) and fed directly into the Sepharose 4B colnmn. Both columns were serially 
linked with small diameter tubing (0.7 111m diameter) to prevent remixing of the already 
partial1y separated proteins. Pure ferritin fractions were collected and concentrated by ultra-
centrifugation (78,000 g, I h). 
§ 2.6.4 1s01atioll and purification of TjR's ./i·om porcine liver (to test TjR recDvelY 
efficiency). 
Fresh porcine liver tissue was cut into small fragments, washed 3 times in PBS (4°C) 
containing 0.01% PMSF, and homogenized in I mM NaHCO/0.5 mM CaCl, buffer (pH 
7.5, 4°C). The homogenate was fIltered through a 150 ~tln nylon mesh and centrifuged 
(2000 g, 30 min, 4°C). The pellet was resnspended in the same buffer and washed twice (~ 
crude vesicle preparate). The pellet was then dissolved in PBS containing 0.5% Triton X-
100 and 0.25% (w/v) Trypsine and placed in a waterbath (3rc, 2.5 h). This solution was 
dialyzed overnight against running tap water, concentrated by ultrafiltration with a 30 kDa 
filter and centrifuged (25,000 g, 4°C, 2 h). Supernatant samples were loaded on a Sepha-
dex G I 00 (Phannacia) column and the 70 kDa fraction was collected, concentrated and 
dialyzed against a start buffer (containing 0.25 M NaCI, 174 mM Na,HPO,.2H,O and 13 
niM sodium citrate, pH 7.2). Samples were then loaded on a column packed with porcine 
Tf coupled to CNBr-Sepharose 4B (pharmacia, Sweden). Prior to loading, the column had 
been incubated overnight with a 0.02M Tris buffer (pH 8.2) containing 50 mM NT A, 2 
mM Fe(III)-citrate, 20 111M NaHCO, and 0.02% NaN" to satmate all Tf iron binding sites. 
After loading, the column was washed with start buffer until a stable baseline was reached. 
The 70 kDa TfR subunit was eluted with a buffer (PH 2.8) containing 0.25 M NaCl, 32 
mM Na2HP04.2H20 and 84 niM sodium citrate. Purity was checked with sodium dodecyl 
sulfate (SDS) polyacrylamide gel electrophoresis on a PhastSystem (see § 2.5.1.1). 
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§ 2.6.5 Isolation qf granulocytes. 
Granulocytes were isolated from citrated porcine blood, freshly obtained from a local 
slaughterhouse according to Pietersma et al (19). Briefly, blood cells were diluted and 
centrifuged over Lymfoprep (Nycomed, The Netherlands). Following isotonic lysis of 
erythrocytes in a mixture of 155 mM NH,CI, 10 mM NaHCO, and 0.1 mM EDTA (PH ~ 
7.4) at 4°C, granuloc)1eS were washed and resuspended in PBS containing 5% (w/v) 
bovine serum albumin (Sigma Chemical, St. Louis, MO). Granulocytes were stored at 4 °C 
until use. 
§ 2.7 Statistical analyses and clll~'e fitting. 
§ 2.7.1 Statistical analyses ferritin data sets. 
Ferritin data sets were analyzed with a Bonferroni t test following a ttrepeated-measures 
analysis of variance lt to test differences in amino acid and carbohydrate composition be-
tween the three ferritin fractions. 
§ 2.7.2 Matlzelllatical analysis of tlze slIIface and total TfR binding experilllents. 
In each individual experiment the percentage nonspecific binding was calculated using 6 
wells incubated with different concentrations of J25I-Tf in the presence of a lOO-fold excess 
of non-labeled Tf. Furthermore, the results from each binding experiment were fitted using 
the following equation in a nonlinear curvefit program (Statgraphics, Statistical Graphics 
Corporation, USA). 
f(x);;;- a*x +c*x 
b+x 
In this equation IIf(xY' represents the amount of bound Tf, "X" free Tf, "a l1 the total TiR 
concentration, "b" the concentration at 50% receptor saturation (Kd) and IIC" represents the 
slope of the linear part of tIus curve fit (= nonspecific binding). Parameters a, band c were 
calculated in an iterative process using the Marquardt algorithm. 
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§ 2.7.3 .A1atllematical analyses of the experimental data on TfR endocytosis and exocytosis. 
TfR internalization was assumed to follow first order kinetics and experimental data were 
therefore fitted to the equation yet) = Btot * (l R e·k.~, using a nonlinear curve fit program. 
nkll represents the TfR internalization rate constant Kin in min'l, ftBtotll represents the 
maximal amount of 59Fe bound to the cell surface at t=O min that can take part in the 
endocytic cycle (see Fig. 6.3). This correction is necessary to compensate for variations in 
the number of surface TfR's due to different culture conditions (see chapter 6). 
TfR externalization was also assumed to follow first order kinetics and data were fitted to 
the equation Yet) = C1 * e,k"' + e2, in which the first tcrm represents the fIrst order 
exocytosis of TfR's. C2 is a constant, introduced to compensate for the fact that evcn after 
1 hour cycle time a considerable percentage of 125r labeled transferrin remains within the 
cell. 
§ 2.8 Transfcl'l'in receptor quantitation and kinctics. 
§ 2.8.1 Radio-Iabelillg of tran.1ferrill. 
Porcine Tf was radio-labeled according to adapted from a method described by Starreveld 
(28). Porcine transferrin was dialyzed for 24 h against an acetate buffer (pH 5.0), contai-
ning 0.04 molll EDTA, to remove all iron. Following dialyses against destilled water and a 
TrislHCI buffer (pH 8.2), apo-transferrin was incubated with ''FeCI, (Atnel~haIll, The 
Netherlands), NTA (nitrilotriacetate) and NaHCO, (30 min, 37°C). Excess "FeCI, was 
removed using a Sephadex PD~lO column (Phannacia, Sweden). Next, S9Pe2-Tf was 
incubated with Na I2S! in a Iodogen coated glass tube. Unbound 1251 was removed with a 
Sephadex PD-IO column, followed by extensive dialyses (3 x 24 h) against a TrisIHCI 
buffer (PH 8.2). Radioactivity was counted in a Packard SOOC autogamma spectrometer. 
Specific activity C"I) ranged from 0.8 - 1.2 x 10' counts/min/mg Tf. 
§ 2.8.2 Surface 7JR measuremellts. 
Blood-brain barrier endothelial cells were used when reaching confluency. Prior to the 
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experiment, cells were pre-incubated for 1 to 2 h at 37 °C with M 199, supplemented with 
HEPES (20 mmollL) and L-Glutamine (4 mmolfL) to deplete all TIR's from Tf. Smface 
TfR measurements were performed as described by Ciechanover (6). 
Briefly: following pre-incubation cells were washed with PBS (4°C) and incubated (for 
h 45 min at 4 °C) with specific amounts of 125I_Tf in M199 up to 100 times Kd to reach 
complete saturation of the TfR's (4). Next, the incubation medium was collected and cells 
were washed 4 times with PBS to remove unbound 1251_ Tr. Surface TfR bound 1251_ Tf was 
collected in a series of wash steps with acidic and neutral buffers. Cells were then 
harvested for protein assessment as described in § 2.5.2.2. Surface bound Tf is expressed in 
ng/flg cell protein. 
§ 2.8.3 Total TjR measurements. 
To assess the total amount of TfR's present in the endothelial cells, a procedure as 
described by Rao (21) was used. Briefly: cells wcre pre-incubated with MI99 to deplete all 
TIR's (sce § 2.8.2), harvested and lysed as decscribed in § 2.5.2.2. Duplicate samples were 
taken from each dish for protein measurements and cell lysates were then incubated (for 2 
h at 4°C) with specific amounts of 1251_Tf in MI99 up to 100 times Kd. Following 
precipitation with 30% ammonium sulfate, the solution was filtered through a 1.2 pm glass 
microfiber filter. Filters were washed 8 times with 30% ammonium sulfate and the 
remaining radioactivity was counted. 
The TiR recovery efficiency of this procedure was checked in a separate series of experi-
ments (see § 2.8.4). Total TIR bound Tf is expressed in ng/flg protein. 
§ 2.8.4 TjR recovery efficiency assessment ill total TfR measurements. 
To test the recovery efficiency of TfR's in cell lysates, the TfR recovery procedure as 
described by Rao (21; see also § 2.8.3), was performed either on (a) 1251_Tf in M 199, (b) 
known amounts of purified half TiR's incubated with 1251-Tf, or (c) crude vesicle prepa-
rates (sce § 2.6.4) incubated overnight at 4 °C with '''1-Tf with or without 0.1 % Triton X-
100. To remove unbound Tf, the vesicle suspension was centrifuged (2000 g, 30 min) and 
the pellet redissolved in 10 vol PBS. This procedure was repeated 5 times, at which point 
radioactivity in the supernatant was less than 5% of that in the pellet. 
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§ 2.8.5 QuantitatioJl ofTfR 's participating ill the elldocy/ic cycle. 
Cells were pre-incubated for 1.5 h at 37°C with M 199, supplemented with 2% BSA 
(w/v), HEPES (20 mmollL) and L-Glutamine (4 mmoI/L). Cells were washed once with 
PBS and then incubated for 1.5 to 40 h with 1500 ng (<: 50 times Kd) J25I_Tf at 37°C. 
Next, cells were placed on icc and rinsed 4 times with PBS (4°C). SlIlface TfR concen-
trations were assessed as described before (see § 2.8.2). Cells were harvested, duplo 
samples taken for protein measurements (see § 2.5.2.2) and radioactivity of the cell sus-
pension was measured. 
§ 2.8.6 Transferrin receptor endocytosis rate measurements. 
Following pre-incubation with semm free medium to deplete Tfl{'s, cells were placed on 
ice and washed with icecold PBS. Next, cells were incubated with 1.6 pg/ml diferric 59Fe_ 
Tf at 4 °C for 1 h 45 min. Prior to the actual experiment, cells were washed 4 times with 
icecold PBS to remove all unbound 59Fe_ Tf. Endocytosis was started by rapidly heating 
petri dishes to 37°C, at the same time adding 2 ml of prewarmed (37°C) medium contai-
ning 1.6 ~lg/ml unlabeled diferric transferrin. Endocytosis was allowed to continue at 37°C 
for fixed time periods, and stopped by rinsing the cells 4 times with iceeold PBS. 
Following 3 wash cycles with acid and nentral buffers respectively (sec § 2.8.2) to collect 
surface bound Tf, cells were harvested and intracellular 59Fe was measured. 
§ 2.8.7 Tram,/errin receptor exocytosis rate measllrements. 
Cells were first pre-incubated with senUl1 free medium for 1.5 hours at 37°C, rinsed 
twice with PBS and then incubated with 1.6 pg/ml I25I labeled difcrric transferrin at 37°C 
for 1 h 45 min. To deplete all smface TfR's prior to the actual experiment, cells were 
placed on ice and washed 3 times with acid and neutral buffers. Exocytosis was started by 
rapid heating to 37°C, at the same time adding 2 tnl of prewanned (37°C) medium 
containing 1.6 Mglml unlabeled diferric transferrin. The experiment was stopped at fixed 
intervals by rinsing cells 4 times with icecold PBS. Surface and intracellular TfR bound 
1251_Tf were measured separately at each interval. 
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§ 2.8.8 Quantification of cellular iron accumulation and release. 
Following pre-incubation at 37°C with senllU free medium, cells were washed twice with 
PBS and incnbated for different time periods up to 24 h with 4.8 flg/ml diferric "Fe-Tf at 
37 °e. At those intervals, cells were placed on ice and washed 4 times with icecold PBS to 
remove unbound 59Fe_ Tf. Next, cells were subjected to 3 washes with acid and neutral 
buffers to assess surface TfR bound "Fe-Tf and then harvested for both protein and 
intracellular iron e9Fe) measurements. The 59Peiprotein ratio represents the net intracellular 
iron accumulation (= iron uptake minus iron release). 
A parallel experiment was set up to measure iron release only. In a number of dishes, 
cells were allowed to accumulate 59Fe for three hours as described above. After three 
hours. medium containing 59Fe was removed, cells were washed with icecold PBS to 
remove unbound 59Pe and sUbjected to three cycles of acid and neutral washes at 4 °C to 
deplete surface TfR's (see § 2.8.2). Following this washing procedure, cells were incubated 
with standard medium at 37°C and after another 3 hours the excreted alllount of 59Pe was 
measured. 
§ 2.9 Rat brain dissection. 
Rats were anesthetized with an intramuscular injection of a mixhlre of ketamine (25 
mg/ml), xylazine (1.3 mg/ml) and acepromazine (0.25 mg/ml). Next, the animals were 
perfused with icecold PBS until the effluent was clear (~ 5 min). Following decapitation, 
the brain was removed and microdissected with the aid of a coronal brain matrix (Harvard 
Apparatus, South Natick, MA), according to the method of Cuello and Carson (9). Briefly, 
the frontal cortex was obtained from a coronal slice of the brain. rostral to a cut made at 
the caudal end of the lateral olfactory tract. Under a dissecting microscope, a razor blade 
was used to hemisect the slice, and the olfactory tract and tubercle were dissected away 
from the frontal cortex. Next, a 4 m111 coronal slice was cut using the caudal edge of the 
optic chiasm as a landmark. From the hemisection of this slice, both the medial sephuu/di-
agonal band of Broca) and a sample of the striatum was dissected as described by \Villiams 
et al (32). The remaining brain was hemisected and the cerebral cortex overlying the right 
hippocampus was removed. An approximately 2 111m2 sample of parietal c0l1ex was taken 
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from the tissue overlying the septal pole of the hippocampus, and a 2 nun2 sample of the 
tcmporalicnthorinai cortex was taken from the tissue surrounding the temporal pole of the 
hippocampus by the method of Zellis and Wree (33). The entire hippocampus was then 
removed and the underlying thalamus pinched off. The dissection was completed be 
separating the cerebellum from the brain stem. All brain regions were frozen on dry ice 
immediately UPOll dissection, and stored at -70°C until processed. 
§ 2.10 Fixation, embedding and transmission electron microscopy. 
§ 2.10.1 Tissue fixation. 
Membrane-grown cells were fixed overnight at 4 °C in a mixture of glutaraldehyde 4% 
(v/v) and formaldehyde 4% (v/v) in sodium phosphate buffer (pH ~ 7.2). The following 
day, membranes were rinsed 3 times (10 min each) in PBS at room temperature and 
postfixed in a mixture of OsO, 1% (w/v) and K,Fe(CN), in PBS (pH ~ 7.4) at 4 °C. 
Subsequently, cells were rinsed in PBS, destilled watcr (room temperature), and then 
dehydrated in alcohol (50 to 96% , 4 steps, 10 min per step). 
§ 2.10.2 Embedding. 
First, membrane-grown cells were placed in a mixture (1:1) of ethanol and Epon for 1 h 
at room temperahlre, followed by 1 h at 37°C in pure Epon. Polymerization took place 
overnight at 60°C. 
The Epon embedding fluid consisted of a mixture of LX-112 (38 ml), DDSA (26 ml), 
MNA (20 ml), and DMP 30 (1.5 mI). 
§ 2.10.3 Sectioning. 
Ultrathin sections of the EpOll embedded membranes were made 011 an Ultratome V 
(LKB, Sweden), equipped with Diatomc 1.5 111111 diamant knives. Sections were collected 
on unmmed 200 mesh copper grids. 
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§ 2.10.4 Staining. 
Uranylacetate was used as the only contrast enhancer, whereas leadcitratc was omitted to 
improve visibility of the gold particles. 
§ 2.10.5 Transmission electron microscopy. 
Sections were studied in a Zeiss EM 902 (Zeiss, Oberkochen, FRO) transmission electron 
microscope. This instrument was equipped with an integrated clcctron spectrometer 
allowing high~rcsolution imaging with energy-filtered electrons (= electron spectroscopic 
imaging (ESI)). For thechnical details, see Sorber et al (25,26) 
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§ 3.1 Summary. 
Two techniques are described for the isolation of porcine serulll transferrin and hemopexin 
respectively, yielding nearly pure proteins (>99%) as tested with crossed immunoelectrop-
horesis. Porcine transferrin has an estimated mass of 79 kDa and porcine hemopexill a 
mass of 62 kDa. 
Both purified proteins were subjected to amino acid and carbohydrate analyses. Based 011 
carbohydrate and sialic acid analyses, it is proposed that porcine transferrin contains olle 
bi-antennary glycan chain, whereas porcine hemopexin contains two bi-antenllary and one 
tri-antennary glycan chains. 
§ 3.2. Introdnction. 
Research on the metabolism of iron in manm18lian species has mainly been focussed on 
peripheral tissues. The presence of iron in brain tissue was already described by Spatz early 
this century (15). However, for decades only a few st"dies were available on this s"bject. 
Iron metabolism of the brain (reviewed in 3) came in view again with the discovery of 
excess iron in certain areas of the brain, associated with neurological disorders e.g. Parkin-
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son's disease (10). Accumulated iron can have deleterious effects on tissues due to its cata-
lytic role in the formation of oxygen free radical species (6,7). 
Transferrin is an iron carrier protein present in a wide range of species in the animal 
kingdom (23). Although its function is no! completely elucidated, transferrin is held 
responsible for a major part of intracorporal iron transportation (4). Contrary to peripheral 
iron metabolism, mechanism and regulation of iron uptake into the brain are largely un-
known (20). However, large numbers of transferrin receptors have been found on the 
luminal side of blood-brain barrier endothelial cells (9), suggesting their involvement in 
this process. 
Hemopexin is a serum glycoprotein with a single high affinity binding site for free heme. 
Due to this high affinity for free heme, hemopexin will scavenge heme molecules 
nonspecifically hound to other serum proteins (12). Endothelial cells can take up free 
heme, thereby rendering these cells more susceptible to oxidative damage (1). Since 
hemopexin prevents the heme uptake by endothelial cells, it may affect both iron metabo-
lism and susceptibility to oxidative stress in these cells. 
Our investigations on regulatory aspects of iron metabolism in porcine brain require 
porcine transferrin and hemopexin of a high purity (:2: 99%). These proteins will be used 
for receptor-binding and transport experiments, in which the accuracy of the kinetic data 
greatly depends on the purity of these proteins (8). Furthermore, antibodies directed against 
these proteins had to be raised for histochemical purposes, again requiring a high purity 
standard. 
To our knowledge, neither of these proteins is commercially available and literature on the 
purification of porcine transferrin and hemopexin is sparse (2,16). In our hands, none of 
the existing techniques yielded the required purity, as checked with crossed immuno-
electrophoresis. \Ve therefore developed modifications to existing techniques to reach our 
objectives. 
Following purification, both proteins were further characterized by the amino acid compo-
sition and number and structure of N-linked carbohydrates. 
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§ 3.3 Materials and methods. 
§ 3.3.1 CI/c1IIicals. 
Bovine serum albumin (BSA), Cibacron Blue 3GA and N-acetylneuraminic acid were 
obtained from Sigma (Sigma, USA). CM-Sepharosc CL-6B, Sephadex G 100, Sephadex G 
75 and Agarose rEF were purchased from PharmacialLKB (pharmacia, Sweden), Bic-Gel 
A l.5m (coarse) was obtained from Bio-Rad (Bio-Rad, The Netherlands). Goat anti-Swine 
total serum protein antibodies were purchased from Nordic (Nordic, The Netherlands). 
LM\V-marker for PAGE was obtained from Pharmacia (Pharmacia, Sweden). All other 
chemicals used, were of the highest purity commercially available. 
§ 3.3.2 1sol0lioll o/pol'cille 11'0Ils/el'l'ill. 
§ 3.3.2.1 Sel'1I111 prelreollllelll. 
A detailed description of tltis procedure can be found in § 2.6.1.1. Briefly: fresh porcine 
plasma was saturated with excess iron, and dialyzed against a solution consisting of Nael 
(0.141110111) and CaCI, (0.01 molll), to precipitate fibrin. Following two precipitation steps 
with (NH,),SO" the solution was dialyzed and stored at -20°C until further use. 
§ 3.3.2.2 COIIIIIIII pl'eparalioll. 
Briefly: BioGel A 1.5m was coupled to Cibacron Blue 3GA at 45°C in the presence of 
Na2CO) and loaded on a column. The gel was equilibrated with start-, gradient- and 
regeneration buffer (see below) before sealing the column. Details of this procedure can be 
found in § 2.6.1.2. 
§ 3.3.2.3 Separolion procedllre. 
This procedure is described in § 2.6.1.3. Briefly: a sample of the pretreated serum was 
loaded onto the colunm, followed by circa 3 column volumes 1.54 nn1101l1 NaN, (startbuf-
fer). Porcine transferrin was eluted with a linear phosphate buffer gradient. 
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§ 3.3.2.4 Regelleratioll Of the COlllllln. 
The procedure for the regeneration of the column is described in § 2.6.1.4. 
§ 3.3.3 Isolatioll of porcille hemopexill. 
A detailed description of this isolation procedure can be found in § 2.6.2. Briefly: fresh 
pooled porcine senUll was treated as outlined above to remove fibrin, precipitated with 50 
% (NH4)2S04 and the supernatant dialyzed against 0.01 m01l1 sodium citrate buffer. 
Aliquots were applied to a CM-Sepharose CL-6B column, and the column was then rinsed 
with 0.01 molll sodium citrate buffer. Next, a linear (0.01 to 0.08 molll) gradient of 
sodium citrate was developed to clute hemopexin and transferrin. Hemopexin containing 
fractions were concentrated and loaded on a Sephadex G 100 column, followed by a 
Sephadex G 75 column to remove contaminants. 
§ 3.3.4 Allalytical techlliqlles. 
Several teclllliques were used to assess the purity of the isolated porcine transferrin and 
hemopexin. A detailed description of these techniques can be fOllnd in chapter 2. 
Transferrin and hemopexin containing samples obtained in either isolation procedure were 
subjected to the follm\~ng analytical procedures: 
- Native polyacrylamide gel electrophoresis (PAGE) 
- Sodium dodecyl sulfate polyacrylamide gel electrophoresis - (SDS)-PAGE 
- Isoelectric foclissing 
- Crossed immunoelectrophoresis 
- Sepharose-concanavalin A chromatography: 
- Protein concentration measurements: 
- Carbohydrate analyses: 
- Analyses of N-acetylglucosfimine and amino acids 
- Sialic acid quantification 
§ 3.4 Results. 
§ 3.4.1 Porcille transferrin. 
Applying pretreated porcine serum to a BioGel-Cibacron Blue COIUlllll resulted in 
chromatograms as depicted in Fig. 3.1A• The number of peaks that could be discriminated 
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during development of the phosphate buffer gradient usually varied from 4 to 6. 
A 
A 
8 
B 
A 
8 
Fig. 3.1: 
A: 
Serum, subjected to a number of precipitation steps was loaded on a Cibacron Blue 3GA 
linked to BioGel A 1.5m column. A typical elution profile is shown in A. S: sample 
application; G: stmi of the phosphate gradient. 
The insert (between brackets) shows a magnification of the chromatogram upon develo M 
ping the phosphate gradient. 1 - 5 indicate the separate transferrin containing peaks that 
could be discerned. Peak 5 contained transferrin in a nearly pure (> 99.5%) form. 
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B' 
Purified porcine transferrin was applied to a Sepharose-linked concanavalin A column. 
Three peaks could be detected (1-3). Peak 2 (97%) was used for further analysis. S: sample 
application; G: stali a-methyl glucopyranoside buffer. 
A sample of each peak was applied to native gradient (8-25%) PAGE (Fig. 3.2A) and 
SDS-PAGE (Fig. 3.2"), showing that only transferrin was present in the last peak. The 
double transferrin band present in native gradient gels appeared as a single band when 
samples were applied to SDS-PAGE (Figs. 3.2"' and 3.2"). 
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Samples from transferrin containing fractions resulting from the BioGel/Cibacron Blue 
column (peak 1-5, Fig. I) were applied to native gradient (8-25%) PAGE. Lane I: LMW 
marker in kDa; lane 2: peak I; lane 3: peak 2; lane 4: peak 3; lane 5: peak 4; lane 6: peak 
5, 10 times concentrated; lane 7: peak 5; lane 8: human 4 sialo transferrin. 
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B: 
Identical samples were also applied to SDS-PAGE (8-25% gradient). Lane 1-8: see 
legends to A. 
Samples from this last transferrin peak were subjected to crossed inullunoelectrophoresis 
to assess its purity (Fig. 3.3). Repeated experiments with this technique, varying the trans-
ferrin/antibody ratio, showed transferrin to be over 99.5% pure. 
Isoelectrlc focussing of purified transferrin yielded 3 major diferric and two mono ferric 
bands (Fig. 3.4) ranging from pH 5.60 to 6.30. 
Purified transferrin was fractionated on a Sepharose-lillked concanavalin A column in 
three separate fractions (Fig. 3.1 iJ). About 97% was located within the second fraction and 
samples from this fraction were used for amino acid and carbohydrate analyses. Results of 
transferrin amino acid analyses are summarized in table 3.1 and compared to porcine 
transferrin data described by 'Velch (22) and human transferrin amino acid sequence data 
from MacGillivray et al (11). Data on carbohydrate and sialic acid residue analyses are 
summarized in table 3.2. 
Fig. 3.3: 
Purified transferrin (peak 5, Fig. 1) was subjected to crossed ilmnunoelectrophoresis. 
Electrophoresis in the first direction was performed in a 1% agarose gel. Electrophoresis in 
the second direction was performed in a gel containing rabbit anti pig serum protein 
antibodies. Only one precipitation arc could be detected. 
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Fig. 3.4: 
Purified porcine transferrin 
and hell10pcxin were applied to 
2 3 4 5 6 7 
a PhastGel IEF (PH 4-6.5) for isoelectric focussing. Lane I and 2: purified transferrin; lane 
3 and 5: human 4 sialo transferrin, pl= 5.25; lane 4: pI marker; lane 6 and 7: purified 
hell1opexin. C: Monoferric transferrin with Fe bound to the CMterll1inal binding site. N: 
Monoferric transferrin with Fe bound to the NMtenninal binding site. 
§ 3.4.2 Porcine hemopexill. 
Hemopexin, isolated according to the procedure described (see § 3.3.3), showed a single 
band when subjected to native gradient PAGE (Fig. 3. 5). Purity of hemopexin was 
conftrmed, subjecting samples to crossed inullunoMelectrophoresis. Electrophoresis in the 
second dimension was performed against porcine semm protein antibodies. Repeated runs 
showed that impurities were less than 1% of the total protein concentration (Fig. 3.6). 
Isoelectric focussing of purified hemopexin yielded at least 4 discernible bands (Fig. 3.4) 
in the range of pH 5.60 to 6,45. 
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Data 011 porcine hemopexill amino acid analyses are summarized in table 3.1 and 
compared to values from Spencer (16). The data on carbohydrate and sialic acid analyses 
are summarized in table 3.2. 
Fig. 3.5: 2 3 4 5 6 
A hcmopexin containing sample from the ion-exchange column and purified hemopexin 
were subjected to native gradient PAGE (8-25% gradient). Lane 1 and 6: LMW-marker in 
kDa; lane 2: hClllopexill containing sample resulting from the CM-Sepharose CL-6B co-
lumn; lane 3: purified porcine transferrin; lane 4: purified hcmopexin; lane 5: purified 
hcmopexin, 10 times concentrated. 
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Fig. 3.6: 
Purified hemopexin was subjected to crossed immunoelectrophoresis. Electrophoresis in 
the first direction was performed in a 1% agarose gel. Electrophoresis in the second 
direction was performed in a gel containing rabbit anti pig serum protein antibodies. Only 
one precipitation arc could be detected. 
§ 3.5 Discussion. 
§ 3.5.1 Porcine transjerrin. 
Our research on iron metabolism in porcine brain required transferrin with a high degree 
of purity (> 99%). Extensive series of experiments were performed in an attempt to purify 
porcine transferrin. However, various combinations of ammonium sulfate precipitation, 
preparative isoelectric focussing, gel-filtration and ion-exchange chromatography (as 
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described in 23) never yielded transferrin with the desired degree of [JUrity. 
Of all existing techniques, isolation of porcine transferrin by means of a BioGeliCibacron 
Blue column according to Baumstark (2), in our hands yielded the highest purity (about 
80-85%). A number of modifications were tried and checked with crossed inununoelectrop 
horesis, resulting in an isolation procedure as described in chapter 2. The purity of the 
resulting transferrin fraction improved upon modification of the phosphate gradient, 
especially if a less steep gradient (0 to 0.1 maUl) was applied. Based on the results of elec-
trophoresis (Fig. 3.£' alld 3.2"), all peaks except for the last (Fig. 3.1A) were discarded. 
Because of this, a considerable amount of transferrin was lost (serum transferrin yield: ± 
35%), but the remaining transferrin fraction was nearly 100% pure. Purity was checked 
subjecting samples to crossed immunoelectrophoresis, which is a very sensitive technique 
to analyze proteins with a (near) identical electrophoretic behaviour (21). Moreover, in 
crossed immunoelectrophoresis the area underneath a peak is proportional to the protein 
concentration. Impurities could only be detected, if the top of the transferrin peak exceeded 
the upper edge of the gel. Peak area measurements indicated that transferrin in this fraction 
was over 99.5% pure. 
Prior to amino acid and carbohydrate analyses, porcine transferrin was applied to a 
Sepharose-linked concanavalin A column. This enabled assessment of transferrin heteroge-
neity due to structural variations in the N-linked glycan chain(s). In this way, porcine 
transferrin could be separated in three fractions. Carbohydrate analysis of the second con A 
fraction (table 3.2) suggests that a major part of porcine transferrin .(97%) contains one N-
linked biantennary glycan chain. This is in agreement with the finding of 2 sialic acid 
residues per molecule porcine transferrin, both in our experiments and by Welch (22). 
Based on these findings and considering known outer chain sequence variations (4,17) we 
therefore propose a glycan chain structure in porcine transferrin as depicted in Fig. 3. 7A• 
Rhamnose as well as human 4-sial0 transferrin (with two bi-antennary glycans) were used 
as an internal standard in tItis procedure. 
The amino acid composition of porcine transferrin (con A II) is shown in table 3.1 and 
compared to the results obtained by Welch (22). Results of both analyses were not identi-
cal, which could either be due to differences in analytical teclmiques or to differences in 
the isolation procedure. 
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A: BI-antennary chain 
SA-Gal-GN-Man~ FlU 
Man --G N--G N--
SA-Gal-GN-Man~ 
B: Tri-antennary chain 
SA 
I SA-Gal-GN-Man~ F~ 
Man ---G N--G N-
SA-Gal-GN-Man~ 
/ 
SA-Gal-GN 
Fig. 3.7: 
Proposed glycan chain structures for porcine transferrin and hemopexin (see text). Adapted 
from De Jong et al (3.07 De Jong 1990). A: proposed stmeture of a bi-antellllary glycan 
chain. B: proposed struchlrc of a tri-antennary glycan chain. SA: sialic acid; Gal: galactose; 
GN: N-acetyl glucosamine; Man: mannose; Fu: fucose. 
In our procedure however, pure human 4 sialo transferrin (prepared according to 5) was 
used as an internal standard in each run and analyzed according to the same technique. 
Results of these analyses were compared to known amino acid sequence data (11) and were 
found to vary less than 2%. 
Isoelectric focussing of porcine transferrin resulted in 5 bands (Fig. 3.4). The upper two 
bands (marked C and N) are most likely mono ferric bands, as they disappeared upon 
additional iron loading of transferrin. The next three major bands are probably due to a 
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variation in the number of sialic acid residues in the N-linked glycans, better known as the 
micro heterogeneity pattern of transferrin (4). The minor bands visible, are probably due to 
genetic variation, as transferrin was isolated from pooled serum. 
§ 3.5.2 Porcine hemopexin. 
Hemopexin is a specific senun l3-glycoproteiil present in mammalian species, with a single 
high affinity binding site for heme (12). To date, only limited knowledge exists as to the 
mechanism of transport and internalization of heme (13). A receptor-mediated transport 
system is proposed in human Hep 02 cells (14), where hemopexin re-enters the circulation 
aftcr releasing heme. Upon degradation, heme iron is recovered for further use. This would 
therefore implicate a second transmembrane iron transport mechanism (besides transferrin). 
In this respect, Taketani et al (18) found evidcnce that iron released from hcme reduces 
transferrin mediated iron uptake. The binding of the heme-hemopexin complex to blood-
brain barrier derived endothelial cells is currently under investigation. 
The isolation of porcine hemopexin consisted of a combination of an ion-exchange and 
several gel filtration chromatography steps, modified from a technique described by 
Spencer et al (16). Adaptations included changes in pH and gradient of the ion-exchange 
colul11n buffer, and application of both a Sephadex G 100 and a Sephadex G 75 column to 
optimize purification of hemopexin. Hemopexin containing fractions from each isolation 
step were routinely checked for contaminating proteins, by applying samples to native 
gradient PAGE (Fig. 3.5). A more accurate estimate of purity (discussed above) was obtai-
ned subjecting samples to crossed immunoelectrophoresis (Fig. 3.6). Repeated experiments, 
varying both the amount of hcmopexin and antibodies, indicated that hemopexin obtained 
in this manner was over 99% pure. 
Data on amino acid analyses of purified porcine hemopexin are summarized in table 3.1. 
On average, our analyses yielded somewhat higher results when compared to data presented 
by Spencer et al (16). Tllis is possibly due to a milder protein hydrolysis step prior to 
amino acid analysis (19). Pure human 4 sialo transferrin (5) with 2 biantennary glycan 
chains was used as an internal standard for both carbohydrate and amino acid analyses. 
Carbohydrate analyses on porcine hemopexin (data sllmmarized in fable 3.2) suggest it to 
contain 2 biantennary and I triantennary glycan chains (Fig. 3.7A and 3. 7ll). 
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Amino acid Tf Pig Tf Hu-Tf Hpx Hpx 
residues COilA II Welch sequence Spencer 
Asp 84 78 79 51 42 
Thr 29 23 30 22 25 
Ser 50 50 41 40 31 
G1u 70 73 60 41 36 
Gil' 46 42 49 47 35 
Ala 61 56 57 31 29 
Val 45 40 45 30 26 
112 Cys 28' 28 38 29' 29 
Met 7 6 9 4 4 
lie 19 23 15 9 10 
Leu 49 58 58 41 39 
Tyr 24 24 25 16 22 
Phe 25 26 29 20 18 
Lys 54 62 58 25 26 
His 13 26 19 19 19 
Arg 26 30 26 32 26 
Trp 7 3 8 16' 16 
Pro 17' 17 17' 12' 12 
Total no of 
I I I II I I residues. 654 665 663 485 454 
Table 3.1: 
Results on amino acid analyses of purified porcine transferrin and hemopexin are 
summarized in this table. Both are compared to known values from literature. 
For porcine transferrin: Welch (3.13 Welch 1990) and for hemopexin: Spencer et al (3.12 
Spencer 1990). Human transferrin amino acid sequence data are shown as reference. 
Results shown are an average of duplo analyses of 3 separately obtained purified protein 
fractions. * data obtained from literature. 
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I Residues: II Transferrin II Hemopexin I 
N-acetyl glucosamine 4 n.d. 
Mannose 3 9 
Galactose 2 7 
Fucose 1 3 
Sialic acid 2 8 
Table 3.2: 
Results on carbohydrate and sialic acid analyses of purified porcine transferrin and 
hemopexin are summarized in tills table. 
Results shown are an average of duplo analyses of 3 separately obtained purified protein 
fractions. 
n.d.: analyses not performed. 
Based on the results of these analyses, the molecular weight of })orcine hemopexin 
(including glycan chains) is estimated to be 62.2 kDa. 
In sUllunary, we describe two techniques for the purification of porcine transferrin and 
hemopexin, respectively. Both transferrin and hemopexin could be isolated in nearly pure 
form, which was checked with both SDS- and crossed immunoelectrophoresis. Carbohydra-
te analyses suggest that transferrin carries one biantcllnary glycan chain, whereas hemop-
exin contains 2 biantennary and one triantennary glycan chains. Based on both amino acid 
and carbohydrate analyses, the molecular weight of hemopcxlll is estimated to be 62.2 kDa. 
Based on 8DS-electrophoresis, the molecular weight of transferrin is estimated to be nearly 
equal to that of human transferrin (± 79 kDa). 
95 
Porcine transferrin and hemopexin isolation. 
References. 
(1) Balla G., Vercellotti G.M., Muller-Eberhard, Eaton I and Jacob H.S. (1991) Exposure 
of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic 
oxygen specics. Lab. Invest. 64: 648-655. 
(2) Baumstark IS. (1987) A simple one-column procedure for the separation of swine and 
human serum transferrins. J. Biochem. Biophys. Meth. 14: 59-70. 
(3) Cormar IR. (1993) Cellular and regional maintenance of iron homeostasis in the brain: 
normal and diseased states. In: Iron in central nervous system disorders. (Eds: Riederer P. 
and Youdim M.B.H.), pp. 1-18. Springer-Verlag, New York. 
(4) De Jong G., van Dijk IP. and van Eijk H.G. (1990) The biology of transferrin. Clin. 
Chim. Acta 190: 1-46. 
(5) De Jong G., van Noart W.L. and van Eijk H.G. (1992) Carbohydrate analysis of 
transferrin subfractions isolated by preparative isoelectric focusing in immobilized pH 
gradients. Electrophoresis 13: 225-228. 
(6) Floyd R.A. and Carney IM. (1992) Frce radical damage to protein and DNA: 
Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. 
Neuro!. 32: S22-27. 
(7) Gutteridge IM.C. and Halliwell B. (1989) Bailliere's Clinical Haematology, Vol 2 (2): 
195-256. 
(8) Hulme E.C. and Birdsall J.M. (1992) Strategy and tactics in receptor-binding studies. 
In: Receptor-ligand interactions. A practical approach. (Ed: Hulme E.C.), Pl'. 63-176. 
Oxford University Press, New Yark. 
(9) Jefferies W.A., Brandon M.R., Hunt S.V., Williams A.F., Gatter K.C. and Mason D.Y. 
(1984) Transferrin receptor on endothelium of brain capillaries. Nature 312: 162-163. 
(10) Jellinger K. and Kienzl E. (1993) Iron deposits in brain disorders. In: Iron in central 
nervous system disorders. (Eds: Riederer P. and Youdim M.B.H.), pp. 19-36. Springer-
Verlag, New York. 
(11) MacGillivray R.T.A., Mendez E., Sinha S.K., Sutton M.R., Lineback-Zins I and 
Brew K. (1982) The complete amino acid sequence of human serum transferrin. Proc. Natl. 
Acad. Sci. USA 79: 2504-2508. 
(12) Muller-Eberhard U. (1988) Hemopexin. Meth. Enzymo!. 163: 536-565. 
(13) Muller-Eberhard U. and Fraig M. (1993) Bioactivity of heme and its containment. 
Am. I Hemato!. 42: 59-62. 
96 
Chapter 3 
(14) Smith A. and Hunt R.C. (1990) Hemopexin joins transferrin as representative 
members of a distinct class of receptor-mediated clldocytic transport systems. Eur. J. Cell 
BioI. 53: 234-245. 
(15) Spatz H. (1922) Uber den Eisennachweis illl Gehirn, besonders in Zentern des 
extrapyramidalmotorischen systems. Z. Ges. Neurol. Psychiat. Berl. 77: 261-290. 
(16) Spencer H.T., Pete MJ. and Babin D.R. (1990) Structural studies on porcine 
hemopexin. Int. 1. Biochem. 22 (4): 367-377. 
(17) Spik G., Coddeville B., Legrand D., Mazurier 1., Leger D., Goavec M. and Montreuil 
1. (1985) A comparative study of the primary structure of glycans from various sera-, 
laeta- and ovotransferrins. Role of human lactotransferrin glycans. In: Proteins of iron 
storage and transport. (Eds: Spik G., Montreuil J., Crighton R.R. and Mazurier 1.), pp. 47-
51. Elsevier Science Publishing Company Inc., New York, USA. 
(18) Taketani S., KoIlllO I-I., Sawamura T. and Tokunaga R. (1990) I-Iemopexin-dependent 
down-regulation of expression of the human transferrin receptor. J. BioI. Chem. 265: 
13981-13985. 
(19) Van Eijk H.G. and van Noort W.L. (1986) The reliability of the use of para toluene 
sulfonic acid for simultaneolls hydrolysis and quantitation of both N-acetyl-glucosaminc 
and amino acids in human transferrins. CHn. Chim. Acta 157: 305-310. 
(20) Van Gelder W., Huijskes-Heins M.I.E., van Dijk J.P., Cleton-Soeteman M.1. and van 
Eijk H.G. (1995) Quantification of different transferrin receptor pools in primary cultures 
of porcine blood-brain barrier endothelial cells. 1. Neurochem. 64: 2708-2715. 
(21) Weeke B. (1973) Crossed immunoelectrophoresis. In: Quantitative immunoelectropho-
resis. (Eds: Axelsen N.H., Kroll J. and Weeke B.), pp 47-56. Universitetsforiaget, Oslo, 
Norway. 
(22) Welch S.A. (1990) Comparison of the structure and properties of serum transferrin 
from 17 animal species. Compo Biochem. Physiol. 97B (3): 417-427. 
(23) \Velcll S.A. (1992) Transferrin structure and iron binding. In: Transferrin the iron 
carrier. (Ed: Welch S.A.), pp. 61-108. CRC Press, Boca Raton, USA. 
97 
CHAPTER 4 
Isolation and partial, characteri-zation :-of a 
440 _ kDa and a 660 kD<,l porcine. sple'en, ferritin 
fraction-, 
This chapter is b_ased on: 
~i; vah Gelder, M.I.E. Huijskes-Heir1:s, D. Klep-
per, ri.L._ van Noort, M.I. _Cleton"'Soeteman and 
If. G. van Eijk 
(1.995) Isolation and partial -characterization 
af .a 440 kDaand a !i60 kDa pard"e spleen 
ferri tin fract'ion-. 
Submitted. 
Chapter 4 
§ 4.0 Contents. 
§ 4.1: Summary. 
§ 4.2: Introduction. 
§ 4.3: Materials and methods: 
§ 4.3.1: Materials. 
§ 4.3.2: Isolation and subfractionatioll of porcine spleen ferritin. 
§ 4.3.2.1: Ferritin isolation method I. 
§ 4.3.2.2: Ferritin isolation method 2. 
§ 4.3.3: Separation of isoferritins. 
§ 4.3.4: Preparation and operation of the combined Sepharose 4B and Sepharose 
6B columns. 
§ 4.3.5: Analytical techniques. 
§ 4.3.6: Quantitative teclllliques. 
§ 4.3.7: Statistical analyses. 
§ 4.4: Results. 
§ 4.5: Discussion. 
§ 4.1 Summary. 
Ferritin isolated from different organs, obtained from three different mammalian species, 
could routinely be separated in a 440 and 660 kDa fraction on non-denaturating gradient 
gels. Both fractions could be isolated with a purity of 96% when applied to two serially 
linked columns, each 200 cm in length, packed respectively with Sepharose 4B and 
Sepharose 6B. Both fractions were equal with respect to subunit composition, iron and 
phosphorus content, as weB as amino acid composition, with the exception of N-acetylglu-
cosamine. Carbohydrate analysis showed that the 440 kDa fraction contained 1.8% (w/w) 
glycans, whereas the 660 kDa fraction contained nearly 5 times as much (neutral) sugar 
residues (8.9%, w/w) and 10 times as much sialic acid. Although not explanatory for the 
apparent difference in mass, the difference in amount of charged side chains can at least 
partially explain the dissimilarity in electrophoretic mobility of the two fractions. 
§ 4.2 Introduction. 
Prokaryotic and eukaryotic cells all contain ferritin as their major iron storage protein. 
According to the I1classicall1 idea ferritin protein is composed of 24 subunits of two types: 
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the H-type of circa 21 kDa and the L-type of circa 19 kDa amounting to a total mass of 
circa 450 kDa. Inter- and intraspecies heterogeneity was explained by the various proporti-
ons in which the subunits assemble. Arranged with 4:3:2 symmetry the subunits form a 
hollow shell, in which up to 5000 iron atoms can be stored (10,11, reviewed 1 and4). 
Although it was accepted that senUll ferritins were glycosylated and tissue ferritins were 
not (5), the existence of a small amount of associated carbohydrates in horse spleen (21), 
and in human spleen, liver and heart have been reported (3,14,18). The amount however, is 
still a subject for discussion. 
Refinement in biochemical research resulted from 1980 onwards in reports on ferdtins of 
different molecular weights due to either assembly of more than 24 subunits (15) or to at-
tachment of a non-ferritin component (19). Passaniti et al (16) report on ferritin interme-
diates of lower molecular weight next to the common ferritin of around 440 kDa. Moreo-
ver, other authors describe either a subunit of different amino acid composition (2), or 
different classes of subunits besides the well known Hand L subunits (6). 
Our current research on porcine brain iron mctabolism requires ferritin of a high purity. 
After improvement of a standard method for the isolation of porcine ferritin, we found next 
to the expected 440 kDa a substantial portion of this ferritin (30%) to consist of an iron-
containing protein of 660 kDa. Testing horse spleen ferritin as a reference we also found 
the two components in about the same ratio. \Ve decided to further explore these findings 
and to report on the composition of subunits, amino acids and carbohydrates of the two 
acquired porcine splecn isoferritins. 
§ 4.3 Materials and methods. 
§ 4.3. J Materials. 
Fresh porcine spleens were obtained from the local slaughterhouse, transported and kept 
on ice until further processing. Horse spleen ferritin, BSA (bovine serum albumin) and 
PMSF (Pheny1methy1su1fony1fluoride) were obtained from Sigma (USA). Sepharose 4B, 
Sepharose 6B and Sephadex G 200 were purchased from PharmaciaILKB (Phannacia, 
Sweden). All other chemicals were of the highest purity commercially available. 
Poyacrylamide gel electrophoresis were performed on both Mini protean system 2 (BioRad, 
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the Netherlands), and Phastsystem (pharmacia/LKB, Sweden). 
§ 4.3.2 Isolation and sub/mctionatiOiI 0/ porcine spleen ferritill. 
§ 4.3.2.1 Ferritin isolation method 1. 
A detailed description of tlils isolation procedure can be found in § 2.6.3.1. Briefly: 
porcine spleen ferritin was isolated according to a method adapted from Penders (17). 
Fresh spleen tissue was homogenized, heated (80 °C, 5 min) and then rapidly cooled and 
centrifuged (3000 g, 45 min). The supernatant was then subjected to a number of centrifuR 
gation steps to yield ferritin with a high purity as confirmed by native and TricineRSDS 
PAGE. 
§ 4.3.2.2 Ferritin isolation method 2. 
Ferritin was also isolated according to a precipitation tecllllique described by Konijn (13). 
This procedure yielded ferritin with a degree of purity comparable to that of ferritin 
obtained by method I. A description of this isolation procedure can be found in § 2.6.3.2. 
§ 4.3.3 Separation o/iso/erritins. 
Porcine spleen ferritin was separated into acid, intermediate and basic fractions by ionR 
exchange chromatography on a DEAE-Sephadex A-25 column. Tlus procedure was 
described by Konijn et al (13). 
§ 4.3.4 Preparation and operation 0/ the combined Sepharose 4B and Sepharose 6B 
columns. 
Ferritin, purified according to either method 1 or 2, could be separated in a 440 and 660 
kDa fraction (see discussion) when applied to two serially linked sepharose 4B and 6B co-
lumns. A description of the preparation and operation of these COlUlllllS can be found in § 
2.6.3.4. 
§ 4.3.5 Analytical techniques. 
Detailed descriptions of the analytical techniques can be found in chapter 2. 
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011 a kfini protean system 2, samples were subjected to: 
- Native polyacrylamide gel electrophoresis (pAGE). 
- Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
- Tricine-SDS Polyacrylamide gel electrophoresis (L and H 
On a Phastsystem, samples 'were subjected to: 
- Native polyacrylamide gel electrophoresis (PAGE). 
- Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
- Isoelectric focussing. 
Ouchter/ony double immU110 d(f/usioll assays were used ill: 
- Alpha-2-macroglobulin assay. 
- Ferritin / al1ti-440 kDa and anti 660 kDa ferritin assays. 
§ 4.3.6 Quantitative techniques. 
(SDS-PAGE). 
subunit ratio's). 
(SDS-PAGE). 
Detailed descriptions of these techniques can be found in chapter 2. 
- Protein, iron and phosphorus assays. 
- Determination of the iron to phosphonls ratio with electron probe microanalysis 
(EPMA). 
- Carbohydrate analyses. 
- Amino acid analyses. 
- Sialic acid quantification. 
§ 4.3.7 Statistical allalysis. 
Data sets were analyzed with a Bonferroni t test following a "repeated-measures analysis 
of variance" to test differences in amino acid and carbohydrate composition between the 
"crude" (see § 4.4), 440 kDa and 660 kDa ferritin fractions. 
§ 4.4 Results. 
Porcine spleen ferritin isolated according to the two procedures described and hencefor-
ward referred to as "crude" ferritin, always yielded two distinct bands when applied to a 
native 4-15% gradient gel (Fig. I, lalle 4) on the Phastsys-tem. A vague third band (Fig. 1, 
laue 3) with an estimated Illass of around 850 kDa, appeared more clearly when the ferritin 
solution was left to stand for a number of weeks. 
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Fig. 4.1: 
Native polyacrylamide gel, 4-15% gradient. Samples were obtained after separation on two 
linked Sepharose 4B and 6B columns. Lane 1: high molecular weight marker (in kDa). 
Lane 2: first ferritin peak to appear in gel-filtration, consisting of ferritin aggregates. Lane 
3: second ferritin peak to appear in gel-filtration, consisting of ferritin aggregates. Lane 4: 
Ucruden ferritin fraction. Lane 5: 660 kDa fraction after 2nd rUll. Lane 6: 440 kDa fraction 
after 2nd run, purity is 89%. Lane 7: high molecular weight marker (in kDa). 
The marker proteins (Fig. 1, lalle 1 & 7) defined the largest band to be located around 440 
kDa and the second band around 660 kDa. The two large dark spots at the top of lane 4 
(Fig. 1) are ferritins with a molecular weight over 1000 kDa, that did not penetrate the 
separating gel. Similar results were obtained with native gradient gels (8-25%) on a mini 
protean system (BioRad). Surprisingly, both major bands were also distinctly present in 
commercially available horse spleen and human placental ferritin (courtesy Dr J.P. van 
Dijk). In all cases both bands stained positively for protein and iron. Densitometric 
analyses showed that about 30% of fresh porcine spleen ferritin was located in the 660 kDa 
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band (Fig. 1, lane 4). "Crude!! ferritin from either isolation procedure was separated on a 
DEAE column with a NaCl-gradient (13). At least 4 subspecies could be separated, which 
each showed a 440 kDa and 660 kDa band when applied to a native gradient gel. Isoelec-
tric focussing of IIcrude" ferritin resulted in multiple bands ranging from pH 4.8 to 5.2. 
Applying "crude" ferritin samples to two serially linked Sepharase columns (see § 4.3.4) 
resulted in a nearly complete separation of the 440 and 660 kDa bands. Densitometric 
analysis of native gradient gels showed each band to be over 96% pure after three runs. 
The L- and II-subunit composition of "crude" ferritin and both the purified 660 and 440 
kDa fractions was assessed using both SDS-PAGE and Tricine SDS-PAGE. Results of the 
16.5% Tricine SDS-PAGE are shown in Fig. 2. Densitometric analysis confirmed a 
predominance of L-subunits (60%) in each of the samples. The L to H ratios in the three 
samples were not significantly different. 
In Table I biochemically obtained iron to protein and iron to phosphorus ratios arc shown. 
The latter are compared to results determined by EPMA. As no difference was found 
between EPMA data acquired from ferritin analyses either in the pyeloform holes or on the 
film itself, the ratios given are the mean of combined data sets. 
Fig. 4.2: 
Tricine-SDS polyacrylamide gel (16.5% T; 3% C). Samples were obtained after separation 
on a Sephadex G 200 column. Lane 1: 440 kDa fraction after 4ili nlIl. Lane 2: 660 kDa 
fraction after 3rd run. Lane 3: crude ferritin. Lane 4: low molecular weight marker in kDa. 
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Porcine spleen mol Fe/mol FelP ratio Fe/P ratio 
ferritins ferritin (biochem.) (EPMA) 
(n ~ 6) (n ~ 6) (n ~ 30) 
"crudetl ferritin 1700 ± 219 # 8.3 ± l.l # 17.5 ± 4.9 
660 kDa fraction 1675 ±244 23.5 ± 11.5 31.9 ± 13.3 
440 kDa fraction 1638 ± 132 30.3 ± 21.2 33.6 ± 14.4 
Table 4.1. 
Data were obtained from three individual isolation procedures in duplo. A # indicates a 
significant difference (p < 0.05) from the other values in that column. 
The means of 6 individual amino acid analyses of three batches of "emdell porcine spleen 
ferritin and both fractions are slIlluuarized in Table II. Only the N-acetyl glucosamine COll-
tent of the 440 and 660 kDa fractions was significantly different (p < 0.02) as shown by 
repeated-measures analysis of variance, followed by a BOllferroni t test. 
Carbohydrate and sialic acid analyses of all fractions are shown in Table 111. Despite 
considerable variation in glucose content between batches, a consistent 5:1 ratio in total 
carbohydrate content (a 10:1 ratio for sialic acid) was found between 660 and 440 kDa 
fractions, respectively. 
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reI. % "cnlde" 660 kDa 440 kDa 
amino acids ferritin fraction fraction 
Asp 11.6 12.6 12.8 
Thr 4.8 4.2 3.9 
Ser 9.3 7.0 6.6 
Glu 14.1 15.0 16.0 
Gly 8.4 8.3 7.5 
Ala 8.3 8.3 7.5 
Val 4.5 4.1 3.8 
Met 2.2 2.0 2.2 
lie 2.4 2.1 1.6 
Leu 11.0 11.6 12.8 
Trp n.d. n.d. n.d. 
Tyr 3.2 3.2 3.3 
Phe 3.9 3.9 4.2 
GIeNH, * 0.6 1.0 0.4 
His 3.7 3.9 4.3 
Lys 5.4 5.7 5.7 
Arg 5.2 5.4 5.9 
. 5 Cys n.d . n.d. n.d. 
total 98.6% 98.3% 98.5% 
Table 4.2: 
Data obtained (in duplo) from three individual isolation procedures. Results were expressed 
as mcans of 6 data sets. An * indicates a significant difference betwcen the 440 and 660 
kDa £i·actions. 
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Carbohydrate residu- "cnldetr 660 kDa 440 kDa 
es (mol/mol) ferritin fraction fraction 
Mannose 14 20 5 
Glucose 39 100 25 
Galactose 48 80 II 
Sialic acid 3 10 I 
% carbohydrates! 4.3% 8.9% 1.8% 
ferritin (w/w) 
Table 4.3: 
Carbohydrate and sialic acid residues are expressed in mol/mol protein. Data were obtained 
in duplo from three individual isolation procedures. Results were significantly different 
within the three fractions (p < 0.01). 
§ 4.5 Discllssion. 
To obtain a porcine spleen ferritin of high purity we used two modified standard procedu-
res, which yielded in each case two distinct bands, appearing at 440 and 660 kDa respecti-
vely in non-dellaturating gradient gel electrophoresis. To exclude the possibility that either 
band was in fact an artifact, native gradient electrophoresis was repeated on another system 
with gels from another manufacturer, yielding identical results. Moreover, we obtained 
similar bands in horse spleen, human placental and porcine heart ferritin, and also, contrary 
to the findings of Linder et al (IS), in porcine liver ferritin. 
Molecular weight estimates of proteins based on the results in non-denahll'ating gel 
electrophoresis are at best unreliable, for electrophoretic mobility of a protein in this type 
of analysis is not only affected by its mass, but also by its size, shape and number of 
charged side chains. \Ve therefore decided to perform a series of experiments to further 
elucidate the nahlre of these two ferritins of different electrophoretic mobility. 
(I) Gel filtration chromatography was applied to separate both fractions. Based on the 
results in non-dellaturatillg gel electrophoresis, there appeared to be a 50% difference in 
molecular weight between both fractions. However, considerable column dimensions (4m) 
and repeated nms (up to five times) were necessary to accomplish separation with an 
acceptable degree of purity. On the one hand these resuits would suggest that the difference 
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in mass between both fractions was less than expected, on the other hand Kav values of 
Sephadex and Sepharose separating gels are nearly equal for two fractions this size (7). 
(II) \Ve could exclude that the apparent difference in mass between both fractions was due 
to a difference in iron load. First, both bands stained for iron, which excluded the possibili-
ty that one fraction was in fact apoferritin. Second, the absence of a smear between both 
bands (Fig. 1, lane 4) suggested against a variation in iron content. Biochemical assays, 
quantitating the amount of iron pcr molecule ferritin in ttcrude ll ferritin and the purified 
fractions (Table J) confirmed that the iron load of the 440 and 660 kDa fractions was not 
significantly different. Moreover, electron micrographs did not show any difference in iron 
core diameter between both fractions (Fig. 4). 
The iron to phosphorus ratio assessed both biochemically and with electron probe micro 
analysis (Table J) showed no significant difference between both 440 and 660 kDa fracti-
ons. However, compared to ttcrudett ferritin there is either a loss of phosphorus or an 
increase in iron in both fractions (compare: 9). According to our data (Table I), the amount 
of iron per molecule of ferritin is equal in all fractions. Therefore, we have to assume a 
loss of phosphorus in both fractions for which we have no explanation. 
(III) A difference in subunit composition between both fractions was ruled out when 
flcrude fl ferritin was applied to a DEAE column (13). Each of the 4 ferritin subspecies 
(acid, intermediate I and 2, basic) yielded a 440 and 660 kDa band on a non-denaturating 
gel. Also, samples of tlerudett ferritin and purified 440 and 660 kDa fractions showed only 
minor differences in subunit composition when applied to a SDSR or a Tricine SDS-PAGE 
(Fig. 2). 
(IV) Up till now, a band appearing above 440 kD has been considered as a ferritin dimer, 
and our results sofar indicated that the 660 kDa fraction might in fact be a dimer of 440 
kDa ferritin, showing a different electrophoretic mobility due to loss of its spherical 
structure (7). Therefore, to facilitate dimer formation, purified 440 and 660 kDa fractions 
were left to stand for a number of weeks at 4 °C and then SUbjected again to non-denatura-
ting gradient gel electrophoresis (4-15%). In the stacking gel above the 660 kDa lane a 
new band appeared. According to manufacturer's information, the 4-15% gel will exclude 
molecules above 1000 kDa and tIus band could therefore be a 660 kDa dimer or polymer. 
In the 440 kDa fraction lane on the other hand, no extra bands appeared. In our hands, the 
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440 kDa fraction showed no tendency at all to form aggregates. 
(IVa) Purified 440 and 660 kDa fractions were dialyzed for 60 h against 8 M urea at 4 'C. 
According to Harrison (11) this could lead to dissociation of ferritin di- and polymers, 
although Yang (22) recently stated that ferritin dimers are not affected by these conditions. 
In our experiments, neither fraction showed any change in electrophoretic mobility in nOIl-
denaturatillg gradient gel electrophoresis following dialysis against 8 M urea. Together, 
these findings suggest against a 660 kDa ferritin fraction consisting of aggregates (or 
dimers) of 440 kDa ferritin, or other nonspecifically attached proteins. 
(V) Santambrogio and Massover (19,20) discovered on non-denaturating gels an additional 
band in rabbit liver ferritin, consisting of ferritin associated to alpha-2-macroglobulin. 
Although this finding would seem to fit the description of our 660 kDa fraction, our 
experimental results indicated otherwise, as in both fractions: (i) SDS-PAGE and Tricine 
SDS-PAGE showed only 19 and 21 kDa bands, (ii) Amino acid analyses (see below) 
revealed no significant differences, (iii) Ouchterlony double immunodiffusion against rabbit 
anti-porcine-serum protein antibodies showed no precipitation. 
(VI) Antibodies generated against each of the purified ferritin fractions cross-reacted with 
samples of both fractions in an Ouchterlony. However, small precipitation arcs deviating 
from the larger tiring" (Fig. 3) suggest against complete homology. As mentioned before, 
contamination of either fraction with other proteins was nlled out (see V), and it would 
therefore appear that the two fractions are not completely identical. 
(Vll) Finally, averaged amino acid analyses of the purified 440 and 660 kDa fractions 
showed no significant differences, with the exception of N-acetylglucosamine (Table Il). 
This carbohydrate residue is an essential element in the core structure of N-linked glycans 
(8). \Ve assumed a difference in ferritin glycosylation and therefore subjected each fraction 
to carbohydrate analysis. These analyses showed a circa 5 to 1 carbohydrate ratio (w/w) 
between the 660 and 440 kDa fractions. The difference in sialic acid composition was even 
more pronounced (Table Ill). In all analyses, the results of Ilcrudell ferritin fitted in be-
tween (Table III). 
This difference in carbohydrate content will not explain the apparent difference in mass (± 
220 kDa) between both fractions, as shown in non-denaturating gel electrophoresis. 
However, electrophoretic mobility of a protein in non-denaturating gel electrophoresis will 
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be influenced by differences in the number of charged side chains (e.g. sialic aeid). 
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Polyclonal antibodies generated against each of the two purified ferritin fractions were 
testcd against both fractions in an Ouchterlony double immunodiffusion assay. A: tmti-440 
kDa ferritin antibodies; B: anti-660 kDa ferritin antibodies. 1: 440 kDa ferritin (undiluted); 
2: 660 kDa ferritin (undiluted). 3: 440 kDa ferritin (diluted 1:2); 4: 660 kDa ferritin (dilu-
ted 1:2). 5: 440 kDa ferritin (diluted 1:5); 6: 660 kDa ferritin (diluted 1:5). 
In summary: porcine spleen ferritin isolated according to different standard procedures 
routinely showed two distinct bands in non-denaturating gradient gel electrophoresis. Both 
fractions are equal in subunit composition, iron load and amino acid composition (except 
for N-acetylglucosamine), but differ in carbohydrate content. Moreover, both fractions 
show incomplete homology when cross-reacted with antibodies generated against both 
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fractions. Together, these findings militate against, but cannot completely mle out the 
possibility that the "660 kDall fraction is in fact a ferritin dimer. However, results indicate 
defInitely that the "660 kDa" fraction is in fact a more glycosylated type of tissue ferritin. 
Whether this difference in glycosylation reflects a difference in cellular function remains as 
yet unknown. 
Fig. 4.4" and 4': 
Electron micrographs of 440 kDa (Fig. 4') and 660 kDa (Fig. 4b) ferritin fractions. Bar 
represents 50 nm. 
III 
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§ 5.1 SummalY. 
Distribution of iron in the brain varies with region, cell type and age. Furthermore, some 
neurological diseases are accompanied by an abnormal accumulation of iron in specific 
areas of the eNS. These findings implicate a mobile intracerebral iron pool; however, 
transport of iron across the bloodRbrain barrier and its regulation are largely unknown. 
\Ve separately quantified surface bound and total cellular transferrin receptor pools in 
primary cuitures of porcine blood-brain barrier endothelial cells. Although 90% of all 
transferrin receptors were located inside the cell. only 10% of these intracellular receptors 
actively took part in the endocytic cycle. Tills large °inactive" intracellular transferrin 
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receptor pool could either function as a storage site for spare receptors, or be activated by 
the cell to increase its capacity for iron transport. 
Data were corrected for nonspecific binding by: (i) separate biochemical assessment using 
a 1 OO~fold excess of unlabeled ligand, (ii) analyzed in a nonlinear curve fit program, which 
resulted in a less elaborate and less biased estimate of nonspecific binding. 
§ 5.2 Introduction. 
As early as 1922, Spatz (35) showed iron to be present in the brain. This finding received 
only little attention for a number of decades (18). Recently however, research in tlus field 
gained momentum when it became clear that (accumulated) iron could have deleterious 
effects by acting as a catalyst in the formation of reactive oxygen species (25,19). These 
reactive oxygen species can damage or modify lipids, proteins and DNA (17,10). Brain 
tissue is very rich in lipids and therefore more vulnerable to oxidative stress than most 
other tissues (13,15,19). 
The overall distribution of iron, transferrin and ferritin in the brain has recently been re~ 
examined (7,27). These studies (reviewed in 8) S)lOW that iron levels in the brain vary with 
region and cell type. Moreover, the pattern of iron distribution in the brain changes with 
age (8, II) and in certain (neurological) diseases. For instance, Alzheimer's and Parkinson's 
disease are accompaIued by an abnormal accumulation of iron in specific areas of the 
central nervous system (7,22). On the other hand, iron deficiency leads to a reduction in 
cerebral iron as well as cerebral function (39). These studies implicate a mobile intrace~ 
rebral iron pool, but the mechanism by which iron enters or leaves the brain is still unclear 
(14). The discovery of transferrin receptors (TIR's) on the luminal side of blood-brain 
barrier endothelial cells (21) clarifies a route by which transferrin (Tf) enters the endot-
helial cell. However, conflicting evidence exists as to the fate of Tf aner uptake (14,28,32). 
Either Tf is returned to the luminal surface (30,33) by an endocytic cycle (9,38), or Tf 
enters the brain by transcytosis (12,14). Factors regUlating transport of iron across the 
blood~brain barrier are as yet unknown (4). 
The purpose of tIus study is to quantify the amount of TfR's on the cell surface, the total 
cellular TIR pool in primary cultures of porcine blood-brain barrier endothelial cells (BBB-
Ee's) and the number of TIR's that actually take part in the transport of iron. The results 
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will be used as a basis for future experiments in search for f..1ctors regulating iron transport 
across the blood-brain barrier. 
§ 5.3 Materials and methods. 
§ 5.3.1 Materials. 
Fresh porcine brain was obtained from the local slaughterhouse. Hanks' Balanced SaIt 
solution (HBSS), M 199 with Earle's saIts, Pungizone (Amphotericin B), Fetal Calf Serum 
(PCS) were obtained from ICN Biomedicals (ICN Biomedicals Ltd, UK). L-Glutamine was 
obtained from Merck (Merck, Germany). Dispase Neutral protease from Bacillus Poly-
myxoma Grade II, mouse anti-human Von \VilIebrand Factor and fluorescein labeled goat 
anti-lllouse IgG were purchased from Boehringer Mannheim (Boehringer Mamlheim, 
Germany). Trypsin from beef pancreas was obtained from BDH (BDE Biochemicals, UK). 
All other chemicals used were of the highest purity. 
§ 5.3.2 Methods. 
§ 5.3.2.1 Blood-brain barrier microvessel endothelial cell isolatioll and culltlring. 
A detailed description of this procedure can be found in § 2.2.1. Briefly: microvascular 
endothelial cells were isolated from fresh porcine brain using a method adapted from 
Mischeck (26) and Meresse (24). Brain tissue was homogenized after careful removal of 
cerebellum, meninges and choroid plexus. The homogenate was resuspended in brain 
culture medium. Dispase was added and the homogenate was gently shaken for 3 hl's, then 
filtered and centrifuged. The bottom layer of the pellet was resuspended and the procedure 
was repeated (3x). Cells were plated all gelatine coated petri dishes. After 30 min culture 
medium was replaced. Culture medium was changed every other day. 
§ 5.3.2.2 Isolation and purification a/porcine ser1l1l1transjerrin. 
A detailed description of tllis procedure can be found in § 2.6.1. Briefly: fresh porcine 
plasma was saturated with iron and fibrins were removed. Following two precipitation steps 
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with ammonium sulfate, the pellet was redissolved and dialyzed. Aliquots were loaded on a 
colunm packed with Cibacron 3GA coupled to BioGel A 1.5m and porcine transferrin was 
eluted with a linear (0 to 0.1 M) sodium phosphate gradient. 
§ 5.3.2.3 Imlatiol1 and purification of h'Gnsfel'l'ill receptors fl'Om porcine liver. 
A detailed description of this procedure can be found in § 2.6.4. Briefly: porcine liver 
tissue was homogenized in buffer, filtered and centrifuged. The pellet was resuspended and 
washed (= crude vesicle preparate), then dissolved in PBS containing Triton X-IOO and 
Trypsin and placed in a waterbath at 37°C. This solution was dialyzed, concentrated and 
then centrifuged. Supernatant samples were fractionated on a Sephadex G 100 column and a 
column packed with porcine 2Fe-Tf coupled to CNBr-Sepharose 4B. The 70 kDa TIR 
subunit was eluted with a buffer (pH 2.8). Purity was checked with SDS-PAGE (see § 
2.5.1.1). 
§ 5.3.2.4 Radio-Iabelillg 0/ tralls/errin. 
A description can be found in § 2.8.1. 
§ 5.3.2. 5 Smface transferrin receptor measurements. 
Surface TfR measurements were performed as described by Ciechanover (6). Blood-brain 
barrier endothelial cells were incubated with t25l_Tf at 4°C, rinsed with PBS and receptor 
bound 1251 -Tf was measured. A detailed description of this procedure can be found in § 
2.8.2. 
§ 5.3.2.6 Total transferrillreceplor measllrements. 
To assess the total amount of TfR's present in the endothelial cells, a procedure as 
described by Rao (29) was used (see § 2.8.3). Blood-brain barrier endothelial cells were 
homogenized, incubated with 1251_ Tf at 4 °C and precipitated with ammonium sulfate. 1251_ 
Tf-TiR complexes were collected on filters and measured. The TfR recovery efficiency of 
tillS procedure was checked in a separate series of experiments (see § 5.3.2.7). 
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§ 5.3.2. 7 TramjeJ'J'illl'eCeptol' l'eCDVe1J' efficiency assessment ill tolal TjR measurements. 
Known amounts of partially purified and purified TfR's were subjected to the procedure 
as described in § 5.3.2.6 to test the recovery efficiency of this procedure. A detailed 
description of this procedure can be found in § 2.8.4. 
§ 5.3.2.8 Quantification aftransferrin receptors participating in the eudoey/ie cycle. 
A detailed description of this technique can be found in § 2.8.5. Briefly: blood-brain 
barrier endothelial cells were washed once with PBS and then incubated for 1.5 to 40 h 
with 1500 ng (;' 50 times Kd) '''1_ Tf at 37°C. Surface and intracellular 'I'fR concentrations 
were assessed separately. 
§ 5.3.2.9 Protein measurements. 
Cellular protein measurements were performed as described in § 2.5.2.2. 
§ 5.3.2.10 DNA lIleaslIl'emellfs. 
Cellular DNA content of each sample was assessed using a Nuclesan DNA kit (Sanbio, the 
Netherlands) according to manufacturers instructions (see § 2.5.2.3). 
§ 5.3.2.11 Alathematical analysis of the receptor binding e.\1Jel'imellts. 
A detailed description can be found in § 2.7.2. Briefly: the percentage nonspecific binding 
was calculated using wells incubated with different concentrations of 1251_ Tf in the presence 
of a IOO-fold excess of non-labeled Tf. Furthermore, the results from each binding 
experiment were fitted using the following equation in a nonlinear curvefit program 
§ 5.3.2.12 Anti-Voll Willebralld illllllllllocytochelllisfly. 
Blood-brain barrier endothelial cells grown on gelatin coated coverslides were incubated 
with mouse anti-human von 'V,illebrand factor immunoglobulins. A detailed description of 
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this technique can be found in § 2.3.l. 
§ 5.4 Results. 
§ 5.4.1 lsolatioll procedure. 
The isolation procedure (as described in § 5.3.2.1), resulted in a more'than 95% pure 
blood brain-barrier microvascular endothelial cell culture. Purity was checked in phase 
contrast light microscopy (Fig. fb) and in immunocytochemistry with antibodies against 
human Von \Villebrand Factor (Fig. fa). Cells were used upon reaching confluency and 
cell counts at that time yielded an average of 4.1 (± 0.4) x 10' cells/cm' (mean ± SD). 
Repeated DNA measurements (n ~ 6) resulted in an estimate of 10.8 pg DNNcel1. 
.II 5.4.2 Quantification of slIIface and total TfR pools. 
The amount of TfR's on the cell surface was assessed in 8 separate experiments. Each 
individual binding plot was the result of 12 to 15 (duplicate) measuring points and 3 
(duplicate) measuring points to estimate nonspecific binding. In Fig. 2 the combined results 
of these experiments are summarized. Nonlinear curve fit analysis yielded a B11L1-,{ value of 
0.031 ± 0.013 ng Tflftg protein (mean ± SD) which equals 3.6 (± 2.8) x 1011 Tf binding 
sites/mg protein (mean ± SD). 
Fig. 1a: 
Inununofluoresce micrograph of a primary cuihlfe of porcine blood-brain barrier endothe-
lial cells incubated with mouse anti-human Von Wille brand Factor. (M ~ 1000x). 
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Fig. lb: 
Phase-contrast micrograph of a primary culture of porcine blood-brain barrier endothe-
lial cells. (Bar: 100 pm) 
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Fig, 2: The results of 8 separate experiments (n = 12, in duplicate) are summarized in this 
figure. Blood-brain barrier endothelial cells were incubated with 125I-Tf at 4 °C and surface 
TiR bound 125I_Tf was measured. Each open circle represents the average of a result in 
duplicate. The binding plot (solid line) was obtained in a nonlinear curve fit program. The 
insert shows the scatchard plot derived from the nonlinear curve fit data, The Y-axis 
represents bound/free Tf, the X-axis represents bound Tf (in Ilg/"g protein). The TfR 
affinity constant derived from this analysis is shown at the top of the insert, 
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The insert in Fig. 2 shows the scatchard plot and affinity constant derived from the 
nonlinear curve fit data. The number of total TfR's is derived from the results of 8 
individual experiments, each consisting of 10 (duplo) experimental data and 3 (duplo) 
experimental data for correction of nonspecific binding. The binding plot resulting from the 
nonlinear curve fit is depicted in Fig. 3. The insert shows the scatchard plot and affinity 
constant derived from the analysis. 
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Fig. 3: 
The results of 8 separate experiments (n = 10, in dupIo) are summarized in tIus figure. 
Lysed blood-brain barrier endothelial cells were incubated with I25J-Tf at 4°C, precipitated 
and 12sI_Tf_TfR complexes were collected. (Individual data are shown in Fig. 5). The 
binding plot was obtained in a nonlinear curve fit program. The insert shows the scatchard 
plot derived from the nonlinear curve fit data. The Y-axis represents bound/free Tf, the x-
axis represents bound Tf (in ngl~tg protein). The TfR affinity constant derived from tIus 
analysis is shown at the top of the insert. 
The B=, value is 0.442 ± 0.180 ng Tf/flg protein (mean ± SD) which equals 4.1 (± 1.8) x 
10" Tf binding sites/mg protein (mean ± SD). 
§ 5.4.3 Assessment o/TfR amollnts, actively participating in the el1docytic cycle. 
Data on the amount of Tfr's actively participating in the en-docytic cycle, are summarized 
in Table J. Data are derived from 3 separate experiments (n = 12) expressed as mean ± 
SD. 
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incubation time surface TfR bound intracell TfR ratio of surface TfR's 
with 1251_ Tf Tf (ng Tf/ftg prot) bound Tf (ng to intracellular TfR's 
(in Ius) Tflflg prot) 
1.5 0.023 ± 0.005 0.029 ± 0.002 0.79 
3.0 0.020 ± 0.001 0.029 ± 0.003 0.68 
6.0 0.018 ± 0.002 0.029 ± 0.003 0.62 
20 0.031 ± 0.004 0.029 ± 0.005 1.07 
40 0.041 ± 0.011 0.041 ± 0.005 1.0 
Table 1: 
Results of 3 separate experiments (12 wells per incubation time in each experiment) on 
the quantification of TfR's actively participating in the endocytic cycle. Cells were incuba-
tcd for 1.5 to 40 Ius at 37 °C with I2SJ_ Tf, followed by separate assessment of surface 
bound and intracellular TfR's. Results are expressed as mean ± SD. The ratio of surface to 
"active" intracellular TtR's is shown in the last column. 
§ 5.4.4 Control experiments. 
Separate series of experiments were performed to estimate the total TfR recovery 
efficiency of our tecllllique. Each set of data points is the mean result (± S.D.) of 4 
individual experiments performed in duplo. Fig. 4 shows that at 30% saturation with 
ammonium sulfate only 2% of the incubated Tf is precipitated, whereas 15 ± 5% (mean ± 
SD) of the purified half TfR is recovered (data corrected for nonspecific precipitation of 
TO. These experiments further show that 72 ± 2% (mean ± SD) of the vesicle membrane 
bound TfR's is recovered, when incubated with 1251_Tf in the presence of 0.1% Triton X-
100. When Triton X-IOO was left out, TfR recovety rate decreased to 58 ± 1% (mean ± 
SD). 
§ 5.4.5 Nonlinear Clll1'ejit analyses a/binding assays. 
As an example of the nonlinear curvefit analyses, individual data points from 8 separate 
experiments quantifying the total amount of TfR's, are presented in Fig. 5. Together with 
these data, the curve fit based on the nonlinear analysis is presented, both in its complete 
form and split in its nonlinear and linear part. The linear part is an estimate of the amount 
of nonspecific binding, 9.7 ± 1.5% (mean ± SD). 
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Experimental results on the quantification of 1251_ Tf-TfR complex recovery rate are 
sUlllmarized in this figure. Standard amounts of,125I_Tf, purified half TfR)251_Tf complexes 
and complexes of 1251_Tf linked to membrane bound TfR's (crude vesicles; see § ...... ) were 
precipitated with llnmloniulll sulfate in various concentrations up to 100% saturation. Each 
data point represents the mean of 4 separate experiments performed in duplo. Results are 
expressed as the percentage of recovered radio-activity and error bars represent 1 SD. Open 
triangles: purified half TfR- 125I-Tf complexes; closed triangles: 1251_Tf. Open squares: 
complexes of membrane bound TfR's and 1251_Tf, without Triton X-IOO. Closed squares: 
complexes of membrane bound TfR's and 1251_ Tf, with Triton X-lOO. 
§ 5.5 Discussion. 
The endothelial cells lining the brain microvasculature are held responsible for the selec-
tive barrier that exists between the circulatory system and central nervous system (16). 
Three major features distinguish the brain microvascular endothelial cells from their 
periferal counterparts: (i) tight junctions connecting adjacent endothelial cells, (ii) a low 
rate of pinocytosis (31) and (iii) membrane bound receptors (14) serving as highly specific 
and selective transport mechanisms across the blood-brain barrier. 
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Fig. 5: 
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Combined data of 8 separate experiments (lO duplo points each) to measure total cellular 
TfR amounts are shown (open circles), Nonlinear curve fit analysis, based 011 the equation 
f(x)~((a * x)/(b+x))+c * x, yields the top curve (- - - -) with an R' of 0.87. 
The equation can be separated in the Langmuir isotherm, predicting a saturable binding 
between receptor and ligand (solid line; see also fig 3) and a linear term, compensating for 
nonspecific binding (- . - . - line), 
Several techniques have been described to isolate and culture brain microvascular 
endothelial cells with a high degree of purity (23). Although each of these techniques has 
been tested for one or more blood-brain barrier endothelium specific characteristics, e.g. 
von \ViIlehrand factor (factor VIII related antigen), problems may still arise. First, 
dedifferentiation due to repeated passaging can affect highly specific cell functions (1,30). 
Secondly, isolated endothelial cells show polymorfism (34) and selection of one subtype 
could yield limited information. Thirdly, astrocytes (5) and pericytes (2) affect growth and 
structure of endothelial cell cultures and could modulate cell specific fUllction characteris-
tics. \Ve therefore performed all our experiments on primary culture endothelial cells (Fig. 
1) with a purity of z 95%, other cells mainly being pericytes and some astrocytes. 
A separate series of experiments was performed to estimate porcine TiR recovery 
efficiency in our total-TfR experiments. TfR has two identical (70 KDa) subunits (37), 
each capable of binding one Tf molecule. Treating TtR containing vesicles (crude vesicle 
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preparate, see § 5.3.2.3) with trypsin will free this hydrophilic 70 kDa subunit from its 
transmembrane segment. The recovery rates of Tf and the 70 kDa TfR subunit-Tf complex 
were low (Fig. 4). Crude vesicles however, contain complete TfR's still anchored in lipid 
membranes and precipitated more readily (Fig. 4). Adding Triton X-IOO increased the TfR 
recovery rate (72%), most likely due to an increased accessibility of the intravesicular 
TfR's for 125I_Tf. The TfR recovery was not complete, probably because vesicle bound 
TfR's are an already partIy purified substrate. Results in cell lysates were not corrected for 
this loss in recovery, because these lysatcs consist of even larger membrane fragments than 
vesicles. This will most likely enhance precipitation and therefore increase the TfR 
recovery rate above 72%. 
Experimental data were analyzed with a nonlinear curve fit program for two reasons. First 
of ali, a mathematical analysis of the raw data set will give the least biased response (20). 
Secondly, an adequate mathematical analysis of nonspecific binding will reduce the need 
for a series of wells reserved for a biochemical estimate of nonspecific binding and 
therefore increase the number of experimental data in the actual experiment. 
The equation used (see § 5.3.2.11) consists of a nonlinear and a linear term. The nonlinear 
(Langmuir) isotherm predicts a saturable interaction between receptor and ligand (20), 
whereas the linear term is introduced to compensate for nonspecific binding. The pooled 
data on surface and total TfR's were analyzed mathematically, yielding an estimate of 
nonspecific binding which was in good agreement with the biochemical assessment of 
nonspecific binding. The mathematical estimation of nonspecific binding in the surface TfR 
experiments was nearly zero and on average less than I % when assessed biochemically. As 
shown in Fig. 5, nonspecific binding in the pooled data of total TfR experiments is 9.7 ± 
1.5% (mean ± SD). The averaged nonspecific binding assessed biochemically was 15 ± 7% 
(mean ± SD). 
Computing the amount of internal TfR's from the results on surface and total TfR 
numbers, we found circa 90% of all TfR's to be located inside the ('.ell, in agreement with 
Raub et al (30). In the individual datasets, however, the number of internal receptors varied 
between 78 and 98%. Nonlinear curvefit analyses on the combined datasets of the total-Tfll. 
experiments resulted in an R2 of 0.88 (Fig. 3), indicating that the total llumber of TfR's is 
rather consistent throughout experiments. Mathematical analysis on the combined datasets 
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of surface TfR experiments only yielded an R2 of 0.57 (Fig. 2), whereas in similar analyses 
on results of individual surface TfR binding experiments R2 ranged from 0.85 to 0.99. This 
indicates a substantial variation in the number of sur£'lCe TfR's between different experi-
ments, which cannot be explained by nonspecific binding as shown both biochemically and 
mathematically « 1%). Moreover, TfR affinity constants of both surface and total TfR 
data sets were not significantly different (p < 0.05). These results suggest that the total TfR 
concentration is more or less constant, while the amount of TtR's on the surface can be 
modulated by the cell, for instance to regulate its iron uptake. 
The number of TfR's actively participating in the endocytic cycle was assessed (Table 1) 
by incubating cells with an excess of 125r -Tf. Based on an estimated recycling time of 90 
min for TfR's (30) incubations were performed up to 40 h (over 25 cycles) to label all 
active TfR's. The number of labeled surface Till's was not significantly different (p < 
0.05) from that found in the experiments on surface TfR quantification. However, only 
circa 10% of all intracellular TfR's could be labeled in tllis way. These results suggest that 
there are at least two separate intracellular TtR pools. One of these pools, roughly equal to 
the alllount of surface TfR's (Table 1), is active in the endocytic cycle, whereas circa 90% 
of ail intracellular TfR's seem to be inactive. This inactive pool could function as a storage 
site to replace those TfR's damaged or lost during the endocytic cycle. On the other hand, 
if TfR's stored in this inactive pool could be "activated!! to participate in the endocytic 
cycle, the inactive pool would serve as a regulatory mechanism for iron transport across the 
blood-brain barrier. Variation in the amount of surface bound TfR's (discussed earlier) 
could be the result of minor changes in the ratio of active to inactive TfR's. 
Berczi et al (3) found that a sigllificant amount of 125J R labeled ligand remained in the 
K562 cell and suggested a third TfR-pathway next to the two described by Stein and 
Sussmann (36). In our experiments however, 40 Ins of incubation with excess 12sI_Tf could 
only reach 10% of all internal TfR's (active pool). It would seem that the proposed third 
TfR-pathway (3) is not connected to the inactive TfR pool as described above. 
To gain further insight in mechanisms regulating iron uptake and transport across the 
blood-brain barrier, we are currently conducting similar experiments on endothelial cells 
cultured in iron poor and iron enriched media. 
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§ 6.3.2.5: Quantitation of intracellular TfR's participating in the endocytic 
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§ 6.3.2.6: Transferrin receptor endocytosis rate measurements. 
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§ 6.1 Summary. 
Iron is an essential element in the cellular metabolism of all mammalian tissues including 
the brain. Intracerebral iron concentrations have been shown to vary with age and in a 
number of (neurological) diseases. To 'date however, factors governing the regulation of 
intracerebral iron concentration are unknown, although there is some evidence to suggest 
that the endothelial cells lining the capillaries in the brain (BBB-EC's) are of major 
importance in this process. To further investigate the role of these BBB-Ee's in cerebral 
iron regulation, primary cultures of porcine BBB-Ee's were grown in either iron-enriched 
(Fe+) or iron-depleted (Fe) culture medium. Fe' cultured BBB-EC's showed a reduction in 
surface bound and total transferrin receptor (TfR) numbers compared to Fe' cultured cells. 
Experiments on the endocytic cycle of TfR's showed that the TfR internalization rate of 
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Fe' BBB-EC's (K" ~ 0.62) was twice that of Fe cultured cells, whereas the TfR externaIi-
zation rate of Fe+ was lower than that of Fe- cultures. Our findings indicate that TtR 
endocytosis rates in BBB-Ee's are in agreement with those found in other cell types. 
Moreover, Fe+ cultured BBB-EC's were able to accumulate more iron intracellulary than 
Fe- ceIls. These results are in agreement with both the kinetic data on TfR's and clinical 
findings in hemochromatosis and suggest that at high peripheral iron concentrations, the 
rate of iron transport across the BBB-EC's is to some extent proportional to tlils peripheral 
iron concentration. 
§ 6.2 Introduction. 
Iron is an essential element in a large number of enzymes required for proper cellular 
functioning (1,16)_ In brain tissue celis, iron can be found in various enzymes involved in 
oxidative phosphorylation, neurotransmitter synthesis and degradation, and myelin 
formation (2,20,27). Both iron deficiency and iron overload change the normal distribution 
pattern of intracerebral iron, resulting in neurological dysfunction and sometimes even in 
overt cellular damage (10,14,15,30,34). 
Contrmy to what is known about the distribution of iron in peripheral tissues, only limited 
information is available on the distribution of iron in the brain (2,6). Recently, morp-
hological and biochemical studies determined the overall distribution of iron, transferrin 
and ferritin in human brain tissue (7,20). However, as discussed in chapter I and 5, the 
cerebral iron pool is subject to changes due to ageing, iron deficiency or overload, and a 
number of neurological diseases (e.g. Alzheimer's disease). The finding of elevated iron 
concentrations in areas prone to damage in Parkinson's and Alzheimer's disease, suggests 
that iron is involved in the pathogenesis of these diseases (see chapter 8). Indeed, some 
(although indirect) evidence for an involvement of oxygen radical species in those diseases 
has been described (9,12,21). 
Regulatory factors governing the uptake and distribution of iron in the brain are as yet 
unknown (3,7). \Vith the discovery of transferrin receptors on the luminal side of the 
blood-brain barrier endothelial celIs (13), it became evident that iron might cross the blood-
brain barrier, although most aspects of this pathway are still unclear (3,19,26,32). Consi-
dering the large surface area of the blood-brain barrier (± 240 cm2/g brain tissue), it can be 
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assumed that the BBB is of major importance in the uptake of iron into the brain (23). In 
earlier work (see chapter 5), experiments were performed to quantify both intracellular and 
surface hound transferrin receptors in primary cultures of BBB-EC's. To further elucidate 
the role of BBB-ECs in the regulatioil of iron transport, we have grown primary isolates of 
porcine BBB-ECs in either iron-enriched or iron-depleted medium, thus mimicking iron 
overload and iron deficiency. Data will he presented on the quantification, distribution and 
kinetics of transferrin receptors on these endothelial cells. 
§ 6.3 Materials and methods. 
§ 6.3.1 Materials. 
Fresh porcine brain was obtained from the local slaughterhouse. Specific chemicals uscd 
for the isolation and culturing of BBB-Ee's are listcd in chapter 5. 
§ 6.3.2 Methods. 
§ 6.3.2.1 Blood-brain barrier microvessel endothelial cell isolation and culturing. 
A detailed description of this procedure can be found in § 2.2.1 and § 2.2.2. Following 
isolation, all cells were cultured according to the standard procedure for 3 days. Subse-
quently, cells designated to be lIiron loaded", were incubated with culhlre medium con-
taining 300 ~lM diferric transferrin (= Pet medium). Pe+ medium was changed every other 
day and experiments were performed when cuihlres were nearly confluent. 
Cells designated to be "iron deficient" were treated according to the standard procedure 
until two days before the actual experiment. At that time, Deferrioxamine (50 ~lg/ml) was 
added to the cuIhlre medium (= Pe' medium) and this was repeated 011 the day before the 
experiment. 
§ 6.3.2.2 RadiO-labeling 0/ trans/errill. 
Experiments were performed with either 1251 and/or 59Fe labeled Tf. A description of the 
radio-labeling procedure can be found in § 2.8.1. 
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§ 6.3.2.3 SWface transferrin receptor measurements. 
Surface TfR measurements were performed as described by Ciechanover (5). BloodRbrain 
barrier endothelial cells were incubated with 125r -Tf at 4 °C, rinsed with PBS and receptor 
bound 125I_Tf was measured. A detailed description of this procedure can be found in § 
2.8.2. 
§ 6.3.2.4 Total transferrin receptor measurements. 
To assess the total amount of TfR's present in the endothelial cells, a procedure as 
described by Rao (22) was used (see § 2.8.3). Blood-brain barrier endothelial cells were 
homogenized, incubated with 125I_Tf at 4 °C and precipitated with ammonium sulfate. 1251_ 
Tf-TfR complexes were collected on filters and measured. The TfR recovery efficiency of 
this procedure was checked in a separate series of experiments (see § 5.3.2.7). 
§ 6.3.2.5 Quantification a/intracellular transferrin receptors participating in the endocytic 
cycle. 
A detailed description of tlus tecllluque can be found in § 2.8.5. Briefly: cells were 
washed once with PBS and then incubated for I to 3 h with 1500 ng (;>: 50 times Kd) 1251_ 
Tf-2Fe at 37°C. Cells were then harvested and intracellular TfR bound 1251_Tf was 
measured. 
§ 6.3.2.6 1)'ansferrin receptor endocytosis rate measurements. 
A detailed description of these single cycle experiments can be found in § 2.8.6. Briefly, 
cells were incubated with 1.6 ltg/ml diferric "Fe-Tf at 4 °C. Endocytosis was started by 
rapidly heating cells to 37°C, at the same time adding 2 tnl of prewarmed (37°C) 
medium containing 1.6 pglml unlabeled diferric transferrin. Endocytosis was stopped at 
fixed time periods by rinsing the cells with icecold PBS. Intracellular 59Pe (as a marker for 
endocytosis) was measured at those time periods. Data sets were analyzed in a nonlinear 
curve fit program according to the equation Y(t) ~ Btot * (I - e-k'~, to yield an estimate of 
the internalization rate constant Km. 
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§ 6.3.2.7 Transferril1 receptor exocytosis rate measurements. 
A detailed description of these single cycle experiments can be found in § 2.8.7. Briefly, 
cells were incubated with 1.6 flg/Illl t251 labeled diferric transferrin at 37°C for 1 h 45 min 
and then placed on ice and washed repeatedly with acid and neutral buffers. Exocytosis 
was started by rapid heating to 37 °e, and stopped at fixed intervals by rinsing cells with 
icecold PBS. Remaining intracellular 1251_Tf (as a marker for exocytosis) was measured at 
those intervals. Data sets were analyzed in a nonlinear curve fit program according to the 
equation Y(t) = C, * e'ktj + C21 to yield an estimate of the externalization rate constant Kout• 
§ 6.3.2.8 Quantification of cellular iron acculIlulation and release. 
TIlls procedure is described in detail in § 2.8.8. Briefly. following pre-incubation with 
serum free medium, cells were incubated for different time periods up to 24 h with 4.8 
!1g1ml diferric 59Fc_ Tf at 37°C. At those intervals, cells were placed on ice, washed and 
harvested for both protein and intracellular iron e9Fe) measurements. The 59Feiprotein ratio 
represents the net iron accumulation (= uptake minus release). 
A parallel experiment was set up to measure iron release only. In a number of dishes, 
medium containing s9Fe was replaced at t = 3 h by standard medium. After another 3 h the 
excreted amount of S9Pe was measured. 
§ 6.3.2.9 Protein measurements. 
Cell protein measurements were performed as described in §2.S.2.2. 
§ 6.3.2.10 Malhemalical analyses of Ihe e.'perimenlal dala on lransjel'!'in receplor binding. 
endocytosis and exocytosis. 
Detailed descriptions can be found in § 2.7.2 and § 2.7.3. 
§ 6.4 Results. 
§ 6.4.1 Quantificalion of sill/ace bound, lolal, and aclive inlracellular transferrin 
receptors. 
Surface bound TfR's were assessed in primary cultures of BBBMEC's grown either in Fc+ 
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or Fe' medium. Cells subjected to either of the culture conditions originated from the same 
isolate. In this way, possible variations due to differences between separate batches could 
be avoided. 
Each individual binding experiment consisted of 10 (duplicate) measuring points and the 
combined results of 4 separate experiments are depicted in Fig. 1. The inserts show the 
result of the nonlinear curve fit program applied to the pooled data sets for Fe+ and Fe' 
cultures. The two curves in the large graph are the result of nonlinear curve fits (see chap-
ter 5) corrected for nonspecific binding. The differences in surface TIR bound Tf between 
Fe+ and Fe' arc considered significant, since data differed more than twice the standard 
deviation (Fe: Bmax ~ 0.037 ± 0.003; Fe': Bmax ~ 0.029 ± 0.003). 
Fig. 1: 
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The results of 4 separate experiments (n = 10, in duplicate) are stmmlarized in this figure. 
Blood-brain barrier endothelial cells, either cultured in iron-enriched (Fe+) or iron-depleted 
(Fe') medium, were incubated with 125I-Tf at 4 °C and surface bound 125I-Tf was measured. 
The binding plots in the large graph were obtained using a nonlinear curve fit program and 
are corrected for nonspecific binding. The solid line represents the fitted binding plot of Fe' 
cultured cells, the intermpted line represents the binding plot of the Fe+ cultured cells. 
The inserts show the original data points of both the Fe' and Fe' cultured cells. Each data 
point is the average of a result in duplicate. X-axis and Y-axis seatings in the inserts are 
identical to those in the large graph. 
Bmax, R2, Seatehard analysis derived TfR affinity constants Ka, and other data are 
summarized in Table 1. 
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Total transferrin receptor assessments were obtained an displayed in a similar way. Results 
arc summarized in Fig. 2 and Table 1. 
Surface bound Total TfR's 
TIR's 
Fe + Fe - Fe + Fe -
Bmax in ng TJl,lg prot 0.029 0.037 0.072 0.090 
Ka ( * 10') 1.25 1.32 0.36 0.28 
R' (nonlin curve fit) 0.85 0.85 0.77 0.88 
no of binding sites/mg prot ( 2.25 2.79 5.45 6.80 
* 10" ) 
% nonspec. binding 1.6% 2.8% 9.3% 7.8% 
Table 1: 
This table summarizes the experimental results on surface and total TfR quantification in 
primary cultures of BBB-EC's. 
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Fig. 2: The results of 4 separate experiments (11 = to, in duplicate) are summarized in this 
figure. Lysed blood-brain barrier endothelial cells, either cultured in iron-enriched (Fe~) or 
iron-depleted (Fe') medium, were incubated with '''[_Tf at 4 °C, precipitated and '''j_Tf_ 
TtR complexes were collected. The binding plots in the large graph were obtained using a 
nonlinear curve fit program and are corrected for nonspecific binding. The solid line repre-
sents the fitted binding plot of Fe- cultured cells, the interrupted line represents the binding 
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plot of the Fe+ culturcd cells. 
The inserts show the original data points of both the Fe+ and Fe culturcd cells. Each data 
point is the avcrage of a result in duplicate. The X-axis represents free Tf (in ng/Ilg pro-
tein) and the Y-axis represents bound Tf (in ng/Ilg protein). 
The number of intracellular TfR's actively participating in the endocytic cycle of BBB-
EC's cultured in Fe+ or Fe- medium was assessed in three separate experiments. Each expe-
riment was performed in sixfold with three different incubation times up to 3 hours. Since 
earHer experiments had made clear that the number of active intracellular TtR's is inde-
pendent of the incubation time (see chapter 5), results of all obtained data were averaged. 
BBB-EC's culturcd in Fe+ medium contained 0.089 ± 0.004 ng bound Tflf1g protein (mean 
± SD). BBB-EC's culturcd in Fe medium contained 0.107 ± 0.005 ng bound TflIlg protein 
(mean ± SD), which means a significant difference (p < 0.05). 
§ 6.4.2 Tramjerl'in receptor kinetics: estimates of endocytosis and exocytos;s rates. 
A series of single cycle experiments were performed to study the effects of iron overload 
and iron depletion on the rate of transferrin receptor endocytosis in primary cultures of 
BBB-EC's. Each series consisted of four separate experiments, with 8 measuring points 
(time intervals) per experiment. The ratc of endocytosis was estimated by measuring 59Fe 
uptake in the first few minutes. Results arc summarized in Fig. 3 and Table 2. Correlation 
coefficients of the nonlinear curve fits were better than 92%. 
endocytosis exocytosis 
Fe- I Fe+ Fe- Fe-l-
Km resp. Kout in 
I 
0.30 
I 
0.62 
• 
0.06 0.05 
mitl' 
T 112 in min 2.3 l.l 11.6 14.6 
Table 2: 
This table summarizes the experimental results on TIR internalization and externali711tion in 
BBB-EC's. (Tin = In 21K;" resp. K,o') 
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Fig. 3: 
Results of four separate single cycle experiments with 8 time intervals per experiment were 
performed to assess the TfR internaliz.:'ltion rate. Intracellular 59Fe was measured: each open 
circle represents the mean ± SD of 4 experiments with Fe- cultured cells; closed circles 
represent the mean ± SD of 4 experiments witi> Fe+ cultured cells. The solid (Fe') and 
interrupted (Fe f ) lines represent the plots derived from the nonlinear curve fit analyses, 
using the equation yet) ~ Btot • (1 _ e·k'~. 
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Fig. 4: 
Results of four separate single cycle experiments with 10 time intervals per experiment 
were performed to assess the TfR externalization ratc, Excreted 1251-Tf was measured: each 
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open circle represents the mean ± SD of 4 experiments with Fe- cul-tured cells; closed 
circles represent the mean ± SD of 4 expe-riments with Fe+ cultured ceBs. The solid (Fe-) 
and interrup-ted (Fe+) lines represent thc plots derived from the nonlinear curve fit 
analyses, using the equation yet) = C1 * e-k'\ + C2• 
Transferrin receptor exocytosis was studied in a similar fashion, measuring the amount 
Op251 labeled Tf that re-entered the medium in a specific timc interval at 37°C. Again, 
each series consisted of four separate experiments, with 8 measuring points per experiment. 
Results are displayed in Fig. 4 and Table 2. Correlation coefficients of the nonlinear curve 
fits averaged 97%. 
§ 6.4.3 Quantification of iron accllmulation 
Cells, cultured in Fe+ or Fe- medium, were incubated for 0.5 to 24 hours with diferric 
CS9Fe) transferrin to quantify iron accumulation (= iron uptake minus release). The averaged 
results of 4 separate experiments are depicted in Fig. 5. 
Fig. 5: 
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Results of three separate experiments with 5 time intervals per experiment were performed 
to quantify iron accumulation_ Each open circle (and solid line) represents the mean ± SD 
of 3 experiments with Fe' cultured cells; closed circles (and interrupted line) represent the 
mean ± SD of 3 experiments with Fe+ culhlred cells. 
A parallel experiment was set up to measure iron release only. The two open triangles 
represent the mean ± SD of 2 experiments with Fe- cultured cells; closed triangles represent 
144 
Chapter 6 
the mean ± SD of 2 experiments with Fe+ cultured cells. 
The insert shows the averaged iron accumulation rate in pmol Fe/J.-lg proteinfh (Y-axis) 
between each two experimental time points (X-axis). Solid bars represent the iron 
accumulation rate in Fe- cultured cells; dotted bars represent the iron accumulation rate in 
Fe+ cultured cells. 
The insert in Fig. 5 shows the net decrease in iron accumulation rate with prolonged 
incubation times. 
After 3 h of iron uptake, iron release during the next 3 h was quantified in 2 separate 
experiments. These results are also displayed in Fig. 5. Iron release in Fe+ cultures was 4.8 
pmol Fe/fIg protein/hour, and 2.9 pmol Fe/fig protein/hour in Fe' cultures. 
§ 6.5 Discussion. 
The total amollnt of iron in the brain, and the distribution of iron over different brain 
regions are subject to changes throughout Iife_ Alterations in the peripheral iron status (e.g. 
hemochromatosis) affect the intracerebral iron concentration, suggesting that iron traffics 
between peripheral tissues and the brain. This raises two questions: (i) where does iron 
enter or leave the brain, and (ii) which factors modulate tlils iron trafficking. 
Brain tissue is isolated from the peripheral circulation by the blood-brain barrier, a 
monolayer of non-fenestrated endothelial cells interconnected by tight jUllctions (25,28). 
The large BBB microvascular surface area and the presence of transferrin receptors on the 
luminal side of the BBB-EC's suggest that the BBB-EC's arc of major importance to iron 
transport. If so, it is conceivable that iron transport is regulated through a modulation of 
TlR quantity, TfR distribution and/or TfR kinetics in these BBB-EC's (31). 
The results in Figs. 1 and 2 and Table 1 show that there is a significant increase in 
surface TfR's, total TfR's and active intraceJlular TfR's in those cells that were cultured in 
Fe- medium as compared to the cells cultured in Fe+ medium. This increase in the number 
of TfR's in Fe- culhlres can easily be explained assuming that low intracellular concentra-
tions of iron induce TfR synthesis (see chapter I) through the IRE-IRF system (17). 
TfR internalization and externalization constants (Kin and KouJ, as determined in single 
cycle experiments (see Fig. 3, Fig. 4 and Table 2), show that cells cultured in Fe- medium 
internalize their TfR's twice as slow as Fe+ cultured ceJls. On the other hand, Fe- cultured 
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cells externalize their TIR's more rapidly than Fe+ cultured cells (see Fig. 4 and Table 2). 
A high Kw. and low Kout ' as in Fe+ cultured cells, will result in a low number of surface 
bound TfR's, and is in accordance with results shown in Fig. 1. 
Our data disagree with the results of Raub et al (24) on TIR receptor kinetics in BBB-
EC's. They found considerably lower values for K;, (0.03 min') and K", (0.017 min'). 
However, the results are not fully comparable due to differences in experimental techniques 
and data interpretation. Our experimental data yield estimates of Kw. and Kout that are in 
good agreement with those found in other cell types (29,33). Moreover, we performed 
experiments (see chapter 7) in which we studied endocytosis of Au-labeled Tf in BBB-
EC's and found a number of clathrin coated pits and vesicles containing Au-labeled Tf 
after 1 min incubation. 
'Ve arc also faced with the problem that assessment of the externalization rate is based on 
measuring the amount of 1251_ Tf that rcmains within the cell after incubation at 37°C. In 
this way, one cannot discern between 1251-Tf that is released from the cell through the 
endocytic cycle, or released otherwise (e.g. transcytosis). To date, the issue of transcytosis 
of Tf through the BBB-EC is still a matter of debate (3, see also chapter 7). However, 
should transcytosis of Tf through the BBB-EC indeed exist, our experimental procedure 
would yield an overestimation of the exocytosis rate, thereby not affecting our conclusion 
as such. 
Studies have shown that 59Pe, when administered peripherally, can be detected within the 
brain after some time (8,11,19). There was also some evidence that BBB-EC's can accu-
mulate iron (18,24). Our results as summarized in Fig. 5, confirm that BBB-Ee's accumuM 
late iron. Since the BBB is a selective barrier that regulates the transpOli of substances to 
and from the brain (Lc. iron), it is possible that iron accumulation in BBB-EC's is in fact 
an artifact due to in vitro cuihll'ing. There is evidence that BBB-EC's function differently 
when co-culhlred with astrocytes (4) and nearly pure BBB-EC cultures (as in our experi-
ments) are devoid of those cells. In vivo, astrocytcs are in close contact with BBB-EC's 
and they could therefore affect or participate in the process of iron transport. 
In our experiments, Fe+ cultured cells accumulate iron more rapidly than Fe- cultured cells. 
This finding is in agreement with the kinetic data on TfR internalization (see Table 2), 
since Fe+ culhlred cells show higher Kin'S than Fe- cultured cells. 
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Based on the difference found in K~'s between Fe' and Fe+ cultured cells (Table 2), one 
would expect iron to accumulate twice as fast in Fe+ cultured cells. However, iron 
accumulation in the BBB-EC is the net result of uptake and release. And although Fe- cul-
tured cells internalize their surface bound TfR's at a slower rate, tlus is at least pat1ially 
compensated as Fe- cells have more TfR's on their cell surface than Fe+ culhlred cells (Fig 
1 and Fig. 3). Moreover, Fe+ cultured cells also show a more rapid release of iron (see Fig 
5), namely 4.8 pmollh (Fe') and 3.9 pmol Fe/h (Fe) (data corrected for differences in 
intracellular iron concentration between both cultures). Together, tlus will dimitush the 
difference in iron accumulation between Fe+ and Fe- cultured cells. Interestingly, the insert 
in Fig. 5 shows that, although the iron accumulation rate decreases with prolonged incuba-
tion times, tlus decrease is not linear. In fact, the accumulation rates seem to stabilize 
within 24 hours, suggestitlg that iron uptake and excretion (= accumulation) itl the BBB-
EC reached equiJIibriulll. Furthermore, experiments with BBB-EC's cultured on porous 
filters (Falcon, Costar) show that these cells also accumulate iron, independent of the 
presence of either diferric Tf or apo-Tf in the lower chamber (results not shown). 
Since Fe+ cultured cells accumulate and release iron more rapidly than Fe- cultured cells, it 
would seem that iron transport across the blood-brain barrier is (p311ly) iron concentration 
dependent. This is in agreement with clinical studies in patients with hemochromatosis, 
showing that elevated peripheral iron concentrations will lead to an increase in intracerebral 
iron. These findings also imply that besides brain tissue, BBB-EC's can also accumulate 
iron, rendering these cells more succeptible to oxidative damage. On the other hand, since 
iron depletion results in increased TfR numbers, higher TfR externalization rates and less 
accumulatcd iron, it would appear that in these circllmstances the BBB-Ee's promote 
transport over accumulation. 
In summary we conclude that: (i) variations in peripheral iron concentration affect both 
the TfR quantity and TfR kinetics of BBB-EC's. (ii) BBB-EC's are capable of iron excre-
tion and accumulation at the same time, and future research in tlus field should therefore 
include studies on the vulnerability of BBB-EC's to oxidative stress. (iii) The rate of iron 
transport across the BBB-EC's at lugh peripheral iron concentrations, is to some extent 
proportional to tlu~ peripheral iron concentration. (iv) Iron depletion will promote iron 
transport over iron accumulation. 
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§ 7.1 Summal'Y. 
The mechanism and regulation of iron transport to the brain are largely unknown. The 
large surface area of the blood-brain barrier capillaries and the presence of transferrin 
receptors on the lum.inal plasma membranes of the blood-brain barrier endothelial cells 
(BBB-EC's) suggest that these cells actively participate in the transport of iron into the 
brain. 
In this chapter we describe the ultrastructural morphology of primary and first passage 
culhues of BBB-EC's grown on various porous membranes. To investigate the mechanism 
of iron transport into and across the BBB-EC's, membrane grown first passage cells were 
incubated with gold-labeled transferrin and studied with electron microscopy. Results will 
be presented, suggestive for a transcytosis of transferrin through the BBB-EC's. 
§ 7.2 Intl'oduction. 
Iron is an absolute requirement for proper neuronal functioning (1,2), but high concentrati 
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ons of intracerebral iron may cause neurodegenerative disorders (e.g. Parkinson's disease) 
(11,13,26). Fortunately, these potentially noxious effects of iron are restrained as the dis-
tribution and storage of this trace element are tightly regulated (6). The exact nature of the 
intracerebral iron regulation is still largely unknown (see chapter 6), although discovery of 
transferrin receptors on the blood-brain barrier endothelial cells (17) indicated that the BBB 
might be involved in the transport of iron into and/or out of the brain. Recent studies 
((14,21,23,25) and chapter 6) clearly demonstrated that BBB-EC's actively take up iron by 
means of receptor mediated endocytosis. The subsequent part of the pathway of iron 
through these cells and into the brain is, however, still subject to discussion (5,7,15). 
In previous experiments (see chapter 6) we demonstrated that BBB-EC's grown on petri 
dishes can take up, accumulate, and excrete iron. Since BBB-EC's (in vivo) have a barrier 
function, it was decided to pursue transport of iron (with gold labeled Tf) in BBB-EC's 
grown on semi-porous membranes. These membranes allow culturing of cells leaving both 
cell sides accessible to compounds under study (compare Ussing chamber (18,36)). 
\Ve describe in tills chapter the results of an electron microscopical study of primary and 
first passage cultures of porcine BBB-EC's grown on different membrane types. Further-
more, we report on the results of an ultrastructural study of the (endocytic) pathway of 6.6 
run gold-labeled transferrin in BBB-EC's. 
§ 7.3 Materials and methods. 
§ 7.3.1 Materials. 
Fresh porcine brain tissue was obtained from a local slaugtllerhouse. Specific chemicals 
used in the isolation and culturing of BBB-EC's are listed in chapter 5. 
Various membrane types were used in the present study, namely: transparant Costar 
Transwell-col culture chamber inserts (6.5 and 24.5 mm diameter) with a 0.4 pm pore size 
(Costar, Badhoevedorp, The Netherlands), transparant Falcon Cyclopore cell culture inserts 
(24.1 111m diameter) with 1 pm pore size, and translucent Falcon Cyclopore cell culture 
inserts (24.1 mm diameter) with 0.45 pm pore size (Becton Dickinson, Franklin lakes, NJ, 
USA). Gold sol (6.6 nm ± 10%) was obtained from Aurion (Aurion, Wageningen, The 
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Netherlands). Epon embedding fluid consisted of a mixture of LX-l 12 (LADD Research 
Industries Inc., Burlington, USA), dodecylsuccinic anhydride (DDSA) (Merck, Darmstadt, 
FRG), methyl norbonene 2,3 dicarboxylic anhydride (MNA) (Merck, Darmstadt, FRG), and 
2,4,6 tris (dimethyl aminomethyl)-phenol (DMP 30) (Merck, Darmstadt, FRG). 
§ 7.3.2 Methods. 
§ 7.3.2.1 Isolation and culluring of blood-brain bmTier endothelial cells on semiporDlis 
membranes. 
A detailed description of the BBB-EC isolation procedure can be found in § 2.2.1 and § 
2.2.3. Briefly, brain tissue was homogenized after careful removal of cerebellum, meninges 
and choroid plexus. The homogenate was resuspended in culture medium containing 
dispase and gently shaken for 3 hours. Following filtration and centrifugation (4x), cells 
were resuspended in culture medium containing peniciHinel streptomycine. 
Cells designated to be I1primar)' cultureslt (Po) were then plated on membranes and culture 
medium was replaced after 1 hour. I1First passage cellsl1 (PI) were first seeded in gelatin 
coated plastic culture flasks, grown to confluenc), and then harvested with trypsinc/EDTA 
in PBS. Following resuspension in culture medium and centrifugation. cells were plated on 
various membranes. Before plating, membranes were preconditioned for 2 hours at 37 °C 
in culture medium containing 20% fetal calf serum. 
§ 7.3.2.2 Isolation and purification 0/ porcine serum trans/en·in. 
TIllS procedure is described in detail in § 2.6.1. 
§ 7.3.2.3 Coupling of 6.6 I1In gold to transferrin. 
A detailed description of this procedure can be found in § 2.3.2. Briefly, diferric porcine 
transferrin was dialyzed against 0.5 mM NaHCO) (PH = 6.4) and mixed (under continuous 
stirring) with the 6.6 nm gold suspension of similar pH. This solution was left to stand for 
15 min, when BSA was added to a final concentration of 1% (w/v). To remove both 
unbound transferrin and gold-aggregates. the transferrin-gold (Au-Tf) suspension was 
centrifuged, loaded on a linear sucrose gradient and centrifuged again. The end product 
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was checked on homogeneity under the electron microscope (see § 7.3.2.5). 
§ 7.3.2.4 Incubation procedure of membrane-grown endothelial cells with gold-labeled 
transferrin. 
This procedure is described in detail in § 2.3.3. Briefly, Po and PI cells were grown on 
membranes until confluent, washed with PBS and the luminal sides of the cells (upper 
chamber) were incubated with ± 1 gglml Au-Tf for 2 h at 4°C. Membranes were then 
washed with icccold PBS and heated to 37 'C to start the endocytic cycle. Endocytosis was 
stopped at 1, 5 or 10 min by rapidly placing the membranes on ice, rinsing the cells with 
icecold PBS and submerging the membranes in fixation fluid. 
§ 7.3.2.5 Fixation, embeddiJlg, staining alld h'allSmissioll elech'oll microscopy. 
These procedures are described in detail in § 2.10. 
Fixation: 
Membrane-grown cells were fixed overnight at 4 °C in a mixture of glutaraldehyde and 
formaldehyde ill sodium phosphate buffer. The following day, samples were rinscd in PBS 
at room temperature and postfixed in a mixture of OS04 and K4Fe(CN)6 in PBS. 
Embedding: 
Following fixation, membrane-grown eells together with the membranes were embedded 
in Epon, and allowed to polymerize overnight at 60°C. 
Sectioning: 
Ultrathin sections of the Epon embedded membranes were made on an Ultratome V 
(LKB, Sweden), equipped with Diatome 1.5 nun diamant knives. Sections were collected 
on unfilmed 200 mesh copper grids. 
Staining: 
Uranylmagnesiumacetate was used as the only contrast enhancer, leadcitrate was omitted. 
Transmission electron microscopy: 
Sections were studied in a Zeiss EM 902 (Zeiss, Oberkochen, FRO) transmission electron 
microscope. TIns instrument was equipped with an integrated electron spectrometer 
allowing high-resolution imaging of stained and unstained sections with energy-filtered 
clectrons (= electron spectroscopic imaging (ESI». 
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§ 7.4 Results. 
§ 7.4.1 Choice of semi-porous membrane type. 
We were able to grow both Po and P, blood-brain barrier endothelial cells (BBB-EC's) on 
all three membrane types (see § 7.3.1), although it took Po cultures considerably longer to 
reach confluency on membranes (± 14 days) than on petri dishes (± 8 days) of the same 
diameter. 
\Ve experienced considerably more difficulties growing BBB-EC's on Costar Transwell-
Col membranes, especially with Po celis, than on Falcon Cyclopore membranes. As Costar 
membranes are very thin (25-50 pm), they tend to sag in the middle when there is culture 
medium in the upper chamber. Since our BBB-EC isolation procedure mainly yields small 
clumps of endothelial cells (i.e fragments of capilJaries), sagging results in an assembling 
of the BBB-EC clumps in the middle of the membrane. As new BBB-EC's mainly 
originate from these capillary fragments, cells in the center part of the membrane will 
already reach confluency while the rim of the membrane is still rather empty. Continuation 
of the culture then leads to post-confluent phenomena in the center of the membrane, such 
as: formation of "holes" in the monolayer (i.e. neovascularization), and loosening of parts 
of the monolayer with concomitant cell death. Moreover, mechanical deformation of these 
membranes also occurs when changing culture medium. This has a negative effect on the 
attachment of BBB-EC's on the membrane, and cells easily come loose when these 
membranes are rinsed. 
Falcon Cyclopore membranes display a more rigid mechanical behaviour and hardly sag. 
As a result, Po cells plated on these membranes show a more homogenous distribution 
pattern throughout the membrane surface. Since all membranes could rather easily be 
sectioned, we chose for the Falcon Cyclopore membranes as the membrane with the best 
mechanical properties. 
§ 7.4.2 MOIphology o/membrane-groll'll Po and PJ blood-brain barrier endothelial cells. 
Both Po and P, cultured BBB-EC's were virtually devoid of other cell types. The BBB-EC 
is an elongated cell with a thickness of about 2.5 to 3 fUll (Fig. 1), retaining its form on all 
membrane types. Po cells grow in mOllolayers with an occasional cell on top of tIus layer, 
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whereas PI cells more often show two or lllore cell layers on top of each other (Fig. 2). 
Figs. 1 alld 2: 
Figs. i (Po) and 2 (PI) are eiectronlllicrographs of stained sections of BBB-Ee's on 
translucent Falcon cyclopore culture inserts. Note the morphological similarity of the cell 
organelles of Po and PI. and the tendency of PI to grow in multiple layers. Ab = abluminal 
(filter side). Bar represents 2.5 ftm. 
Both Po and PI cells synthesize basal membrane-like material, although it is our impressi-
on that the material made by Po cells is thicker and more regular than that of PI cells 
(compare Figs. 3 alld 4). 
Both Po and PI cells are interCotlllected by tight junctions (Figs. 5 alld 6 ), regardless of 
arrangement in l11onolayers or lUultilaycl's. Coated pits and vesicles as well as caveolae are 
a COIlUllon finding in Po and PI cells. The coated pits are mainly located in the luminal 
membrane, although they are also present in the abluminal membrane of Po and PI cells 
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(Figs. 3 and 5). There is also suggestion of PlllOC)10sis at both sides of the cell. 
Fig. 3: 
Elcctronmicrograph of stained section of PI BBB-Ee's. Note the basal membrane-like 
material (EM); coated pits (CP) on the luminal and abluminal (Ab) side, and the active 
endoplasmic reticulum (ER). N = nucleus. Bar represents 2.5 ~un. 
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Fig. 4: 
Electronmicrograph of stained section of Po BBB-Ee at higher magnification. Note the 
electron-dense basal membrane-like material (BM) in the abluminal (Ab) side and the 
swollen rough endoplasmic reticulum (RER). :MVB = multivesicular body, Lu = luminal 
side. Bar represents 0.5 /.Ull. 
Fig. 5: 
Elcctronmicrograph of PI BBB-Ee's (stained section) at higher magnification. Note the 
coated pits (CP) and vesicles (CV). TJ ~ tight junction, L ~ lysosome, G ~ Golgi, F ~ 
fibrils, Lu = luminal side, M = mitochondrion. Bar represents 0.5 /.Ull. 
6 Ab 
Fig. 6: 
Electronmicrograph of PI BBB-Ee's (stained section). Note the metabolic activity of the 
cell as judged by a row of caveolae (C) and a lysosome with whorls. TJ = tight junction. 
Bar represents 1 pm. 
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In Fig. 4 and Fig. 5 a multitude of cellular organelles can be discerned in both Po and PI 
cells: rough and smooth endoplasmic reticulum, mitochondria, Golgi, lysosomes, multive-
sicular bodies, and a large number of fibrils. The general morphological appearance is 
suggestive for an active cellular metabolism. 
§ 7.4.3 Wtrastructllral stlldy 0/ gold-labeled tralls/errill elldocytosis in PJ blood-braill 
ban'ier endothelial cells. 
Endocytosis of Au-Tf was allowed to continue for either 1, 5 or 10 min at 37°C. 
Unstained sections of the 1 min incubations show gold particles in various stages of the 
endoc)1ic cycle (Figs. 7 throlJgh 10). Fig. 7 shows two Au-Tf particles attached to the 
luminal membrane of the BBB-EC. The indentation of the cell membrane at tIus Au-Tf 
binding site shows processing of the membrane. Note the organisation of the lipid bilayer 
around the two gold particles. 
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Fig. 7: 
ESI micrograph of unstained section of P, BBB-EC. Note the lipid bilayer being processed 
around the 6.6 mn gold particles. The gold particles indicate the presence of Tf. Lu = 
luminal side. Bar represents 0.1 J.un. 
In Fig. 8 two coated pits, each containing multiple Au-Tf particles, can be observed. One 
of these coated pits seems to be closing to form a coated vesicle (see inserts Fig. 8), 
Lu 
---." 
Fig. 8: 
ESI micrograph of unstained section of PI BBB-Ee. Two subsequent stages of internaliza-
tion of Tf (marked by 6.6 nm gold particles) at the luminal (Lu) side after I min incubati-
on time. Insets A and B show this process at higher magnification. Bar represents 0.25 pm. 
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Fig. 9 shows a group of Au-Tf particles located in an organelle, probably representing and 
early endosome. Note the single gold particle on the outer (luminal) membrane and the 
cysterns of the Golgi apparahls. Interestingly, in these I min incubations, we also found 
intracellular Au-Tf particles at the abluminal (membrane) side of the BBB-EC (Fig. 10). 
Lu 
Fig. 9: 
ESI micrograph of unstained section of PI BBB~EC after min incubation time, showing 
a 6.6 run gold pat1icle (marked Tf) on the verge of being internalized (arrowhead). Note 
several gold particles in an organelle probably representing an eady endosome (arrowhead). 
Lu = luminal side, G = Golgi. Bar represents 0.25 11m. 
Micmgraphs of BI3B-EC's incubated for 5 min with Au-Tf confirmed the finding of Au-
Tf particles at the abluminal side. A number of vesicles with Au~ Tf particles can be seen in 
Fig. 11. The localization of these vesicles is suggestive for a transcytotic pathway of Au-Tf 
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through the BBB-EC. Moreover, Fig. 12 shows a detailed photomicrograph of the 
abluminal cell membrane, with two Au-Tf particles probably on the brink of being 
released. 
Fig. 10.-
ESI micrograph of unstained section of PI BBB-EC. An example of possible transcytotic 
process after I min incubation time. Note 6.6 rm1 gold particles (marked Tf) at the luminal 
(Lu) and abluminal (Ab) side of the cell (arrowheads). Bar represents 0.25 fUll. 
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Lu 
, 
~' .. 
Fig. 11: 
ESI micrograph of unstained section of PI BBB-EC after 5 min incubation time. Overview 
of possible transcytotic process. Note the 6.6 Illll gold particles (marked Tf) in tubulovesi-
cular structures at the luminal (Lu) and abluminal (Ab) side (arrowheads). Bar represents 
0.25 fUll. 
12 Ab 
Fig. 12: 
ESI micrograph of unstained section of PI BBB-EC after 5 min incubation time. Note the 
6.6 nm gold particles (marked Tf) on both sides of the abluminal (Ab) membrane 
(arrowhead). Bar represents 0.25 ~lm. 
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§ 7.5 Discussion. 
BBB-Ee's display, like all endothelial cells, a certain polarity i.e. a luminal and an 
abluminal side (3). The procedure of culturing cells on membranes and co-sectioning them 
with the cells allows the observer to differentiate between luminal and abluminal side. 
Moreover, culturing of BBB-Ee's on porous membranes offers interesting perspectives for 
e.g. transport studies. There are relatively few studies on the latter subject (10,18,29,37) 
and even less on the ultrastructural morphology of BBB-EC's grown on membranes (9,21). 
It is our experience that BBB-EC's do not readily attach to just any surface (e.g. glass, 
membranes), and this may have contributed to the paucity of studies on this subject. Our 
first attempts to grow BBB-EC's on Costar filters completely failed and results did not 
improve until we exchanged the Gentamycine in our culture medium for penicillinc/strepto-
mycine (see § 2.2.3), a phenomenom for which we have no valid explanation. 
Po and PI cells are typical endothelial cells showing evidence of a very active metabolism. 
This is in line with resnlts of biochemical studies reported earlier (4,18,20). PI compared to 
Po cell may display less contact inhibition, as they show an increased tendency to grow in 
multiple layers upon reaching confluency. 
Several shldies have shown that iron can enter and (presumably) leave the brain (8,14,27,-
34,35). Although there are some areas devoid of a blood-brain barrier that may allow free 
passage of solutes (see chapter I), the BBB-EC is still the most likely site for the transport 
of iron. The presence of high affinity TfR's on the luminal BBB-EC membrane in 
combination with a large capillary surface area are in support of this view (17,24). Recent 
biochemical investigations have demonstrated that: (i) 125I_Tf can enter the BBB-EC by 
receptor mediated endocytosis (15,25,27), and (ii) a major part (2 60%) of this 125I_Tf is 
recycled to the luminal surface (see chapter 6). There are however, also some biochemical 
studies indicating that transcytosis of Tf through the BBB-EC does occur (14,15,19). The 
issue of Tf transcytosis and the quantitative extent of this proces are still under debate (IS). 
One of the aims of the present study was to visualize the endocytic cycle of TfR's at an 
ultrastructural level. Much to our surprise our experimental results are suggestive for a 
transcytosis of at least part of the Au-Tf through the BBB-EC. 
Experiments on TfR endocytosis were performed with PI cells cultured on Falcon 
cyclopore membranes. Tlus membrmlC was chosen for reasons as stated in § 7.4.1. 
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Although we would have preferred to use Po cells, PI BBB-EC's were chosen for a 
practical reason. Since porous membranes require a much higher (3 to 4 fold) plating 
density than petri dishes of the same diameter, sufficient quantities of cells from a single 
batch of BBB-EC's for a TfR. endocytosis experiment could only be obtained from a first 
passage (PI) culture. In our opinion, the observed tendency of PI BBB-EC's to grow in 
multiple layers in some areas of the porous membrane will not be of major influence on 
the behaviour of Tf. Even in those areas were PI cells grow in multiple layers, the formati-
on of tight junctions apparently is not affected (Fig. 5). Moreover, we found no evidence 
of Au-Tf particles in intercellular clefts, suggesting that the intercellular barriers remain 
intact in P \. 
In order to visualize the endocytic cycle, we had to choose a compound to label Tf. Horse 
radish peroxidase was unsuitable, as the DAB-deposit obscures the fine ultrastructural 
localization of Tf (31). We therefore decided to use gold particles, in spite of earlier 
reports (22) showing that gold labeled Tf was directed to lysosomes after receptor mediated 
endocytosis. From literature we conceived that two factors can affect the [mal destination 
of the Au-Tf molecule: (i) size of the gold particle, and (ii) the type of cell involved 
(16,30). In Hep G2 cells, 8 and 20 nIll Au labeled Tf was eventually found in lysosome-
like structures and not recycled to the cell surfhce (22). In the same cell type however, 
Woods (38) reported that 5 mn Au labeled Tf trafficked through the same endosomes as 
native Tf and eventually left the cell, suggesting that Au-Tf was recycled to the cell 
surface. These conflicting results may be explained by the difference in Au particle surface 
area. For example, 10 nm gold can bind 7 to 12 hmnunoglobulin molecules, whereas 6 11111 
Au particles can only bind 1 or 2 (manufacturees information). A 10 nm gold particle, 
loaded with Tf molecules, can therefore simultaneously interact with more than one 
transferrin receptor (TfR). Once bound to more than one TfR, a 10 nm Au-Tf particle 
would rigidly fixate a membrane segment of the endosome. Tllis may obstmct sorting of 
the Tf-TfR. complexes (32,33), thereby intermpting the endocytic pathway, possibly with 
subsequent lysosomal degradation (22). Based on these data, we chose for 6.6 nm Au as a 
compromise between visibility in the electron microscope and capacity to bind Tf molecu-
les. In fact, we found Au-Tf in tubulovesicular stmctures and did not detect any Au-Tf 
particles in lysosomes. 
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Our experimental results (see § 7.4.3) with Au-Tf are suggestive for the existence of a 
receptor mediated transcytotic transport of Tf through the BBB-EC, as Au-Tf appears at 
the abluminal side of the cell (see Fig. 10 through 12). The alternative, an uptake of Au-Tf 
via the abluminal membrane is less likely, as: (i) Au-Tf was administered to the luminal 
side of the cells and access to the abluminal side was hampered because of the tight juncti-
ons, (ii) TiR's have never been demonstrated on the abluminal membrane (17,15), and (iii) 
we found no morphological evidence in support of Au-Tf uptake (by coated pits) at the 
ahlulllinal side of BBB-EC's. Our experimental results also indicate that transcytosis of An-
Tf is a receptor mediated process, as: (i) Au-Tf at the luminal membrane was located 
within coated pits, and (ii) addition of unlabeled diferric Tf to the Au-Tf incubation 
mixture completely blocked the binding and uptake of Au-Tf. Recent experiments 
conducted by Kang et al (19), showing that OX-26 (anti-TfR antibody) coupled compounds 
could be retrieved within the brain, are in support of tIus view. 
Roberts et al were unable to show transcytosis (in vivo) of horse radish peroxidase labeled 
Tf (27,28). However, according to the author's description, the coupling of horse radish 
peroxidase to diferric Tf included lowering of the pH to 6.0 and addition of dithiothreitol. 
These reaction conditions might affect Tf-iron binding and lower Tf-iron saturatioIl. Subse-
quently, a low Tf-iron saturation may affect the pathway of Tf through the BBB-EC in 
vivo. 
Several biochemical reports show that there is indeed transcytosis of Tf through the BBB 
(8,15,19,35). These studies comprise several techniques and report the transport of either 
"Fe, 1251_ Tf, or OX-26 coupled peptides through the BBB. Our morphological results 
underline these biochemical findings. Moreover, the rapid uptake of Au-Tf as shown Fig. 
8, is also in good agreement with internalization rates derived from our biochemical experi-
ments on 'I'iR mediated endocytosis (as described in chapter 6) and data from literature (5). 
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§ 8.1 Summary. 
Oxidative stress is thought to be involved in the pathophysiology of aging and a number 
of diseases, e.g. Parkinson's and Alzheimer's disease. These diseases are accompagnied by 
alterations in the intracerebral concentration of iron, a transition metal capable of cataly-
zing the formation of reactive oxygen species. Blood-brain barrier endothelial cells (BBB-
EC's) are probably involved in the regulation of the iron flux into the brain and may 
therefore contribute to the cause of these diseases. In this chapter we show both biochemi-
cally and morphologically that BBB-EC's grown under iron-enriched culture conditions are 
more susceptible to oxidative stress than cells grown under iron-depleted conditions. 
In vivo, hypoxia and subsequent reoxygenation of tissue may lead to a surge of reactive 
oxygen species and concomitant oxidative damage. Granulocytes, that show an increased 
adherence to damaged tissues, are also involved in these events. \Ve investigated the effects 
of 2 111"8 of hypoxia followed by a brief (5 min) period of reoxygenation on granulocyte 
adherence to BBB-EC's, and show that this adherence is reduced in cells cultered in iron-
enriched conditions. \Ve hypothetize on the role of iron herein, possibly through a 
suppression of phospholipase A2 activity. 
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§ 8.2 Introduction. 
Reactive oxygen species are implicated as a key factor in a wide variety of diseases 
(14,31,39) and the effects of reactive oxygen species on DNA, RNA, proteins, and lipids 
are well documented (1,4,9,15). Transition metals (e.g. iron) are considered essential in 
oxidative damage, either acting as catalysts in the formation of highly reactive oxygen 
species like the hydroxyl radical (011) (11,25,32) or alternatively, participating in the 
formation of reactive iron-oxygen complexes known as perferryl ions (Fe3+02) (8,51). In 
fact, the list of diseases in which an involvement of transition metals is suspected, is still 
expanding (31,39). 
One of the tissues containing considerable concentrations of iron, is brain tissue. As 
already noted by Hallgren (27) and confirmed more recently (reviewed in 13), certain areas 
in the brain (e.g. globus pallidus) display iron concentrations equal to that of liver (per 
gram wet weight). Besides, brain iron concentration is subject to changes and increases 
with age (13,50) and in certain neurological disorders (e.g. Parkinson's disease) (13,17,57). 
In addition, recent studies show that brain tissue is highly sllsceptible to oxidative damage, 
as a result of: (i) high concentrations of poly unsaturated fatty acids (PUF A's), and (ii) 
relatively low concentrations of antioxidants (e.g. catalase) (19,29). 
In chapter 9, results will be presented on the relationship between iron concentration and 
oxidative damage in different brain regions. The present study focusses on the I1porte d'en-
tree" of iron into the brain. Iron transport to the brain is mediated by the endothelial cells 
lining the capillaries in the brain (BBB-BC). We previously showed (see chapter 6) that, in 
respons to an increase in peripheral iron concentration, BBB-EC's accumulate more iron 
despite a down-regulation in the number of surface bound and total TfR's. Since BBB-
EC's 0) contain enzymes like monoamine oxidase and xanthine oxidase, (ii) have a close 
proximity to ample oxygen (bloodstream), and (iii) display an active intracellular metabo-
lism with abundant mitochondria, iron accumulation may render these cells more suscepti-
ble to oxidative damage (6,7,37). 
\Ve report in tIus chapter on the effects of an oxidizing system (vitamin C and H20 2) on 
BBB-EC's, cultured in either iron-enriched or iron-depleted culture medium. The suscepti-
bili!)r of BBB-EC's to oxidative damage is assessed measuring the increase in protein 
carbonyl groups following exposure to the oxidizing system. Carbonyl groups are the 
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principal product of metal~catalyzed oxidation of proteins and can be quantified using 2,4 
dinitrophenyl hydrazine (DNPH) (40,56). Based on the reaction of DNPH with protein 
carbonyl groups, we also developed a novel technique to visualize oxidative damage in cell 
culhlres. 
In addition, we report on the effects of hypoxia/reoxygenation on the adherence of 
granulocytes to primary cultures of BBB-Ee's, in relation to the intracellular iron concen~ 
tration. 
§ 8.3 Materials and methods. 
§ 8.3.1 Materials. 
Fresh porcine brain tissue was obtained from a local slaugtherhouse. Specific chemicals 
used in the isolation and culturing procedure of BBB~EC's are listed in chapter 5. Rabbit 
anti dinitrophenyl and swine anti-rabbit immunoglobulins (fluorescill labeled) were 
purchased froIll DAKO (DAKO AlS, Denmark). Bovine non-fat dried milk powder 
(Blotto), 3-aminopropyltriethoxysilane (Sigma), and 2,4 dinitrophenyl hydrazine were 
obtained from Sigma (Sigma, st. Louis, MO, USA). Hexadecyltrimethylammonium 
bromide was purchased from Merck (Merck, FRG). 
§ 8.3.2 Methods. 
§ 8.3.2.1 1solation and cllltliring of blood-brain barrier endothelial cells in iron-enriched 
alld iron-depleted medium. 
A detailed description of the BBB-EC isolation procedure can be found in § 2.2.1. Briefly, 
brain tissue was homogenized after careful removal of cerebellum, meninges and choroid 
plexus. The homogenate was resuspended in culture medium containing dispase and gently 
shaken for 3 hours. Following filtration and centrifugation (4x), cells were resuspended in 
culture medium and plated on 5 em petri dishes. After 3 days, cells were subjected iron-
enriched (Fe+) or iron-depleted (Fe') culture conditions as described in § 2.2.2. To avoid 
possible differences between separate batches of BBB-EC's, Fet and Fe- grown cells within 
one experiment always originated from the same isolation batch. 
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§ 8.3.2.2 Protein carbonyl measurements. 
A detailed description of titis procedure can be found in § 2.5.2.10. Briefly, blood-brain 
barrier endothelial cells were grown to near confluency under standard (see § 2.2.1), iron-
enriched or iron-depleted conditions (see § 2.2.2), washed and harvested. Following 
sonication and centrifugation, supernatant was incubated with 2,4 DNPH and left to stand. 
An additional aliquot of each sample was incubated with 2 M HCl instead of DNPH 
(blank). Following precipitation of the proteins, pellets were washed to remove unbound 
DNPH and redissolved in 6 M guanidine hydrochloride. Aliquots of this solution were 
taken for protein measurements (see § 8.3.2.3). Carbonyl conccntrations were measured 
directly by reading samples spectrophotometrically at 367 nm, after correction for blanks 
and guanidine BCl. Protein carbonyl concentrations were expressed in nmol/mg protein. 
§ 8.3.2.3 Protein measurements. 
Protein conccntrations of the sonicated cell suspensions were measured according to the 
procedure described in § 2.5.2.1. 
§ 8.3.2.4 Oxidizillg system. 
To test the relative susceptibility of BBB-EC's to oxidative damage and the effect thereon 
of iron-enriched and iron-depleted culturing, cells were exposed to an oxidizing system 
composed of vitamin C and B20 2• A detailed description of this procedure can be found in 
§ 2.2.5. Briefly, cells (culture dishes and cover slides alike) were rinsed with PBS and 
incubated with M199 culhll'e medium containing 2 mM vitamin C. After 15 min 2 mM 
H20 2 was added to the medium and cells were kept at 37°C for the duration of the 
experiment. 
§ 8.3.2.5 2,4 Dinitrophel1yl hydrazil1e immunocytochemfsllJI. 
A detailed description of this procedure can be found in § 2.3.4. Briefly, primary isolates 
of BBB-EC's were grown on glass cover slides coated with 3-aminopropyltriethoxysilane. 
From day 3 on, 50% of the cultures were exposed to iron-enriched medium as described in 
§ 2.2.2, whereas the remaining 50% were grown under normal culture conditions (see § 
2.2.1). To avoid possible differences between separate batches of BBB-EC's, Fe' and 
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standard grown cells within one experiment always originated from the same isolation 
batch. 
After 10 days, cells were rinsed with PBS, fixed in methanol, and incubated with a 
mixture of 2,4 DNPH, methanol and sodium phosphate buffer. Following removal of 
uubound DNPH with ethyl acetate/ethanol, cells were incubated in 5% (w/v) Blotto to 
block nonspecific binding. Cells were then rinsed with PBS, incubated for 1 h with rabbit 
anti-dinitrophenol (l: IOO), rinsed again and incubated for 1 h with Swine anti-rabbit 
immunoglobulins Fluorescin (1:200). Covcrslides were washed, mounted on glass slides 
and viewed with a Zeiss Axioskop fluorescence microscope. This microscope was equipped 
with a triple pass filter set for simultaneous viewing of FITe, Texas Red, and DAPI. 
Images were taken with Fugicoior Super G400 ASA film. 
§ 8.3.2.6 Granulocyte adherence assay. 
The adherence of granulocytes to primary cultures of BBB-EC's was tested in a procedure 
described by Pietersma (47). Details of this technique can be found in § 2.5.2.12. Briefly, 
primary cultures of BBB-EC's, grown in either Fe+ or Fe' culture medium were incubated 
for 2 h under hypoxic conditions (pO, '" 7.5 mm Hg). Control cultures (both Fe+ and Fe') 
were kept under normoxic conditions. Meanwhile, granulocytes were isolated from fresh 
porcine blood as described in § 2.6.5, suspended in PBS and stored at 4 °C until lise. 
The adherence of granulocytes was studied 5 min after reoxygenation of the BBB-EC's. 
Hypoxic medium overlying the cells was removed and replaced by normoxic Hanks' 
balanced saIt solution. This medium was removed after 5 min and replaced by the granulo-
cyte suspension. After another 5 min at 37°C, cells were washed and incubated with 5% 
hexadecyltrimethylammoruum bromide to extract myeloperoxidase. The myeloperoxidase 
activity was uscd to assess the number of adherent granUlocytes (procedure described in § 
2.5.2.11). 
§ 8.3.2. 7 Statistical analysis of the granulocyte adherence assay data. 
Data derived from the granulocyte adherence assays were analyzed by means of the 
Wilcoxon's signed rank tcst for paired data. This approach yields slightly less effective (± 
96%) predictions when results follow a normal (Gaussian) distribution pattern. However, it 
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warrants a correct interpretation of results that are not normally distributed or have a 
unknown distribution pattern. Results were considered significant if p < 0.05. 
§ 8.4 Results. 
§ 8.4.1 Protein carbonyl concentration meaSllrements. 
Primary cultures of BBB-EC's, grown in either Fe+ or Fc' culture conditions, were cither 
exposed to an oxidizing system consisting of vitamin C and H20 2 or lcft untreatcd (§ 
8.3.2.4). Protcin carbonyl concentration was detected by incubation with 2,4 dinitrophenyl 
hydrazine (§ 8.3.2.2). As tested separately, wc found that varying DNPH-protein incubation 
times (between 5 and 60 min) did not notably affect the final concentration of protein-DNP 
derivatives (results not shown). On the. other hand, prolonged incubation timc (hours) will 
promote nonspecific binding of DNPH to the substrate (22). Sonicates were therefore 
allowed to react for 15 min before protcins were precipitated with trichloroacetic acid. 
Averaged results of separate cxperiments, expressed in nmoles of carbonyls/mg protein, 
are sunmlarized in Fig. 1. 
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Cells grown in either Fc+ (gray bars) or Fe- (whitc bars) culture conditions were incubated 
with 2,4 DNPH to measure protein carbonyl concentrations under basic conditions (no 
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OD), or upon exposure to an oxidizing system for either I h (OD Ih), 2 hrs (OD 2h), or 3 
hrs (OD 3h). The striped bar represents protein carbonyl concentrations in cells cultured 
according to standard procedures and without oxidative damage. Results are expressed in 
nmol carbonylslmg protein. Bars represent means ± SEM of 4 separate experiments. 
Basic levels of protein carbonyl concentrations are not significantly affected by Fe+ or Fe' 
culture conditions when compared to cells grown under standard culture procedures. Both 
Fe+ and Fe' cultured BBB-Ee's show a significant increase in protein carbonyl concen-
tration with prolonged exposure (up to 3 h) to the oxidizing system. Moreover, results 
show that Fe+ cultured cells are significantly more susceptible to oxidative damage than Fe' 
cultured cells. 
§ 8.4.2 Dillitrophenyl immunocytochemistry. 
Oxidative damage in BBB-Ee's as a result of exposure to vitamin C and H20 2 was 
visualized in a novel immunocytochemical assay (Fig. 2 to 5). These cells originated from 
the same isolation batch and were maintained under identical circumstances, with the 
exception of the iron concentration in the culture medium. Fe' culturings were not 
performed to exclude the possible contribution of carbonyl groups in deferrioxamine. All 
cover slides were photographed in one session using the same film and exposure time for 
all cover slides. 
Fig. 2 (standard culturing) shows that a background level of fluorescence due to a number 
of carbonyl groups always present in cultured BBB-EC's. It was our impression that Fef 
cultures (Fig. 4) on average show a somewhat more intense background fluorescense. In 
Fig. 3 standard cultures exposed for 1 11 to an oxidizing system show an increase in 
fluorescence, especially in the cytoplasm and at the rim of the cells. Maximum fluorescen-
ce is found in Fe+ cultured cells exposed to oxidative stress (compare Fig. 5 to Fig. 3). 
Interestingly, next to an intense fluorescense in the cytoplasm and plasma membrane, Fe+ 
grown BBB-Ee's under these conditions also show a marked increase in fluorencese in 
their nuclei (Fig. 5). 
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Fig. 2 
Primary isolates of BBB-EC's were plated on cover slides and grown in standard culture 
medium. After 10 days, cells were fixed and incubated with DNPH to detect protein 
carbonyl groups. Bound DNPH was made visible with anti DNPH inull.unoglobulins and a 
fluorescent secondary antibody. TillS photograph shows the basic fluorescence pattern, due 
to carbonyl groups always present in these cells. 
Fig. 3 
Primary isolates of BBB-EC's were plated on glass cover slides and grown in standard 
culture medium. After 10 days cells were exposed for 1 h to an oxidizing system. Further 
treatment was as described in Fig. 2. 
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Fig. 4 
Primary isolates of BBB-EC's were plated on cover slides and grown in iron-enriched 
culture medium. After 10 days, cells were fixed and incubated with DNPH to detcct 
protein carbonyl groups. Bound DNPH was made visible with anti DNPH iUlllluno-
globulins and a fluorescent secondary antibody. Note the difference in fluorescent staining 
when compared to Fig. 2. 
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Fig. 5 
Primary isolates of BBB-Ee's were plated on glass cover slides and grown in iron-enriched 
culture medium. After 10 days cells were exposed for 1 h to an oxidizing system, fixed 
and incubated with DNPH to detect protein carbonyl groups. Bound DNPH was made 
visible with anti DNPH immunoglobulins and a fluorescent secondary antibody. This 
photograph clearly shows the intense fluorescence as a result of an increase in carbonyl 
groups. 
§ 8.4.3 Granulocyte adherence to blood-brain barrier endothelial cells. 
Results on the adherence of granulocytes to Fe+ and Fe' cultered BBB-Ee's, either under 
nOfmoxic conditions or subjected to hypoxia, are depicted in Fig. 6. Data are the averaged 
results of two separate experiments in twelve fold and expressed as percentage of increase 
or decrease in adherent granulocytes. Adherence of granulocytes in Fe+ and Fe' cultured 
BBB-Ee's maintained at nonnoxic conditions are set to 100%. As shown in Fig, 6, Fe+ 
cultured cells show a significant decrease in granUlocyte adherence during hypoxia, 
whereas Fe' culhlred cells show a slight, although not significant, increase in adherence. 
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Fig. 6 
Cells grown in either Fe+ (gray bars) or Fe' (white bars) culture conditions were incubated 
with granulocytes to quantify adherence following hypoxia + reoxygenation (hypox Fe' and 
hypox Fe+). Results are compared to identical cultures kept at normoxic conditions (control 
Fe' and control Fe+). Results are expressed as mean percentage adherence of granulocytes 
relative to results found in Hormoxic conditions (set to 100%). Error bars represent SEM of 
two separate experiments in twelve fold. 
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In a parallel experiment we tested whether the number of adherent granulocytes was 
affected by the amount of granulocytes that were added to the cultures. Results are 
displayed in Fig. 7 and show that the number of adherent granulocytes is Iineary related to 
the amount of incubated granulocytes, irrespective of culture conditions. Since results in 
Fig. 7 were obtained from BBB-Ee's originating from one isolation batch, adherent 
granulocytes could be expressed in numerical values. 
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Cells grown in either Fe+ (triangles) or Fc' (circles) culture conditions were incubated with 
various quantities of granulocytes (X-axis, in millions) following hypoxia + reoxygcnatioll 
(filled circles and triangles). and compared to BBB-Ee's kept at nonnoxic conditions (open 
circles and triangles). Since results were obtained from BBB-Ee's originating from one 
isolation batch, adherent granulocytes could be expressed in absolute numbers (Y-axis, in 
thousands). 
§ 8.5 Discussion. 
Oxidative damage is thought to be involved in the pathophysiology of aging and a large 
number of diseases, although in most cases it remains unclear whether this oxidative 
damage is a cause or a result of disease (28,33,42,45,48,52). The question of "post or prop-
terll is inherent in the fact that reactive oxygen species have a very limited life span, as 
they readily interact with other compounds (18,25,48). Assessment of oxidative damage is 
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therefore mainly based on indirect techniques, measuring the reaction products generated in 
the oxidation of biomolecules (48). To this purpose, the detection of lipid peroxidation 
products, e.g. malondialdehyde and 4-hydroxynonenal, have been widely used (18,25,48). 
In recent years oxidative modification of another major group of biomolecules, namely 
proteins, came to attention (2,16,59). As already described by Garrison et al in 1962 (22) 
and investigated in more detail by Amici and others (2,35,58), radiation-induced as well as 
metal catalyzed oxidation of proteins result in the formation of carbonyl derivatives (C=O) 
due to conversion of the side chains of certain amino acids. Histidine, arginine, lysine and 
proline appear to be particulary sensitive to this type of oxidation (2). 
Oxidative modification of proteins results in conformational changes and promotes frag-
mentation and cross-linking (36). This may cause loss of biological function and will 
usually enhance degradation (16,54), although some oxidized proteins become in fact more 
resistant to degradation (23). Moreover -analogous to the generation of radical interme-
diates (e.g. alkoxy radicals) in the process of lipid peroxidation (12,34)- exposure of 
proteins to reactive oxygen species may also result in the formation of reactive protein 
compounds Lc. "protein peroxides" and "protein bound reducing moieties" (16,54). The 
latter compounds are capable of reducing transition metals (e.g. iron), and could therefore 
promote the generation of reactive oxygen species via the iron-catalyzed Haber-\Veiss cycle 
(11,16,30) (see also chapter 1). In general, oxidative inactivation and/or modification of 
proteins have been implicated in the process of aging (l6,45,59). Of particular interest in 
this respect are the results of Oliver et al (43) on cultured fibroblasts of patients with 
progeria (premature aging). These cells show a significantly higher percentage of oxida-
tively modified proteins than age-matched controls. 
In our experiments, protein carbonyl groups are detected by incubation with 2,4 dinitrop~ 
henyl hydrazine to form hydrazone derivatives (technique previously described by Levine 
and others (40,43,53,55)). Based on the experiments of Keller et al (38), who described an 
\Vestcrn im11lunoblot assay with anti dinitrophcnyl immunoglobulins to detect oxidatively 
modified proteins, we developed a novel im11lunofluorescence staining teclmique to 
visualize these oxidative modifications, Le. carbonyl groups, in cell cultures. As a first step, 
the procedure involves fixation with methanol, being a mild fixative without carbonyl 
groups. In this way, the staining will merely detect carbonyl groups formed as a result of 
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exposure to oxidative stress. 
OUf quantitative data on protein carbonyl concentration and the results of the immunoche 
mical experiments with anti dinitrophenyl hydrazine are in good agreement with each 
other. Fig. 1 10 5 clearly show that, as was hypothetized before, Fe+ cultured BBB-EC's 
are more susceptible to oxidative stress. Judging from the fluorescence pattern, oxidative 
damage is revealed by a general increase in protein carbonyl groups throughout the 
cytoplasm (Fig. 5), possibly somewhat stronger at the plasma membrane (Fig. 4 alld 5). 
Results in Fig. 1 show that the basic (= no oxidative stress) protein carbonyl concentration 
was not significantly affected by culture conditions. However, there appears to he a slight 
increase in fluorescence in Fe+ grown BBBMEC's as compared to cells culhlred in normal 
conditions (compare Fig. 2 and 4). Since cells within a single inullunochemical experiment 
originated from the same isolation batch (see § 8.3.2.5) and were treated identically, the 
difference in iron concentration in these cultures is the only parameter that could bring 
about this variation in fluorescence. Tlus suggests that even without exposure to an explicit 
oxidizing system, Fe+ cultured cells are more susceptible to this type of stress. 
In vivo, a surge of reactive oxygen species and concomitant oxidative damage may occur 
as a result of: (i) reoxygenation of hypoxic tissue (10,26,63), (ii) activation of granulocytes 
(5,44), or (iii) a combination of both (7,47). Previous studies in peripheral tissue derived 
endothelial cells showed that hypoxia increased intracellular xantlune oxidase activity (60). 
Reoxygenation of these cells resulted in an outburst of toxic reactive oxygen species (e.g. 
H20 2) (41), and was accompagnied by an increased permeability of the endothelial mono M 
layer to albumin, and an increased adherence of granulocytes to these endothelial cells 
(41,60). Since the increase in xantlulle oxidase activity is a likely source of these reactive 
oxygen species (7,10,24), it would appear that endothelial cells arc both source and target 
of reactive oxygen species (7,41). As for granulocytes, (ischemic) tissue damage will lead 
to the generation of inflammatory mediators, promoting the adherence of granulocytes to 
endothelial cells by stimulating the expression of adhesion molecules and platelet-activating 
factor (PAF) of both endothelial cells and granulocytes (46,47). Endothelial cell damage is 
attributed to the reactive oxygen species released by stimulated granulocytes (46,47,62) and 
tlus damage markedly increases with elevated iron concentrations within the endothelial 
cells (5,62). 
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Our biochemical experiments confirm that Fe+ cultured BBB-EC's are more easily 
damaged by exposure to an oxidizing system than Fe' cultured cells. However, after a brief 
(5 min) period of reoxygenation of hypoxic BBB-EC's we found a decreased adherence of 
granulocytes to Fe+ cultured cells, whereas adherence to Fe' BBB-EC's did not differ from 
that in nonnoxic controls (Fig. 6). Although this finding is in contrast to what we 
expected, previous studies on granulocyte adherence to endothelial cells exposed to hypoxia 
(and reoxygenation) also yielded conflicting results (47,60). 
In line with our results, Pietersma et al (22) found a decreased adherence of granulocytes 
to umbilical vene endothelial cells exposed to hypoxia. They showed that soluble factors 
which could reduce granulocyte adherence (e.g. NO, adenosine) were not elevated and 
hypothetically attributed their results to the absence of inflammatory mediators that are 
normally released from tissue surrounding the endothelial cells. 
On the other hand, Terada et al (60) show that ischemialreperfusion indeed increases 
granulocyte adherence to endothelial cells. However, they exposed cells for 48 h to 
hypoxia and 4 h of reoxygenntion prior to their tests. As shown in Fig. 1, increase in 
protein carbonyl groups is directly related to the duration of the exposure. In our opinion, 5 
min of reoxygenation will only yield minor changes, whereas 4 hrs of reoxygenation will 
probably result in more -if not extensive- cellular damage and concomitant granulocyte 
adherence. In fact, our results indicate that an increase in granulocyte adherence to BBB-
EC's may not occur until sufficient oxidative damage has been inflicted upon the cell 
(compare 46). This implies that both Fe' and Fe+ cultured cells in our experiments were not 
expected to show any change in granulocyte adherence. Interestingly, Fe+ cultured BBB-
EC's show a significant decrease in granulocyte adherence. This may be explained by the 
direct inhibitory effects of Fe" and Fe" on phospholipase A, (20,21). Tllis enzyme releases 
aracllidonic acid from phospholipids for the biosynthesis of leukotriene B, and PAF, which 
are potent activators of the inflammatory process (3,49,61). A reduction in PAF could 
concomitantly result in a decreased adherence of granulocytes (3). An elevated intracellular 
iron content could therefore initially suppress granulocyte adherence by inhibition of PAF 
synthesis. Prolonged reoxygenation however, might cause cellular damage with subsequent 
increase in granulocyte adherence. Further research will be necessary to gain more insight 
in the mechanisms underlying the adherence of granulocytes to BBB-EC's. 
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§ 9.1 Summal'Y. 
Iron dysregulation is thought to contribute to the oxidative damage seen in ncurodegcncraM 
five processes like Alzheimer's and Parkinson's disease. Oxidative stress may also 
contribute to the process of Ilormal aging, but the role of iron in this process is less clear. 
To better characterize the role of iron in normal aging, the concentrations of iron, 
transferrin, ferritin, and protein carbonyl groups are measured in nine separate regions of 
Fisher 344 rat brains. The largest (± 30%) age-related increase in brain iron concentration 
is seen in the temporal cortex, medial septum, and cerebellum. Ferritin concentration in the 
same brain regions increases 50 to 250% with age, while increase in protein carbonyl 
concentration is only -27 to +4% of that of young rats. These results indicate that an 
increase in the major iron-binding protein ferritin compensates for any age-reiated increase 
in iron concentration, and that the increased ferritin is cytoprotective and prevents the 
accumulation of protein carbonyl groups (the principal product of metal-catalyzed oxidation 
of proteins). 
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§ 9.2 Introduction. 
Iron is the most abundant trace element in the brain, essential in ceBular metabolism (e.g. 
fatty acid synthesis and DNA synthesis) and neurotransmitter synthesis and degradation (2) 
(chapter I). Iron transport and storage are tightly regulated processes, involving proteins 
(e.g. transferrin) with a high affinity for iron. It is thought that these proteins (at physiolo-
gical pH) prevent iron from acting as a catalyst in the formation of reactive oxygen species 
(13,15), whereas unbound (LMW) iron can readily promote the production of reactive 
oxygen species (5,11). 
Brain tissue is prone to oxidative damage due to its high concentration of poly unsaturated 
fatty acids (PUFA's) and reduced concentration of catalase (10,18) (discussed in chapter I). 
Oxidative damage occurs in specific brain regions in neurodegenerative diseases (19,23), 
but also nonspecifically in normal aging (4,16). Concomitantly, aging rat and human brains 
also display changes in the concentration and distribution of iron and iron binding proteins 
(7,17). 
In this study, experiments were performed to test the hypothesis that in rats specific brain 
regions display an altered iron status due to aging. For this purpose, the levels of iron, 
transferrin and ferritin were measured in nine separate brain regions of young and aged 
rats. Furthermore, protein carbonyl groups (the principal product of metal-catalyzed 
oxidations of proteins) were quantified in each region, to monitor possible changes in 
oxidative damage due to alterations in the regional iron status. 
§ 9.3 Materials and methods. 
§ 9.3.1 Materials. 
Young (4 month) and aged (24 month) Fischer 344 male rats were obtained from the 
National Institute on Aging colony at Harlan/Sprague-Dawley (Indianapolis, IN). Rats were 
housed in small groups, at 22 °C, with a photoperiod of 12 h per day. All rats had ad 
libitum access to water and Purina Laboratory Chow 500 I (Richman, IN). 
Materials: 
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§ 9.3.2 Methods. 
§ 9.3.2.1 Brain dissection. 
A detailed description of this technique can be found in § 2.9. Briefly, rats were anestheti-
zed, perfused with icecold PBS for 2:: 5 min and then decapitated. Brains were microdissec-
ted according to Cuello and Carson (8). Samples were obtained from the frontal cortex, 
medial septum, striatum, parietal mld temporal cortex, hippocampus, thalamus, cerebellum 
and brainstem. All sections were frozen immediately upon dissection and stored at _70°C 
until further processing. 
§ 9.3.2.2 Brain tissue preparation. 
Brain regions were thawed on ice and homogenized in 0.25 M sucrose containing 10 mM 
PMSF at a total volume of 60 fll/mg tissue weight. Aliquots were either kept on ice for 
immediate protein, transferrin, and ferritin determinations, or frozen at -20°C for subse-
quent iron determinations. 
Analogous brain regions were thawed on ice and sonicated in 0.0 I M Sodium Phosphate 
buffer (pH ~ 7.4), containing 0.1% Triton X-IOO. The sonicate was centrifuged (10 min, 
40000 x g, 4°C) and supernatants were used for protein and protein carbonyl determinati-
ons. 
§ 9.3.2.3 Transferrin and ferritin immllnosorbent assays. 
A detailed description can be found in § 2.4.3. Briefly, standards (transferrin and ferritin) 
and brain homogenates were applied to nitrocellulose membranes (in triplicate) as descri-
bed by Roskams and Connor (21). Following incubation with the primary antibody (rabbit 
anti-rat transferrin or rabbit anti-horse ferritin), membranes were incubated with 125r -goat 
anti-rabbit IgG. Membranes were then rinsed, dried and packed with film (15 h). Develo-
ped films were analyzed on a densitometer. 
§ 9.3.2.4 Total iron determinations. 
A detailed description can be found in § 2.5.2.8. Briefly, total iron concentrations in brain 
homogenate samples were determined using flame atomic absorption spectrophotometry 
195 
Iron and oxidative damage in aging in rat brain. 
following digestion with nitric acid for one week at 37°C. 
§ 9.3.2.5 Carbonyl determinations: biochemical assays and Westerll blots. 
Protein carbonyl concentration was detcrmined as outlined by Smith et al (24). The 
procedure is described in detail in § 2.5.2.10. Briefly, protein carbonyl groups were 
allowed to form hydrazone derivatives with 2,4 dinitrophenylhydrazine (2,4 DNPH). 
Following precipitation with trichloroacetic acid, these hydrazone derivatives were rinsed to 
remove unbound 2,4 DNPH. Samples were redissolved and read spectrophotometrically at 
367 nm. 
For Western blots, brain sample homogenates of 4 rats had to be pooled, in order to 
obtain sufficient quantities of protein for analysis. Samples were treated as outlined above, 
redissolved in SDS buffer and loaded on a 10% polyacrylamide gel. Following electropho-
resis, proteins were transferred to nitrocellulose and incubated with anti-dinitrophenyl 
antisera. Control lanes consisted of pooled samples that did not undergo derivitiz..'ltion with 
2,4 DNPH, but otherwise treated in the same manner. 
§ 9.3.2.6 Data allalyses. 
Data on regional concentrations of iron, transferrin, ferritin and protein carbonyl groups 
are expressed as mean ± SEM in both young (4 month) and aged (24 month) rat brains. 
Statistical significance between age groups for individual brain regions was determined 
using an unpaired T -test, and statistical significance among brain areas within either age 
group was determined using the Scheffe F-test, with p s 0.05 considered significant. 
§ 9.4 Results. 
§ 9.4.1 11'011. 
Regional brain iron concentration ranges between 0.39 ± 0.05 and 0.77 ± 0.09 Fe/mg 
protein (Fig. 1 A). \Vithin each age group, brain regions are divided into high, intermediate, 
and low iron concentration groups (Table 1). In the 4 month old group, iron concentration 
is highest in the frontal cortex and lowest in the medial septum, parietal cortex, striatum, 
and cerebellum. Intermediate iron concentrations, not significantly different from either the 
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Fig. IA and 1 B 
Levels of iron in nine separate brain regions of both young (black bars) and aged (gray 
bars) rats, expressed per mg protein (A),or per unit brain wet weight (B). Data are presen-
ted as mean ± standard error of the mean, with n = 6 for young rats and n = 8 for aged 
rats. An asterisk above a given brain region indicates the level of iron is higher in the aged 
group; with p <; 0.05 by an unpaired T-test. 
In the 24 month old group, iron concentration is highest in the brainstem, frontal and 
temporal cortex, and lowest in the striatum, medial septum, parietal cortex and hippocam-
pus. In this age group, intermediate iron concentrations (not significantly different from 
both the high and low iron group) are found in thalamus and cerebellum. 
In general, levels of brain iron (per rug protein) tend to be higher in the 24 month old 
group (Fig. I A), although this trend is significant only for the cerebellum and the medial 
sephllll. When expressed per unit wet weight (Fig. 1 B), iron concentrations in the temporal 
cOliex are also significantly different in the 4 and 24 month old groups. 
§ 9.4. 2 Ferritil/. 
Regional brain ferritin concentrations range between 0.060 ± 0.006 and 0.429 ± 0.032 fIg 
ferritin/mg protein (Fig. 2A). Within each age group, brain regions have been divided into 
high, intermediate, and low ferritin concentration groups (Table I). In the 4 month old 
group, ferritin concentration is highest in the frontal cortex, medial septum, and temporal 
cortex, and lowest in the striatum and cerebellum. Intermediate ferritin concentrations are 
found in the parietal cortex, thalamus, hippocampus and brainstem. Results in the interme-
diate group do not differ significantly from those in the high and low ferritin groups. 
In the 24 month old group, ferritin concentration is highest in the medial septum, 
intermediate in the frontal cortex, brainstem, and temporal cortex, and lowest in the 
striatum, parietal cortex, hippocampus, cerebellum, and thalamus. \Vithin the 24 month old 
group, the high, intermediate, and low ferritin concentration groups all differ significantly. 
\Vithin each brain region, ferritin concentration increases with age (Fig. 2A), and ferritin 
concentrations on the average are 1.7 times higher in the 24 month old group. This trend is 
significant in all brain regions except the hippocampus. 
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Fig. 2A and 2B 
Levels of iron-binding protein ferritin (A) and transferrin (B) in nine separate brain 
regions of both young (black bars) and aged (gray bars) rats. Data are presented as mean ± 
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standard error of the mean, with n = 6 for young rats and n = 8 for aged rats. An asterisk 
above a given brain region indicates the level of iron-binding protein is higher in the aged 
group; with p ,; 0.05 by an unpaircd T ·test. 
§ 9.4.3 Tram/errin. 
Regional brain transferrin concentrations range between 0.96 ± 0.05 and 8.80 ± 1.90 1-lg 
transferrin/mg protein (Fig. 2B). \Vithin each age group, brain regions have been divided 
into high, intermediate, and low transferrin concentration groups (Table 1). In the 4 month 
old group, transferrin concentration is highest in the frontal cortex, and lowest in the 
brainstem and parietal cortex. The transferrin concentration is intermediate in the temporal 
cortex, medial septum, cerebellum, thalamus, hippocampus, and striatum, and does not 
differ significantly from either the high or the low transferrin groups. 
In the 24 month old group, transferrin concentration is highest in the frontal cortex and 
lowest in the brainstem. Due to a large intra-regional variability, brainstem transferrin 
concentration is significantly lower only in comparison with the frontal cortex, striatum, 
hippocampus, and thalamus. Among the 24 month old group, transferrin concentration is 
considered intermediate in the temporal cortex, medial septum, parietal cortex, cerebellum, 
thalamus, striatum, and hippocampus. 
\Vithin each brain region, there is no significant effect of age on transferrin concentration 
(Fig. 2B). Although transferrin concentration tends to be slightly higher in 24 month old 
group than in 4 month old group, this trcnd is not significant in any brain region. 
§ 9.4.4 Protein carbonyls. 
Regional brain protein carbonyl concentration ranges between 1.88 ± 0.16 and 8.21 ± 0.49 
nmol/mg protein (Fig. 3). \Vithin each age group, brain regions have been divided into 
high and low protein carbonyl concentration groups (Table 1). In the 4 month old group, 
protein carbonyl concentration is high in the parietal cortex, cerebellum and frontal cortex, 
and low in temporal cortex, brainstem, thalamus, medial septum, hippocampus, and 
striatum. 
In the 24 month old group, protein carbonyl concentration is high for the parietal cortex 
and cerebellum, and low in the temporal cortex, brain stem, thalamus, striatum, frontal cor-
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tex, medial septum, and hippocampus. The effect of age on protein carbonyl concentration 
within each brain region is presented in Fig. 3. When compared to the 4 month old group, 
there is a 40% decrease in carbonyl concentration in the frontal cortex of the 24 month old 
group, while the carbonyl concentration of both the temporal cortex and hrainstem is 
slightly hut still significantly decreased in tillS group. The trend for decreased carbonyl 
concentration in parietal cortex is not significant (p .:-:;:; 0.08). 
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Fig. 3 
Levels of protein carbonyl groups in nine separate brain regions of both young (black 
bars) and aged (gray bars) rats. Data are presented as mean ± standard crror of the mean, 
with n = 6 for young rats and n = 8 for aged rats. An asterisk above a given brain region 
indicates the level of protein carbonyl groups are lower in the aged group; with p 5" 0.05 
by an unpaired T-tcst. 
Representative \Vestern blots of hippocampus, parietal cortex and cerebellum are shown in 
Fig. 4. A lack of nonspecific binding by the anti-dinitrophenyl antibody is clearly shown in 
the even numbered lanes, that contain brain samples not reacted with 2,4 DNPH (see § 
9.3.2.5). The protein c(lrbonyl staining pattern shows only minor changes between different 
regions and both age groups. 
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Fig. 4 
\Vestcrn blot staining protein carbonyl groups of sonicates of hippocampus (lanes 1, 2, 3, 
4), frontal cortex (lanes 5, 6, 7, 8), and cerebellum (lanes 9, 10, 11, 12). Lanes were 
loaded with 50 !J.g protein, pooled from 4 rats. Lanes 1, 2, 5, 6, 9, 10 are sonicates from 
young rats, while lanes 3, 4, 7, 8, 11, 12 are sonicates from aged rats. Even numbered 
lanes are control lanes containing pooled samples that did not undergo initial hydrazone 
derivitization, as outlined in materials and methods. Numbers in MW lane (between lanes 8 
and 9) are apparent molecular weights expressed in kD. 
§ 9.5 Discussion. 
In the present study, regional rat brain iron concentrations as determined by flame atomic 
absorption spectrophotometry, are in agreement with results in earlier studies (22,26). The 
highest brain iron concentration in young Fisher rats is found in the frontal cortex, while in 
aged rats iron concentration is highest in frontal cortex, brainstem and cerebellum. These 
ftndings do not correlate with prior colorimetric and histochemical studies in which the 
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basal ganglia, substantia nigra, deep cerebellar nuclei, and circumventricullar organs have 
the highest staining intensity (3,12,14). This lack of correspondance may reflect an 
averaging effect in the spectrophotometric (atomic absorption) method, where iron-rich 
cells are homogenized with iron-poor cells in a gross regional brain dissection. On the 
other hand, the disagreement could be the result of intrinsic differences in the various 
detection methods. Iron compounds visualized histochemically by the Perls' reaction 
include ferritin and other major iron storage compounds, whereas flame atomic absorption 
spectrophotometry of acid digested tissue homogcnates detects total tissue iron. These 
quantitative data suggest that lUallY brain regions may contain significant levels of iron that 
is tightly bound to enzymes and heme-containing compounds, and therefore undetectable 
with histochemical techniques. 
Results show an age-related increase in the iron concentration in several brain regions 
(Fig. fA), especially in the temporal cortex, medial septum and cerebellum. Tlris finding is 
consistent with previous work (21) reporting a 33% increase in total cortical iron in rats 
between the ages of 2.5 and 24 months. In that same study however, the highest brain iron 
concentration in aged rats as measured colorimetrically, was found in the cerebellum-pons 
region. TillS age-related increase in cerebellar iron concentration was correlated to the 
intense iron staining seen in oligodendrocytes and fibers of the deep cerebellar nuclei, and 
the increased iron staining of Purkinje cells and microglia in aged rats (3). 
Since the age-related increase in iron concentration does not appear to be unique to the 
cerebellum, the mechanisms of iron accumulation may also be more widespread within the 
brain. Indeed, in humans non-heme iron has been shown to increase from birth up to the 
age of thirty in several areas of the basal ganglia and cortex (12). Further iron increases 
(up to 80%) are seen in the substantia nigra, caudate and putamen of normal elderly hu-
mans, and excess iron depositions can be found in the globus pallidus in humans with 
Alzheimer's and Parkinson's disease (17). 
Next to an initial difference in iron concentration between the frontal, parietal and 
temporal lobe of the cortex in the young rat (Fig. IA) there is also a difference in age-
related changes in iron concentration in these regions. These findings suggest that cortical 
iron is differentially regulated at the regional level, as has been proposed for subcortical 
brain regions (6). 
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In the present ShIdy, certain areas (e.g. hippocampus) show no age-related changes in total 
iron concentration. However, in prior studies of rat hippocampal sections, histochemical 
staining showed that neurons throughout the granular and pyramidal layers contained iron 
in small vesicles that became more abundant in aged animals (3). It would therefore appear 
that although the hippocampal regions show no increase in iron with age biochemically, 
there may be a shift in neuronal iron stores in histochemically stainable iron. Tilis possible 
shift in neuronal iron stores may be significant. If loosely bound iron is more cytotoxic, 
aging neurons may be Illore susceptible to oxidative damage. A lllore detailed cellular 
analysis is needed to assess the significance to hippocampal neuronal vulnerability to 
oxidative damage. 
Ferritin concentrations in the present study (Fig. 2A) are lower than those reported 
previously in rats (21). This difference Illay be a result of using 125I-conjugated secondary 
antibody in the present study (instead of HRP-colljugated secondary antibody). The 
iodinated secondary antibody extends the linearity of the standard curve and increases the 
assay sensitivity at lower ferritin concentrations. 
Earlier semi-quantitative shldies in rats have shown that ferritin concentrations decrease in 
all brain regions from birth until weanling, after which ferritin concentrations begin to rise 
with no sigllificant regional differences in concentration (21). The 1.1 to 2.5 fold increase 
in regional brain ferritin concentration in the aged rats of this study is in agreement with 
reports on the two fold increase in ferritin concentration seen in all rat brain regions (21), 
and with the 1.7 to 10 fold increase in both heavy and light chain isoforms of ferritin seen 
in regions of human brain (7). 
The age-related increase in brain ferritin concentrations could not be detected in postmor-
tem brain samples of patients with Alzheimer's or Parkinson's disease (7). Since oxidative 
damage (probably) contributes to the lleurodegenerative changes seen in the latter disease 
(9), this finding supports the theory that ferritin is protective against iron-induced oxidative 
damage (I). 
Both young and aged rats show regional differences in brain transferrin concentration, and 
results show a consistent (but not significant) increase in regional transferrin concentration 
with age (Fig. 2B). Previous quantitative data on regional differences in rat brain trans-
ferrin levels are limited, but similar to those in the present study (21). 
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Regional differences in transferrin concentration may reflect variations in iron require-
ment. A minor increase in transferrin concentration over a prolonged period of time may 
therefore be of biological significance, contributing to the increase in total brain iron. 
However, because the age-related increase in transferrin is only a fraction of that in total 
iron, it appears that there is a general decrease in brain iron mobility with increasing age. 
Carbonyl groups (C~O) are normally present in proteins at a low level. Recent studies 
suggest that metal-catalyzed oxidation can induce the formation of carbonyls in proline, 
arginine, lysine, and histidine residues (24). Protein carbonyl concentrations may therefore 
indicate to what extent of oxidative stress proteins have been exposed. 
In the present study, protein carbonyl concentrations in the brain are of the same magnitu-
de as those reported previously in Mongolian gerbil brainstem and cortex (20) and human 
parietal and occipital cortex (23). In the 4 month old rats, highest levels of protein 
carbonyl concentration were found in cerebellum, frontal and parietal cortex (Fig. 3). \Ve 
found no pUblications on this subject with which to compare our results. On the other 
hand, Zaleska and Floyd (27) showed that lipid peroxidation was highest in the rat 
cercbeHum and cortex. Likewise, Subbarao and Richardson (25) demonstrated that rat 
cerebellum and amygdala have the highest endogenous peroxidative activity of eight brain 
regions. These data in. combination with our results suggest that the cerebellum and cortical 
regions have the highest oxidative activity, and may represent regions with increased 
susceptibility to oxidative damage. 
Contrary to prior studies in aged humans and gerbils (4,23), the present study in rats 
shows a significant decrease in protein carbonyl concentration in brainstem, frontal and 
temporal cortex. Possibly, these conflicting results represent a species-specific difference in 
susceptibility to oxidative stress. Another possibility is, that this discrepancy is caused by a 
difference in mode of storage of age related iron. As discussed before, a difference in 
mode of storage may lead to more or less oxidative damage. 
In summary, our results clearly show that different brain regions regulate iron concentrati-
ons independently. Moreover, regional increase in iron is accompagnied by a concomitant 
increase in ferritin. The decrease in protein carbonyl concentration with age in cerebellum 
and temporal cortex, despite a significant increase in total iron, supports the notion that 
ferritin is protective against oxidative stress. 
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Future studies on the mode of cerebral iron accumulation, e.g. iron increase with or wit-
hout concomitant increase in (iso)ferritin, may contribute to a better understanding of 
certain neurological disorders, e.g. Parkinson's and Alzheimer's disease. 
Table 1 
Brain regions organized according to relative concentrations of iron, ferritin, transferrin, 
and protein carbonyl groups, for both young (4 month) and aged (24 month) rats. 
(a) Brain regions in the high concentration group are significantly greater than those of the 
low concentration group (p :::; 0.05; Scheffe F-test); while those in the intermediate concen-
tration group do not differ significantly from either the high or low concentration groups. 
(b) Brain regions in the high concentration group are significantly greater than those of the 
intermediate concentration group, which are significantly greater than those of the low 
concentration group (p ~ 0.05; Scheffe F-test). 
(*) In the low concentration group of 24 month old transferrin, the braillstem is also 
significantly lower than the striatum, hippocampus, and thalamus of the intemediate 
concentration group (p ~ 0.05; Scheffe F-test). 
(#) In the high concentration group of 4 month old protein carbonyl rats, the parietal cortex 
is significantly greater than the cerebellum, which is significantly greater than the frontal 
cortex (p ~ 0.05; Scheffe F-test). 
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Age Relative concentration 
low intemlediate high 
Iron 4' Cerebellum Thalamus Frontal ctx 
Striatum Hippocampus 
Medial Sept. Temporal ctx 
Parietal ctx Brainslem 
24' Hippocampus Cerebellum Temporal ctx 
Parietal ctx llIalamus Frontal ctx 
Medial Sept. Brainstem 
Striatum 
Ferritin 4' Cerebellum Brainstem Temporal ctx 
Striatum Hippocampus Medial Sept. 
Thalamus Frontal ctx 
Parietal ctx 
24b Thalamus Temporal ctx Medial Sept. 
Cerebellum Brainstcm 
Hippocampus Frontal ctx 
Parietal ctx 
Striatum 
Transferrin 4' Parietal ctx Striatum Frontal clx 
Brainstem Hippocampus 
Thalamus 
Cerebellum 
Medial Sept. 
Temporal ctx 
24' Brainstem * Striatum Frontal ctx 
Hippocampus 
Thalamus 
Cerebellum 
Medial Sept. 
Temporal clx 
Parietal ctx 
protein carbo· 4' Striatum Parietal ctx # 
nyls Hippocampus Cerebellum 
Medial Sept. Frontal clx 
Thalamus 
Brainstem 
Temporal ctx 
24' Striatum Cerebellum 
Hippocampus Parietal ctx 
Medial Sept. 
Frontal clx 
'nJalamus 
Brainstem 
Temporal ctx 
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General discussion and conclusions. 
Discussion and conclusions. 
§ 10.0 Contents. 
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§ 10.4: Transferrin receptor distribution. 
§ 10.5: Endocytosis and trauscytosis. 
§ 10.6: Iron accumulation and susceptibility to oxidative stress. 
§ 10.7: Conclusions. 
§ 10.8: Future research. 
§ 10.1 Introduction. 
Iron is an essential clement in the cellular metabolism and depletion will result in 
malfunction and evenhtally cell death. Under certain circumstances, however, iron may also 
have deleterious eiIects on the cell. As a transition metal, free or low molecular weight 
iron (see § 1.6) is capable of catalyzing the formation of reactive oxygen species, causing 
damage to cellular DNA, proteins and lipids alike. Due to a tightly regulated system of 
transport and storage, these noxiolls effects of iron are largely prevented. 
In brain tissue, the margins between iron deficiency and iron overload are rather narrow. 
Although separated from the peripheral circulation by a highly selective barrier, brain 
tissue can be affected by both iron depletion and iron overload. Certain neurological 
diseases (e.g. Parkinson's disease) probably result from inappropriate intracerebral iron 
concentrations. Moreover, due to a high concentration of PUFA's and relatively low 
concentration of catalase, brain tissue is more susceptible to oxidative damage than most 
other tissues. 
Although recent investigations have established the regional distribution of iron in the 
central nervous system, both mechanism and regulation of iron transport into the brain are 
to a large extent unknown. Considering the presence of transferrin receptors on the luminal 
surface of brain capillary endothelial cells, and the large surface area of the brain capilla-
ries, it was assumed that these cells constitute the nporte d'entreen of iron into the brain. It 
was the purpose of this thesis to further investigate the mechanism and regulatory factors 
underlying this transport. 
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§ 10.2 Experimental model. 
The first and most important limitation to this study was the availability of fresh brain 
tissue. Ideally, we would have liked to conduct our experiments on freshly isolated human 
blood-brain barrier endothelial cells. However, as there is - for obvious reasons - only a 
limited availability of fresh human brain tissue, our experimental aims would have been 
severely restricted. Based on the expert opinion of Professor Voogd from the department of 
Neuroanatomy and Professor Stefanko from the department of Pathological Anatomy, it 
was decided to use porcine brain tissue as an alternative. This choice was mainly based on 
the gross anatomical similarity between the human and porcine brain. Moreover, by 
courtesy of Ivlr van der Zan and co-workers of the Rotterdamse Varkensslachterij, we had a 
nearly endless supply of fresh porcine brain and other tissues at our disposal. 
§ 10.3 Isolation and culturing techniqucs. 
A number of techniques have been described to isolate blood-brain barrier endothelial 
cells (BBB-EC's). Most of these techniques yield very limited quantities of BBB-EC's and 
require repeated passaging of cells to obtain sufficient material for experimental purposes. 
However, with each cell division the odds of functional dedifferentiation in culhlre will 
increase (l). Since BBB-EC's are highly specialyzcd barrier cells with a variety of 
selective transport mechanisms (e.g. transferrin receptors), it is conceivable that repeated 
passaging and concomitant dedifferentiation will affect or alter these mechanisms. In order 
to prevent (as much as possible) these effects, we only used primary cuihlres of BBB-EC's 
in our experiments with the exception of our morphological studies, in which we used first 
passage cells. 
l\1oreover, BBB-Ee's are a heterogeneous popUlation of cells (8) and we observed that 
repeated passaging altered the appearance of the cultures. This is probably due to differen-
ces in growth pattern and division rate between the different subtypes of BBB-EC's. Since 
the BBB-EC subtypes found in vitro are a reflection of the heterogeneity of these cells in 
vivo (4), all subtypes should be included when investigating typical BBB-EC functions 
(e.g. transport). Our primary cultures of BBB-EC's fulfilled this requirement. 
In general, working with living organisms and primary cultures increases the variability in 
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experimental results. To minimize these adverse effects: (i) we performed all experiments 
in the same growth phase of the cultures, and (ii) we increased the number of measuring 
points per experiment (§ 5.5). Since none of the existing isolation techniques yielded 
sufficient quantities of BBB-EC's, we developed an isolation teclmique with a sufficient 
yield of viable BBB-EC's to meet our experimental requirements. 
§ 10.4 Transferrin receptor distribution. 
As shown in chapter 5, BBB-EC's grown under standard culture conditions display two 
distinct populations of transferrin receptors (TfR's): (i) those located on the outer cell 
membrane, and (ii) TfR's located within the cell. The latter group can be subdivided into a 
group of TfR's that actively participate in the endocytic cycle, and another group that 
appears to be quiescent (inactive TfR pool). We hypothetized that this quiescent group of 
TfR's constituted in fact a reserve pool of TfR's that could be activated if the intracellular 
iron requirements increased. Results in chapter 6 confirm this hypothesis inasmuch that the 
BBB-EC's grown under iron-depleted (Fe') conditions have significantly more surface 
bound and intracellular TfR's than cells grown under iron-enriched (Fe') conditions. 
In neither Fe+ nor Fe- cultured BBB-Ee's quiescent TfR's could be detected. In case of 
the Fe- cultured cells it seemed that all TfR's from the quiescent pool were mobilized to 
participate in the endocytic cycle, thereby increasing the iron uptake capacity of the cell. 
However, the total amount of 'I'fR's in the Fe- cultured cells (Le. culturing in deferrioxami-
ne-enriched medium) is far less than that of BBB-EC's grown under standard culture 
conditions (see chapter 5). Since neither the isolation procedure nor the total TfR quan-
titation assay were changed, we have no explanation for this discrepancy other than a 
possible (toxic) effect of deferrioxamine. The decrease in total TfR's as found in the Fe+ 
cultured cells can easily be explained in the light of the IRE-model (see § 1.3.1.5.1). 
Assuming that the IRE-regulatory mechanism is valid for BBB-EC's, high intracellular 
concentrations would suppress TfR synthesis and reduce the total number of TtR's. 
However, we doubt whether the IRE-model is applicable to the BBB-EC iron metabolism. 
The IRE-model describes the interaction of a number of processes involved in the regulati-
on of iron uptake and storage. The intracellular iron concentration has a pivotal role in this 
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process, basically steering the system by negative feedback. However, as discussed before, 
BBB-Ee's probably participate in the transpOll of iron into the brain. Iron uptake by the 
BBB-Ee may therefore fulfill the intracellular iron requirements of the BBB-Ee itself, or 
those of other cell types in the brain. In the current concept of the IRE-model, a high intra-
cellular iron concentration in BBB-EC's would reduce iron uptake and block iron transport 
to the brain, which might be in contrast with their main function. OUf findings as described 
in chapter 6 and reports from in vivo observations (Le. hemochromatosis), show that iron 
transport across the blood-brain barrier is at least partially iron concentration dependent. 
§ 10.5 Endocytosis and tl'anscytosis. 
How does iron reach the brain? The limited number of studies on tlus subject have not yet 
elucidated the issue (3). On the contrary, although some investigators were able to trace 
peripherally administered transferrin (Tf) into the brain, others could not show transcytosis 
of Tf across the BBB-EC. This contradiction may result from differences in techniques 
applied in these investigations. Basically, three different techniques were used: 
(i) In vivo experiments in which 125I-labeled Tf was administered peripherally. Transferrin 
was indeed detected in the brain. However, these studies cannot exclude the possible 
Itleakage lt of Tf across those vesicles in the brain that lack a blood-brain barrier (see § 1.4). 
(ii) An in vitro experiment in which BBB-Ee's were grown on a porous membrane. Raub 
et al (6) used i25I-labeled Tf to show that only a small percentage of Tf crossed the BBB-
EC's. Again, intercellular leakage cannot be ruled out. 
(iii) An experiment by Roberts et al (7) who used horse radish peroxidase labeled Tf. 
Once administered peripherally, it was traced within the BBB-EC's, although no evidence 
of transcytosis was found. In our opinion, the horse radish peroxidase-Tf coupling 
procedure might have yielded a high percentage of apo-Tf (discussed in chapter 7). 
Our experiments, as described in chapter 6, show that BBB-EC's recycle Tf through 
receptor mediated endocytosis with recycling kinetics that are in agreement with those 
found in. other cell types. However, up to 40% of the internalized Tf was not rehnned to 
the luminal surface within 1 hour (± 4 x TouJ, indicating that some Tf molecules may be 
routed differently (Le. may be transc)10sed). In support of tIllS view, our morphological 
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experiments with gold-labeled Tf are suggestive for a transcytotic pathway through the 
BBB-EC. Electron migrographs revealed that: (i) gold-labeled Tf at the luminal membrane 
was located within coated pits, and (ii) addition of unlabeled diferric Tf completely 
blocked the binding and uptake of gold-labeled Tf. Combining (i) and (ii) we presume that 
nonspecific fluid phase endocytosis of gold labeled Tf is not a major mechanism (see 
chapter 7). 
\Ve also showed that BBB-Ee's can take up as well as release iron, even though iron 
uptake was considerably faster than iron release (see chapter 6). 
Together, these findings suggest that both receptor mediated endocytosis and receptor 
mediated transcytosis occur within the BBB-Ee, although we are not sure if and to what 
extent these processess are coupled. Indirect evidence of the transcytotic process was provi-
ded by Pardridge (see chapter 7), who showed that small pharmaceutical compounds 
coupled to OX-26 (anti-TfR immunoglobulins) could be retrieved within the brain compart-
ment. 
However, the issue of iron transport into the brain has not been solved yet. \Ve still have 
to quantify Tf transcytosis through the BBB-Ec' Based on the results of iron accumulation 
versus iron release, we estimate that transcytosis of Tf is relatively low when compared to 
receptor mediated endocytosis. Since the pathway of iron becomes obscure once it is 
released from Tf in the endosome, we cannot exclude the possibility of yet another iron 
transport mechanism in the BBB-Ee. On the other hand, we may have underestimated the 
release of iron from the BBB-Ee. Our BBB-Ee cultures are devoid of astrocytes, with 
which they are closely related in vivo. Recent shldies with co-cultures of BBB-Ee's and 
astrocytes showed that these astrocytes affect the barrier characteristics of BBB-Ee's. It is 
therefore conceivable that astrocytes influence or even pal1icipate in the iron transp0l1 
process. 
§ 10.6 Iron accumulation and susceptibility to oxidative stress. 
The prevalence of neurological diseases in which iron is implicated (e.g. Parkinson's 
disease), increases with age. As shown in chapter 9, the intracerebral iron concentration 
increases with age. The question is: are these two phenomena related? One might speculate 
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that certain neurological diseases are caused by a disturbance in the storage of iron, or that 
once a treshold level has been reached cells become intoxicated by iron. However, even 
more important is the question why the intracerebral iron concentration increases with age. 
It seems unlikely that an aged brain would require lUorc iron, considering that both 
metabolic rates and absolute cell number decrease with age. In our opinion, the age related 
increase in cerebral iron concentration is a result of an increased blood-brain barrier 
permeability, if not an increase in blood-brain barrier damage. 
In general, age related changes have been attributed to an increase in oxidative damage 
and there is 110 reason to assume the blood-brain barrier would be spared. On the contrary, 
as argued by Betz (2) (see also chapter 8) the BBB-EC is in fact a likely site for oxidative 
damage to occur. Oxidative damage may occur if two conditions are met: (i) the presence 
of reactive oxygen species (e.g. superoxide), and (ii) the presence of transition metals (e.g. 
iron). Xanthine oxidase, monoamine oxidase and mitochondria have been implied in the 
synthesis of reactive oxygen species, and all arc abundantly present in the BBB-Ee. As for 
transition metals i.e. iron, most intracellular iron is stored in transferrin and ferritin and 
therefore unable to exert its catalytic role in the formation of reactive oxygen species (e.g. 
hydroxyl radical). On the other hand, free (or LMW) iron can readily participate in the 
formation of reactive oxygen species. It would therefore seem that the nmobile" LMW or 
free iron pool, rather than the total iron concentration, will increase the susceptibility of the 
BBB-EC's to oxidative stress. 
It was Lauffer (5) who recently stated that people of the U\Vestern worldsu are at risk to 
develop diseases related to an increased iron concentration. A high dietary intake of iron-
rich animal proteins (see chapter 1) without a concomitant increase in iron loss would 
cause an elevated iron flux and could render us more susceptible to oxidative damage. As 
shown in chapter 8, BBB-Ee's grown under Fe+ conditions are more susceptible to 
oxidative stress than Fe- cells. This is in support of our experiments in chapter 6, showing 
that Fe+ BBB-Ee's accumulate and release more iron than their Fe' counterparts. It is 
conceivable that a prolonged Wgh dietary intake iron intake would lead to an increase in 
iron metabolism in the BBB-Ee's, This in turn would lead to a longlasting increase in 
oxidative stress which might affect these highly specialized barrier cells. This is in 
agreement with the histochemical results of chapter 8, showing that Fe+ grown BBB-Ee's -
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even without exposure to an oxidizing system- seem to have more protein carbonyl groups 
than their the Fe' cultured cells, Moreover, this increase in protein carbonyl groups (as 
indicator for increased oxidative damage) appears to be focussed in the plasma membrane 
of these cells. 
Experimental results in chapter 9 show that although there is a general increase in cerebral 
iron concentration with age, there is no concomitant increase in protein carbonyl groups. 
\Vc attributed this to a protective effect of ferritin, which increased concomitantly with the 
iron concentration. On the other hand, it might also be a species (Le. rat) related phenome-
non, since other shldies have shown that human brain tissue displays an increase in lipid 
peroxidation products with age. 
Evidence of increased susceptibility to oxidative stress in vitro is not yet proof for an 
increased permeability of the blood-brain barricr to iron in vivo. Nevertheless, we suggest 
that in vivo an elevated peripheral iron concentration may contribute to an increase in 
ccrebral iron concentration. This may be due either to blood-brain barrier leakage as a 
result of oxidative damage (chapter 8), or to an iron concentration dependent increase in 
iron uptake (as shown in chapter 6). 
§ 10.7 Conclnsions. 
Based on the experimental results presented in this thesis, we conclude that: 
(i) BBB-EC's participate in the transport of iron to the brain, although the mechanism(s) 
have not yet been completely elucidated. 
(ii) Receptor mediated endocytosis of Tf takes places at the luminal membrane of the 
BBB-EC, and internalization as well as externalization rate constants are similar to those 
found ill other cell types. 
(iii) BBB-EC's can both acculllulate and release iron. This process partly depends on the 
peripheral iron concentration: Fe+ cultured BBB-EC's accumulate more iron than Fe' 
cultered cells. 
(iv) Receptor mediated transcytosis of Tf -as based on ultrastmchlral evidence- may occur 
within the BBB-EC as part of the total iron transport mechanism. 
(v) BBB-EC's grown in iron-enriched culture medium are more susceptible to oxidative 
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stress compared to iron-depleted cells. In fact, even without being exposed to an oxidizing 
system, Fe+ grown BBB-Ee's display minor histochemical changes. 
(vi) Age related intracerebral iron increase will not always lead to an increase in oxidative 
damage. A protective effect of ferritin, Of a species related difference in susceptibility 
might be of influence. 
§ 10.8 Future research. 
As always, experimental results yield more questions than answers. In general, this thesis 
describes certain aspects of the iron transport into -and possibly through- the BBB-EC. 
Unfortunately, we have not been able to elucidate the intracellular pathway of iron within 
these cells. Over the years, the issue of iron transport into the brain has been debated 
without reaching a conclusion and additional work will be needed to solve this enigma. 
Based on our findings, we propose that fuhue research in tIus field should include: 
(i) Confirmation and quantification of receptor mediated transcytosis of Tf through the 
BBB-EC. 
(ii) Studies on the iron uptake and release of BBB-EC's co-cultured with astrocytes. 
(iii) Further investigations into the regulation of iron metabolism in the BBB-EC. Is the 
IRE-model applicable to this process? 
(iv) In vivo quantification of oxidative modifications of BBB-EC's. \Vhat effects of 
prolonged increase in peripheral iron concentration (e.g. hemochromatosis) can be observed 
at the blood-brain barrier? Is age and/or disease related cerebral iron increase a cause or a 
result of changes in blood-brain barrier permeability? 
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§ 11.0 Contents. 
§ 11.1: Summary. 
§ 11.2: Samenvatting. 
§ 11.1 Summary. 
Iron is a trace element vital to nearly all living organisms. However, in certain circum-
stances iron may also have deleterious effects. This duality is clearly displayed in brain tis-
sue. A decrease in cerebral iron concentration is associated with reduced cognitive 
fUllctions, whereas an increase in iron concentration can be found with age and in a 
number of neurological diseases (e.g. Parkinson's disease). Although recent studies did 
establish the overall distribution of iron in the brain, the mechanism and regulation of iron 
transport into the brain are largely unknown. 
Brain tissue is separated from the peripheral circulation by the blood-brain barrier, a 
highly selective barrier that controls the transport of most solutes into and out of the brain. 
The endothelial cells that constitute this barrier display a large number of transferrin recep-
tors on their luminal cell surface, suggesting that these cells are involved in the transport of 
iron into the brain. 
Tllis thesis describes the results of a study on the mechanism and regulatory aspects of 
iron transport across the blood-brain barrier endothelial cells. During our investigations, the 
following issues were addressed: 
(i) Can iron enter the brain via the blood-brain barrier endothelial cells? 
(ii) Which mechanism is responsible for the transport of iron across the blood-brain 
barrier? 
(iii) Does the blood-brain barrier endothelial cell adjusts its iron metabolism in response 
to changes in the extracellular iron concentration? 
(iv) To what extent will high iron concentrations affect the stmcture and function of the 
blood-brain barrier endothelial cell? 
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Chapter 1: 
This chapter summarizes the current views on: 
(i) Function and distribution of iron. 
(ii) Mechanisms of iron uptake and storage. 
(iii) Regulatory aspects of iron uptake. 
(iv) Stmcture and function of the blood-brain barrier. 
(v) Iron uptake, storage and distribution in the brain. 
(vi) Iron and oxidative damage. 
Chapter 2: 
All techniques that contributed to the experimental results presented in tIus thesis, are 
described in this chapter. 
Chapter 3: 
For our experiments, we required porcine transferrin with a high (z 99%) degree of 
purity. Tllis chapter describes the isolation, purification and structural characterization of 
porcine transferrin and hcmopexin. 
Chapter 4: 
Ferritin is the major iron storage protein in mammalian tissues. In native polyacrylamide 
gel electrophoresis purified ferritins from different species all yielded two distinct bands, 
440 and 660 kDa respectively. In tltis chapter we summarize the results of the isolation, 
purification and partial characterization of the two porcine ferritins. 
Chapter 5: 
In tius chapter we describe a lugh yield isolation procedure to obtain from fresh porcine 
brain tissue nearly pure (as tested with anti Von \Villebrand factor immunoglobulins) bat-
ches of blood-brain barrier endothelial cells. Furthermore, we investigated the distribution 
of transferrin receptors in primary cultures of these cells. Three different transferrin 
receptor pools were detected and quantified. 
In addition, the results of a standard biochemical technique to assess nonspecific binding 
223 
Summary - samenvatting. 
of transferrin were compared to estimates of nonspecific binding derived from a nonlinear 
curvefit analysis of the experimental data. 
Chapter 6: 
To test whether blood-brain barrier endothelial cells adjust their iron metabolism in 
response to variations in the extracellular iron concentrations, primary cultures were 
subjected to either iron-enriched or iron-depleted culture conditions. Tllis chapter gives an 
overview of the effects of changes in extracellular iron concentration on: (i) numbers of 
surface bound and intracellular transferrin receptors, (ii) rate constants of transferrin recep-
tor internalization and externalization, and (iii) rates of iron accumulation and release. It is 
shown that despite a down regulation of surface and total transferrin receptor numbers, the 
rates of iron accumulation and release are related to the extracellular iron concentration. 
Chapter 7: 
Primary and first passage cultures of blood-brain barrier endothelial cells were grown on 
various types of porous membranes. In this chapter we demonstrate that the ultrastnIctural 
appearance of these ceHs was similar on all membrane types. Minor differences were 
observed between cells derived from either primary or first passage cultures. 
In addition we describe the results of histochemical experiments with first passage blood-
brain barrier endothelial cells incubated with 6.6 Illn gold-labeled transferrin. The pathway 
of these gold-transferrin conjugates within and through the cell is visualized by means of 
electron microscopy. Results are suggestive for a receptor mediated transcytosis of 
transferrin through the blood-brain barrier endothelial cell. 
Chapter 8: 
Since blood-brain barrier endothelial cells grown under iron-enriched conditions accumula~ 
te more iron than cells grown under iron-depleted conditions, we hypothetized that iron-
enriched grown cells are more susceptible to oxidative stress. In tllis chapter, a new 
immunochemlcal technique is presented to visualize the amount of oxidative damage in cell 
cultures. As described, both biochemical and immunochemical experiments show that iron-
enriched cultured cells are more susceptible to oxidative stress. 
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In addition we measured the adherence of granulocytes to the blood-brain barrier 
endothelial cells following 2 hours of ischaemia and a 5 min period of reoxygenation. 
Results show that the adherence of granulocytes to cells grown in iron-enriched cultures is 
reduced. A suppressive effect of increased intracellular iron concentration on phospholipase 
A2 is speculated. 
Chapter 9: 
As known from studies in human brain tissue, both the iron concentration and the 
concentration of products resulting from oxidative damage increase with age. In this 
chapter we show that 24 month old rats display a significant increase in total iron and 
ferritin concentration in several brain regions when compared to 4 month old rats. 
However, oxidative damage as assessed by the alllount of protein carbonyl groups, did not 
increase concomitantly. This is attributed to a protective effect of the increase in ferritin 
and/or a species related difference in susceptibility to oxidative stress. 
Chapter 10: 
In this chapter we consider the results of previous chapters in relation to their significance 
in vivo. Although recent studies have shown that certain neurological diseases are 
accompagnied by high intracerebral iron concentrations, to date there is only limited 
knowledge on the role of the bloodRbrain barrier in these processes. Our results indicate 
that high peripheral iron concentrations may affect the intracerebral iron concentration both 
directly (uptake and release related to the iron concentration) and indirectly (increased 
susceptibility to oxidative stress). 
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§ 11.2 Samellvatting. 
Ijzer is als spore-element van levensbelang voor bijna aile levende organismen. In 
bepaalde omstandigheden kan ijzer cchter ook schadelijke effecten hebben. Dit dualisme 
komt duidelijk naar voren in de hersenen. Er is een associatie tussen een verlaagde 
ijzerconcentratie in de hersenen en afgenomen cognitieve functies, tenvijl een verhoogde 
ijzereoncentratie gevonden kan worden bij veroudering en bij een aantal neurologisehe aan-
doeningen (bijv. ziekte van Parkinson). 
Hoewel recente studies een duidelijk beeld hebben opgeleverd van de ijzerverdeling in de 
hersenen, is er nog niet veel bekend over het transport van ijzer naar de hersenen en de 
wijze waarop dit geregeld wordt. Hersenweefsel is van de perifere eirculatie gescheiden 
door de bloed-hersen barriere. Deze zeer selectieve barriere regelt het transport van de 
meeste wateroplosbare stoffen van en naar het hersenweefsel. De feitelijke barriere wordt 
gevormd door endotheel cellen die de wanden van de eapillairen in de hersenen bekleden. 
Deze cellen bevatten cen groot aantal transferrine reeeptoren op het luminale celoppervlak, 
hetgeen erop zou kunnen duiden dat de bloed-hersen barriere endotheel eellen betrokken 
zijn bij het ijzer transport naar de hersencn. 
Dit proefschrift beschrijft de resultaten van een onderzoek naar het mechanisme van het 
ijzertransport naar de hersenen via de bloed-hersen barriere endotheel cellen. In ons onder-
zoek komen de volgende vraagstukken aan de orde: 
(i) Kan ijzer de hersenen bereiken via de endotheel cellen van de bloed-hersen barriere? 
(ii) \Velk mechanisme is verantwoordelijk voor het transport van ijzer over de bloed-
hersen barriere? 
(iii) Past de bloed-hersen barriere endotheel eel zijn ijzermetabolisme aan onder invloed 
van veranderingen in de extracellulaire ijzerconcentratie? 
(iv) In hoeverre worden de structuur en functie van de bloed-hersen barriere endotheel eel 
aangetast door hoge ijzerconcentraties? 
Hoofdstuk l: 
In dit hoofdstuk worden de huidige illZichten over de volgende onderwerpen samengevat: 
(i) Functie ell verdeling vall ijzer ill het lichaam. 
(ii) MechanisIl1en voor ijzeropname en opslag. 
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(iii) Regulatie van ijzeropname. 
(iv) Struchmf en functie van de bioed hersen barriere. 
(v) Opname, opslag en verdeling van ijzer in de hersencll. 
(vi) IJzcr en oxidatieve schade. 
Hoofdstuk 2: 
In dit hoofdstuk worden aile technieken beschreven die een rol gespeeld hebben bij de 
totstandkoming van dit proefschrift. 
Hoofdstuk 3: 
Zeer zuiver (;::: 99%) varkenstransferrine was voor OIlze experimcnten cen absolute 
noodzaak. Dit hoofdstuk beschrijft de isolatie, zuiverillg en karakterisering van de stmktuur 
van varkenstransferrine en Rhcmopexinc. 
Hoofdstuk 4: 
Ferritine is het belangrijkste eiwit voar de ijzer opslag in zoogdieren. Gezuiverd ferritine 
van verschillende diersoorten bleek in natieve palyacrylamide gel electroforese twee apartc 
banden te geveu, met een molecuul lllassa van respectievelijk 440 ell 660 kDa. Dit 
hoofdstuk vat de resultaten samen van de isolatie, zuivering en gedeeltelijke karakterisering 
van de twee subtypen varkensferritine. 
Hoofdstuk 5: 
In dit hoofdstuk beschrijvcll we de isolatie van bloed-hersen barriere endotheel cellen uit 
vers herscnweefsel. De procedure zoals beschreven gaf een hoge opbrengst aan cellell van 
dit type. Verontreiniging met andere celtypen was miniem. zoals bleek uit testen met 
immunoglobulinen gericht tegen de Von Willebrand factor. 
In primaire kweken van bloed~hersen barriere endotheel cellen onderzochten we voorts het 
voorkomen en de verdeling van transferrine receptoren. Drie verschillende transferrine 
receptor "pools!! konden worden onderscheiden, die elk werden gekwantificeerd. 
De resuItaten van de receptor-bindingsexperimenten werden geanalyseerd met behulp van 
een wiskundig computerprogranuua. De aldus verkregen schartillg van de aspecifieke 
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binding werd vergeleken met het resultaat verkregen uit standaard biochemische tech-
nieken. 
Hoofdstuk 6: 
Primaire cellijnen werden gekweekt in ijzerverrijkt of ijzerarm medium om te onderzoeken 
of bloed-hersen barriere endotheel cellen hun ijzermetabolisme aanpassen onder invloed 
van verandcringen in de ijzerconcentratie. Dit hoofdstuk geeft cen overzicht van de effecten 
die veranderingen in de extracellulaire ijzerconcentratie hebben op: (i) het aantal trans-
ferrine receptoren in de cel en de aan het celoppervlak gebonden receptoren, (ii) de 
snelheid van endocytose en exocytose van de transferrine receptor en (iii) de snelheid 
waannee en de mate waarin ijzer gestapeld en afgegeven wordt. 
\Ve Iaten zien dat, ondanks een afname zowel in het aautal oppervlakte receptoren als in 
het totaal aantal transferrine receptoren, de mate van ijzerstapeling en ijzerafgifte afllan-
kelijk is van de extracellulaire ijzerconcentratie. 
Hoofdstuk 7: 
Primaire en eerste passage cultures van bloed-hersen barriere endotheel cellen werden 
gekweekt op verschillende soorten poreuze membranen. Zoals dit hoofdstuk laat zien, is de 
ultrastmcturele morfologie van deze cellen onafhankelijk van het type membraan waarop 
gekweekt is. \Ve zagen slechts kleine verschillen in uitrastmctuUf tussen cellen in primaire 
cuihues en na een passage. 
Verder beschrijven we de resultaten van experimenten met eerste passage bloed-hersen 
barriere endotheel cellen ge'incubecrd met 6,6 1m} goud gelabeld transferrine. Met behulp 
van het elcctronenmicroscoop werd de weg die dit goud-transferrine complex aflegt in de 
eel zichtbaar gemaakt. De resultatcn suggereren dat receptor gemedieerde transcytose van 
transferrine door de bloed-hersen barriere endotheel eel kan plaats vinden. 
Hoofdstuk 8: 
\Ve veronderstelden dat ijzcrverrijkt gekweekte bloed-hersen barriere endotheel eellen 
gevoeliger zijn voor oxidatieve stress, omdat deze cellen meer ijzer stapelen dan cellen die 
in ijzerarme omstandigeheden gekweekt werden. In dit hoofdstuk wordt een nieuwe 
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immunochemische tcchniek beschreven om het verschil in oxidatieve schade in celkweken 
zichtbaar te maken. Zoals aangetoond in zowel biochemische als iuullunochcmische 
experimenten blijken cellen geJ..·weekt in ijzerverrijkte omstandighedcll inderdaad gevoeliger 
voor oxidatieve stress. 
Daarnaast werd de hcchting van grallulocyten aan de bloed-hersen harriere endotheel 
cellen gcmetcn. In deze experimenten werden de cellen gedurende twee uur aan ischacmie 
en vervolgclls 5 minuten aan reoxygenatie blootgesteld. De resultaten latcn zien dat de 
hechting van granulocytcn aan die cellen, die gekweekt zijn in ijzerverrijkte omstandighc-
den, verlaagd is. Mogclijk is deze venninderde hechting te wijten aan het fcit dat cell hogc 
intraceHulaire ijzerconcentratie de a"-1iviteit van het fosfolipase A2 kan onderdrukken. 
Hoofdstuk 9: 
Onderzoeken in humaan hersenweefsel tonen aan dat de concentratie zowel van ijzer als 
van produkten die ontstaan door oxidatieve schade toenemen met de leeftijd. In dit 
hoofdstuk vergelijken we 24 maanden oude ratten met 4 maanden oude soortgenoten. De 
ondere ratten vertonen cen duidelijke toename van zowel de totaal ijzer als de ferritine 
concentratie in enkele gebieden in de hersenen. De mate van oxidatieve schade, vastgesteld 
aan de hand van de hoeveelheid carbonyl groepell in eiwitten, nam echter niet evenredig 
hiennee toe. Dit effect is mogelijk het gevolg van een beschermende werking van het 
ferritine, of weI een species gerelateerd verschil in gevoeligheid voor oxidatieve stress. 
Hoofdstuk 10: 
In dit hoofdstuk overwegen we de implicaties van de resultaten van ons in vitro onderzoek 
voor de situatie in vivo. Hoewel reeente onderzoeken hebben aangetoond, dat bepaalde 
neurologische aandoeningen gepaard gaan met hoge ijzerconcentraties in de hersenell, is er 
tot op heden slechts weinig bekend over de rol van de bioed-hersen barriere in dit verband. 
\Ve concIuderen uit onze resultaten dat hoge concentraties perifeer ijzer van invloed kunnen 
zijn op de ijzercollcentratie in de hersenen, zowel direct (opname en afgifte gerelateerd aan 
de ijzerconcentratie) ais indirect (toegenomen gevoeligheid voor oxidatieve stress). 
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Dankwoord. 
Dit proefschrift kwam tot stand met de hulp van velen en ik wil op deze plaats dan ook 
graag iedereen bedanken die er zijn of haar steentje aan heeft bijgedragen. Zonder deze 
"vel en" tekort te willen doen, zijn er een aantal mensen die ik met name wil bedanken voor 
hun illzet en steun. 
Henk, hooggeleerde promotor, je stond altijd klaar met goede raad als een experiment niet 
wilde lukken, of de kindcren weer eens stecht geslapen hadden. Je inzet voor studenten en 
AlO's kent zijn weerga niet en krijgt -ten onrechte- niet de waardering die het verdient. Ik 
zie uit naal' de concerten die we gezamenlijk nog zullen bezoeken. 
Maud. je kritische blik en vermogen tot helder formuleren hebben dit proefschrift 
(hopelijk) tot een begrijpeJijk geheel gemaakt. Met veel genoegen denk ik terug aan het 
utlmiswerken" in Stolwijk en ik hoop het nog vaak te bezoeken (maar dan niet om te 
werken). 
Marja, zonder jou had ik al dit werk niet kunnen doen. Je onvermoeibare inzet -ook buiten 
kantooruren- je efficiente werkwijze en oog voor details laten zich aileen met superIatieven 
beschrijven. Ik zal onze "ontbijten" missen, ook alliggen varkenshersenen soms wat zwaar 
op de maag. 
Prof. Koster, Hans, am de een of andere reden liepen onze gesprekken altijd uit en was 
het eigelllijke onderwerp al snel uit het oog veri oren. Je brede kennis en beiangstelling, 
alsmede je kritische kijk op experimentele procedures en resultaten hebben me vaak op de 
goede weg geholpen, of de relativiteit van mijn inspanningen laten zien. 
Hans van Dijk, aan jou dank ik mijn inzichten op het gcbied van de receptor kinetiek en 
niet-lineaire curvefits. Nel (leerde mij pipetteren), \Vim, Martin, Linda en Ben dank ik voor 
aile hulp en gezelligheid in de afgelopen jaren. Mijn collega-AIO's Peter en Christel wens 
ik veel sterkte en Peter, nu heb je eindelijk wat rust op het lab. 
De leden van de lezerscommissie dank ik voor de snelle beoordeling van het manuscript. 
Ashraf en CIU'is dank ik voor al het werk wat ze voor mij gedaan hebben en ik wens ze 
succes met hun verdere carriere. Peter van Run, Tar Van as en Ann Langeveld dank ik 
voor de mooie I1plaatjes" die dit proefschrift sieren. 
Dhr van der ZOIl, John, Kees, Cor (Piukkie), Marcel, Hans en vele anderen van de 
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Rotterdamse varkellsslachterij dank ik voor al die kercn dat ze mij vers varkenshersenweef-
sel gaven. 
Dr Connor, Jim, I would like to thank you for your hospitality and support during my stay 
at your lab. Hopefully, we'll meet next year. 
De mceste dank ben ik echter verschuldigd aan mijll vrouw \Vilma. Je onvoorwaardelijke 
steun en begrip, ais de cellcll weer cens etcn 1110esten hebbcll of cen experiment wat 
uitliep, hebben het mij mogelijk gemaakt dit onderzoek te verrichten. Dit proefschrift draag 
ik dan ook op aan jon en onze beide ZOOI1S, Jasper en Bart. 
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